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ABSTRACT OF THE DISSERTATION 
 
The Dynamics of Human and Rattlesnake Conflict in Southern California 
 
by 
 
Aaron Grant Corbit 
 
Doctor of Philosophy, Graduate Program in Biology 
Loma Linda University, September 2015 
Dr. William K. Hayes, Chairperson 
 
Human-rattlesnake conflict occurs when rattlesnakes are discovered in 
human-dominated areas and are deemed to pose an unacceptable risk to humans 
because of their venomous bite. In this dissertation, I investigated the nature of 
this conflict from the perspectives of both the behavioral and survival risks posed 
to rattlesnakes and the medical risks posed to humans. In the first of three studies, 
I investigated the effects of short- and long-distance translocation (SDT and LDT) 
of nuisance wildlife as a way of mitigating conflict between humans and naturally 
occurring Red Diamond Rattlesnakes (Crotalus ruber) near residential 
development in southern California. Snake activity ranges and risk of moving 
near human-modified areas were larger for LDT and SDT snakes than for non-
translocated snakes. Snakes moved closer to human-modified areas and required 
translocation more often during the summer. Snakes translocated greater distances 
were less likely to return to human-modified areas, and translocation did not 
affect snake survival. In the second study, I investigated the etiology and severity 
of human envenomations using a retrospective review of 354 snakebite cases 
admitted to Loma Linda University Medical Center between 1990 and 2010. Male 
snakebite victims and those using alcohol or drugs were more likely to sustain 
 xviii 
bites to the upper extremity, distal to the ankle or wrist, and via illegitimate 
provocation of the snake. Snakebite severity was positively associated with snake 
size, negatively associated with patient mass, and independent of patient age, 
snake taxon, anatomical location of bite, legitimate versus illegitimate (provoked) 
bites, and time until hospital admission. Effectiveness of CroFab antivenom was 
similar for all southern California venomous snake taxa. In the final study, using 
the same medical data, I assessed the usefulness of several factors as predictors of 
overall snakebite severity, symptom progression, and antivenom use. Initial 
snakebite severity score, size of the envenoming snake, and patient mass were 
significant predictors. I suggested several rules of thumb that could help clinicians 
anticipate antivenom needs. Overall, this dissertation contributes to our 
understanding of the effects of mitigation translocation on rattlesnakes and the 
epidemiology and clinical management of venomous snakebite in southern 
California.  
 
 1 
CHAPTER ONE 
INTRODUCTION 
Human-Wildlife Conflict 
To say that humans and wildlife are in conflict is somewhat of an understatement. 
We, as humans, dominate almost every ecosystem on the planet (Vitousek et al. 1997). 
We directly impact between 75–83% of the Earth’s land (Sanderson et al. 2002; Ellis & 
Ramankutty 2008) and significantly impact 96% of the world’s oceans (Halpern et al. 
2008). Our impact has generally not been a positive one with 338 known vertebrate 
extinctions since the year 1500 (Ceballos et al. 2015) and many more species 
experiencing serious population declines (Butchart et al. 2010) largely due to 
anthropogenic forces like habitat destruction, overexploitation, pollution, human war and 
conflict, and global climate change (Chivian & Bernstein 2008).  
However, the ways in which humans negatively impact wildlife populations is 
generally not what is meant by the term human-wildlife conflict in the scientific 
literature. Rather, the reverse is meant with the term largely referring to situations were 
wildlife negatively impacts (or has the potential to impact) humans (Peterson et al. 2010). 
Different species may affect humans in different ways, however, common motifs involve 
herbivores impacting food crops, carnivores impacting human safety, or meso-mammals 
(e.g. raccoons) causing property damage (Peterson et al. 2010). The term human-wildlife 
conflict itself has been criticized because, given the definition the term conflict, it implies 
the incorrect notion of wildlife as a conscious human antagonists. The real conflict, it is 
argued, is between human groups who may advocate competing agendas, for example, 
groups advocating species conservation vs. those attempting to expand or preserve 
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livelihoods or economic interests. Thus, human-wildlife conflict involves two aspects— 
human-wildlife impacts, which involve the negative impacts of wildlife on humans, and 
human-human conflicts between those wishing to conserve and protect wildlife and those 
with competing interests and attitudes (Peterson et al. 2010; Young et al. 2010; Redpath 
et al. 2014). 
Human-Rattlesnake Conflict: Snakebite 
Both of these aspects of human-wildlife conflict are evident in the case of 
rattlesnakes. The human-wildlife impact of rattlesnakes fits the common motif of a 
carnivore impacting human safety. In United States, rattlesnakes often come in contact 
with people (Nowak & Riper 1999; Mccrystal & Ivanyi 2008) and even though public 
perception of the risk posed by venomous snakes (including rattlesnakes) may be inflated 
(Hardy et al. 2001; Gibbons & Dorcas 2002), they do represent a legitimate medical risk. 
Rattlesnake envenomation can cause potentially life-threatening hematotoxicity and 
neurotoxicity, as well as significant local soft tissue damage that can result in long-term 
physical and emotional morbidity (Dart et al. 1992; Smith & Bush 2010; Williams et al. 
2011) and significant financial cost (Corneille et al. 2006). However, in the U.S. and 
Canada, this risk is mitigated by a fully modernized health care system. Although some 
2,683–3,858 venomous snake envenomations occur annually in the U.S., only 5–7 deaths 
are reported (Kasturiratne et al. 2008). 
Many factors can influence the risk of snakebite, including those that relate to the 
snake and those that relate to the human (Hayes & Mackessy, 2010). In terms of the 
snake, hospital-based studies have consistently shown that larger snakes tend to cause 
more severe bites (Wingert & Chan 1988; Hayes et al. 2005; Janes et al. 2010; see also 
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Hackett et al. 2002) because they inject larger quantities of venom (Hayes 1991; Hayes 
2008). However, the idea that more provoked snakes deliver more venom, and therefore a 
more severe bite, has had mixed support, especially for rattlesnakes (Herbert 1998; 
Rehling 2002). Venom composition, which varies with ontogeny and among populations 
and taxa, also affects clinical severity (Hayes & Mackessy 2010; Massey et al. 2012). In 
terms of the human victim, evidence supporting the suggestion that smaller patients tend 
to have more severe bites has also been mixed. While some studies have supported this 
contention (Hayes et al. 2005; Pinho et al. 2005), others have failed to detect this 
relationship (Parrish et al. 1965; Janes et al. 2010). Bite severity might also be influenced 
by site of the bite, dictated largely by human behavior (Wingert & Chan 1988; Moss et al. 
1997; Tanen et al. 2001); presence of clothing (Herbert & Hayes 2009); general health 
(Tanen et al. 2001; Benítez et al. 2007; Ribeiro et al. 2008); delay to treatment (Pinho et 
al. 2005; Michael et al. 2011; Paul & Dasgupta 2012; Saravu et al. 2012); and the 
treatment itself. 
Physicians who treat snakebite have varying levels of education and experience 
regarding proper treatment. For the most part, they must rely on expert advice provided 
during their course of training or continuing education. Many rely entirely on one or two 
key sources of information, which include: 1) the product package insert for CroFab or 
Anavip, the two currently approved medications (antivenoms) for treatment of North 
American viperid envenomations; and 2) authoritative reviews that provide an algorithm 
for treatment, such as Lavonas et al., (2011). These sources of information are generally 
based on the best available clinical research. However, advances continue to be made in 
snakebite treatment, and room exists for improvement. 
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One key research tool has been the development of the snakebite severity score 
(SSS). This scoring method was developed by Dart et al. (1996) and scores bite severity 
from 0–20 points based on the objective evaluation of clinical parameters in six 
categories: local wound effects, hematologic (coagulation) parameters, and symptoms 
associated with the pulmonary, cardiovascular, gastrointestinal, and central nervous 
systems. The scores for each of these categories, which range from 0–3 or 0–4 are 
evaluated separately and then summed to obtain a final score. Higher SSS scores indicate 
a more severe bite. This tool has been used to glean important information regarding 
treatment options, and to provide a better understanding of the factors that contribute to 
snakebite severity. As examples, SSS has been used to assess the effect of anatomical bite 
location on clinical severity (Moss et al. 1997), to assess the effectiveness of CroFab in 
children (Offerman et al. 2002), to assess the effects of the size of the envenoming snake 
on bite severity (Janes et al. 2010) and recently to compare the incidence of late 
coagulopathy in patients treated with CroFab versus the recently FDA approved 
antivenom (Anavip; Bush et al., 2015). 
Historical Attitudes toward Rattlesnakes 
The human-human conflict surrounding rattlesnakes is also evident in the 
opposing attitudes of those who desire to conserve and protect rattlesnake species and 
those who have a deep-seated, visceral animosity towards snakes in general and 
venomous snakes in particular. Venomous snakes and humans have had a complex 
relationship throughout recorded history. In many respects, the ways that humans have 
interacted with and impacted snakes has been similar to our interactions with other 
species. Venomous snakes have been impacted by many anthropogenic forces, including 
 5 
habitat destruction and fragmentation, hunting pressure, harvesting for food and 
traditional medicine, and climate change (Gibbons et al. 2000; Dodd 2001; Böhm et al. 
2013). Yet, the dynamics of the human-snake relationship have also been profoundly 
affected by human attitudes and culture—perhaps to a greater degree than many other 
species (Mundkur 1983). Snakes seem to elicit strong emotional reactions in people. 
Evidence from the field of psychology has suggested that, while the fear of snakes is 
learned, it can be learned more quickly than fears to other things (Öhman & Mineka 
2003). This may explain why ophidiophobia (the irrational fear of snakes) is common in 
the United States (Agras et al. 1969).  
However, irrational fear is not the only way these deep emotional reactions to 
snakes have been expressed throughout history. Many cultures have had profound 
reverence for and even worshiped snakes (Mundkur 1983). This can be seen in the 
culture of the Native American peoples and their attitudes toward rattlesnakes (Sasaki et 
al. 2008). Many Native American tribes had taboos against killing rattlesnakes, believing 
the snakes had supernatural powers and would harm humans (via their venom or natural 
disaster) if not treated with respect. The Hopi, for example, believed that rattlesnakes 
could control the weather, and that periods of drought resulted because they had abused 
rattlesnakes (Sasaki et al. 2008). Other tribes considered rattlesnakes to be allies. The 
Mohicans and the Delawares called them “grandfather,” with some believing that 
rattlesnakes could act as guardians by warning them of danger with their rattle (Sasaki et 
al. 2008).  
Unfortunately, this same level of respect was not shared by those who colonized 
the Americas, particularly from Europe. These people tended to think of rattlesnakes as 
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dangerous vermin that interfered with their way of life. This attitude may have been 
exacerbated by the fact that many of these colonists were Christian and, based on certain 
passages in the Bible (i.e. Genesis 3:1; 3:14), associated snakes with the Devil and the 
fall of humanity into sin (Sasaki et al. 2008). Regardless of the origins of these attitudes, 
these colonists subscribed to the idea that the only good rattlesnake was a dead one, and 
killed any they found. This lead to organized efforts to eradicate rattlesnakes, beginning 
in the early 1700s (Sasaki et al. 2008). These attitudes persist to the present, and are 
nowhere more evident than at modern rattlesnake roundups, the largest of which (the 
Sweetwater Jaycees Rattlesnake Round-up in Texas) indiscriminately slaughters as many 
as 18,000 snakes in a single weekend event (Weir 1993; Sasaki et al. 2008).  
Contemporary Attitudes toward Rattlesnakes 
These attitudes of fear and prejudice continue to play out when humans and 
rattlesnakes come into conflict in North America. The fact that rattlesnakes possess a 
medically significant venomous bite does not help their image. However, there are many, 
including scientists and conservationists, who recognize the intrinsic beauty and value in 
these animals. Despite the risks they pose to humans, rattlesnakes comprise an important 
part of the ecosystems to which they belong. They are often top-order predators in the 
habitats they occupy. Thus, even the loss of a few snakes from the population could result 
in significant ecological consequences (Shine & Koenig 2001; Estes et al. 2011; Sullivan 
et al. 2015). Some of these consequences could have direct negative impacts on humans. 
For example, destabilization of ecosystems and reduction of biodiversity has been 
suggested to put humans at increased risk of zoonotic diseases (Keesing et al. 2006; 
Ostfeld & Keesing 2014). Rattlesnakes may play a role in that balance by consuming 
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rodents, which can be disease vectors. Indeed, one study has suggested that Timber 
Rattlesnakes (Crotalus horridus) reduce the incidence of Lyme disease in the 
northeastern U.S. by helping to control small mammal populations (Kabay 2013). Thus, 
negative attitudes toward snakes in general, and rattlesnakes in particular, can not only 
impede conservation (Dodd 1993) but may also impact human health. 
Mitigation of Human-Rattlesnake Conflict 
However, determining the best action to take when human-rattlesnake conflict 
occurs is not always clear. Middle ground must be found between those who would 
emphasize public safety and those who wish conserve and protect rattlesnake species. 
Certainly rattlesnakes pose some risk to humans but, from the perspective of the 
conservationists, human-rattlesnake conflicts can also be of great risk to the snake. When 
humans encounter a rattlesnake in the wild, one of two things can happen, depending on 
what the human decides. The decision could be to avoid further contact with the 
rattlesnake, and leave it alone, or to deal somehow with the rattlesnake. The human 
decision to avoid the snake and leave it alone is certainly the best option from the 
perspective of the snake. Given the previously mentioned attitudes and biases many 
people have, humans often decide against leaving the snake alone, which often results in 
killing of the snake. Human-rattlesnake conflicts that occur on private residential 
property may place the snake at even greater risk. In this situation, the human may feel 
that leaving the snake alone is not a viable option because the snake poses too great a risk 
to them or their family if it remains on their property. In many cases, a property owner 
may decide to kill the snake, though a wildlife management professional may also be 
called in to remove the offending snake (Mccrystal & Ivanyi 2008). Understanding the 
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dynamics of human-rattlesnake conflict and the risks to both humans and snakes is 
essential for managing conflicts and risks, and is vital to inform conservation efforts for 
the snakes. 
Mitigation Translocation 
In general, animals removed from conflict with humans are generally dealt with in 
one of two ways—euthanization or mitigation translocation (Craven et al. 1998). 
Mitigation translocation is defined as the action of moving nuisance wildlife to areas 
where they are no longer in conflict with humans (Sullivan et al. 2015). The public often 
supports this option over euthanization because it is considered more humane (Massei et 
al. 2010).  However mitigation translocation can have negative consequences for the 
translocated animal. Survival for translocated animals requires that they be able to find 
and secure critical resources (i.e. mates, food, shelter) in an unfamiliar environment while 
competing for these resources with resident conspecifics and avoiding predation (Massei 
et al. 2010).  This is a difficult task and may result in translocated animals exhibiting 
erratic movement patterns and suffering high mortality rates and, at least in the short term 
(Massei et al. 2010; Sullivan et al. 2015). How well an animal deals with the stress of 
translocation depends, to some degree, on species ecology. Omnivores are often more 
likely to survive after translocation than herbivores and more generalist herbivores are 
often adapt more quickly than carnivores (Griffith et al. 1989; Massei et al. 2010).  
Beyond the effects of translocation on the individual animal, mitigation 
translocation may negatively affect resident animals in the areas where translocated 
animals are moved to.  Translocated animals may introduce disease, disrupt social 
structure, or contribute to outbreeding depression (Burke 1991; Reinert 1991; Chipman et 
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al. 2008; Massei et al. 2010; Sullivan et al. 2015). Moreover, mitigation translocation 
may not always be effective (Fischer & Lindenmayer 2000).  Translocated animals may 
continue to come in conflict with humans, either by returning to the original conflict area 
(Cunningham 1996; Linnell et al. 1997; Massei et al. 2010; Sullivan et al. 2015), or by 
moving to new conflict areas after translocation (Linnell et al. 1997; Massei et al. 2010). 
One study that involved mitigation translocation of leopards in India found an opposite 
effect of what was intended, with translocated leopards posing more of a risk to humans 
that non-translocated ones (Athreya et al. 2011).   
Concerns regarding mitigation translocation center largely on the distance that the 
nuisance animal is moved. Animals moved a short distance suffer fewer consequences 
but are more likely to return to areas of conflict, whereas animals moved a longer 
distance are less likely to return but may suffer higher rates of mortality and contribute to 
population-level problems (Massei et al. 2010). Some studies define translocation 
categories relative to the home range size of the animal, with short-distance translocation 
(SDT) being within the animal's normal home range, and long-distance translocation 
(LDT) extending beyond the home range but usually within the local breeding population 
or deme (Hardy et al. 2001). These distances can vary from several hundred meters for 
reptiles and small mammals (e.g., McGregor et al. 2008) to many kilometers for larger 
mammals (e.g., Athreya et al. 2011). Translocations of much greater distances, beyond 
the local deme, have been referred to as regional or intra-continental translocation (Loss 
et al. 2011). 
Overall, many variables must be taken into consideration when deciding the best 
course of action when dealing with human-wildlife conflict. In many cases the human 
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interests involved (crops, safety, property, etc.) must be respected and the animal causing 
the impact must be removed. Deciding whether euthanization or mitigation translocation 
is the best option requires assessing the human and ecological dimensions on a species by 
species or case by case basis. 
Mitigation Translocation of Nuisance Rattlesnakes 
Human-rattlesnake conflict is a case in point. At present, only a limited number of 
studies have examined human-wildlife conflict related to rattlesnakes. These studies have 
been limited to looking at the effects of translocation on the translocated snakes 
themselves with no studies looking at the effects of translocation on conspecifics in area 
snakes are translocated into.  As with translocation in other species, most studies reveal 
that translocated rattlesnakes tend move more and have more erratic movement patterns 
than untranslocated snakes (Reinert & Rupert 1999; Nowak et al. 2002; Brown et al. 
2008; Brown et al. 2009). However, with respect to mortality, studies have been mixed. 
Increased mortality has been cited as major reason why mitigation translocation in snakes 
fails (Sullivan et al. 2015). However, while some studies have shown a significant 
increase in the mortality of translocated rattlesnakes (Reinert & Rupert 1999; Nowak et 
al. 2002), others have not  (Brown et al. 2008; Brown et al. 2009). Some studies have also 
looked at the effectiveness of SDT vs LDT in mitigating human-rattlesnake conflict. 
Despite one study that concluded that SDT was effective (Sealy 2002), most others report 
that SDT snakes often return to conflict areas (Hardy et al. 2001; Brown et al. 2008; 
Brown et al. 2009)  therefore may not ultimately solve the problem that translocation was 
intended to resolve.  
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Given the potential problems with translocation some may consider euthanization 
as the best option. However, indiscriminant use of euthanization is also problematic. As 
mentioned previously, rattlesnakes are integral members of their ecological communities, 
and disruption of these communities may result if even a few rattlesnakes are removed. 
Euthanization may also be problematic when the nuisance species is endangered or 
protected. Euthanization may run counter to conservation efforts, and may be contrary to 
legal mandates that require maintenance of protected lands and the species they contain 
(Nowak & Riper 1999).  
 Additional research is sorely needed to better understand the impact of mitigation 
translocation on rattlesnake ecology, particularly in terms of mortality and the impacts of 
translocation on conspecifics in areas where snakes are translocated into. It is only by 
having a thorough understanding of the impacts of our mitigation strategies on the 
dynamics of human-rattlesnake conflict that we can we make informed decisions that are 
in the best interests of both rattlesnakes and humans.  
Specific Objectives 
In this dissertation, I begin, in chapter 2, by examining the effectiveness of 
translocation as a strategy to mitigate-human rattlesnake conflict and the effects of 
translocation on the snakes themselves. I studied the effect of short-distance translocation 
(SDT) and long-distance translocation (LDT) on Red Diamond Rattlesnakes (Crotalus 
ruber) located near a residential development in Southern California using 
radiotelemetry. I also examined sexual and seasonal differences in movement patterns 
and space use by the snakes, and how these relate to residential development. 
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In Chapter 3, I examine the major way in which rattlesnakes negatively impact 
humans, particularly in relation to their venomous bite. I describe the results of a 
retrospective review of the medical records of snakebite victims at the Loma Linda 
University Medical Center. This study looked at factors related to the etiology and 
clinical severity of rattlesnake envenomations in southern California. These factors 
included the species and size of the snake, the mass and the anatomical location of the 
bite on the victim, the type of interaction the victim had with the snake (legitimate or 
illegitimate), and the time between the bite and the victim’s arrival at the hospital. This 
study also examined when, during the year and time of day, human-rattlesnake 
interactions resulting in snakebite were most likely to occur. 
In Chapter 4, I continue to examine human envenomation by rattlesnakes, this 
time looking at it from the perspective of a clinician. Using the same medical record data 
as the previous chapter, I examine whether assessing several factors related initial 
presentation at the hospital could predict symptom progression and the amount of 
antivenom needed to resolve symptoms. These factors were the same as in Chapter 3, 
including the species and size of the snake, the mass of the victim and the anatomical 
location of the bite, the type of interaction the victim had with the snake (legitimate or 
illegitimate), and the time between the bite and the victim’s arrival at the hospital. 
In chapter 5, I summarize and discuss the results from my research as a whole. 
My findings should provide a clearer picture of the nature of human-rattlesnake conflict 
in southern California. They should aid those involved with wildlife management in 
making decisions about how to mitigate human-rattlesnake conflict, and they should 
benefit clinicians in treating snakebite victims.  
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Abstract 
Mitigation of human-rattlesnake conflict generally involves euthanizing or 
translocating the offending rattlesnake. Of these, translocation is generally considered 
more humane, especially by the general public. However, it may significantly impact the 
individual snake that is translocated. We studied the effect of short-distance translocation 
(SDT) and long-distance translocation (LDT) on Red Diamond Rattlesnakes (Crotalus 
ruber) located near residential development in Southern California. Depending on 
measure (minimum convex polygon, local convex hull, range length), activity ranges of 
LDT snakes were 38.6–67.1% larger than those of SDT snakes, which, in turn, had 
activity ranges that were 77.0–152.9% larger than those of non-translocated (NT) snakes. 
Snakes moved closer to human modified areas during the summer, and were translocated 
most often during that season at the behest of property owners. Analysis using Cox 
regression revealed that both SDT and LDT snakes were more likely to move into 
human-modified areas subsequent to translocation than NT snakes. For translocated 
snakes, every 1 m increase in distance moved resulted in a 1.2% decreased risk of 
moving into a human-modified area, and a 1.5% decreased risk of returning to the site of 
capture. We found no differences in the survival rate between translocated snakes (LDT 
an1d SDT) and NT snakes. Our findings suggest that LDT of nuisance snakes may be a 
viable option for at least some rattlesnake species. To reduce confusion arising from 
different meanings of the terms SDT and LDT among different studies, we propose 
standardizing the terms for distance of movement as alpha- (within the individual's home 
range), beta- (within the local deme), gamma- (beyond the local deme), and delta-
translocation (to regions unoccupied by the species, including inter-continental). 
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Introduction 
As human residential and commercial development encroaches upon natural 
areas, human interactions and conflicts with native wildlife inevitably increase (Conover 
2002; Rosie Woodroffe et al. 2005). In many cases, these interactions are positive, 
providing a basis for public interest in native species and their conservation. However, 
many of these interactions are also undesired, with wildlife either causing property 
damage or injury to humans, or being perceived as a significant risk of causing such. To 
mitigate human-wildlife conflict, two options may be used: 1) limit human access to 
areas were conflict may occur; or 2) remove the offending animals. Limiting human 
access to potential conflict areas is often the best choice, as it can minimize disturbance 
to the animals and the risks to the public. It has also been shown to be effective 
(Fernández-Juricic et al. 2004; Benn & Herrero 2014; Carter et al. 2014). However, this 
method is predicated on identifying specific areas with a significant increased risk of 
conflict, and having the legal authority to limit human access to the area. Yet there are 
many situations where these two criteria cannot be met, either because no specific areas 
of increased risk can be identified, or because the legal authority to restrict human access 
cannot be obtained. The latter issue is particularly acute when nuisance wildlife moves 
onto private property, as the legal authority to mitigate the conflict by limiting a person’s 
access to their own property generally cannot be obtained. In such cases, removing the 
offending animal is the only option apart from doing nothing. 
Animals removed from conflict with humans are generally dealt with in one of 
two ways: euthanization or translocation (Craven et al. 1998). Translocation simply refers 
to the movement of one or more organisms from one place to another, and has been used 
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as an overarching term that covers a number of wildlife management practices, including 
establishing, reestablishing, or augmenting populations for conservation purposes 
(Griffith et al. 1989; Reinert 1991; IUCN/SSC 2013). 
Mitigation translocation, defined as the action of moving nuisance wildlife to 
areas where they are no longer in conflict with humans (Sullivan et al. 2014), is often 
preferred over euthanization, particularly by the public, which views it as more humane 
(Massei et al. 2010). However, many studies examining the effects of translocation have 
urged caution based on three potential concerns. First, translocated animals often suffer 
high mortality rates, and exhibit erratic movement patterns, at least in the short term 
(Massei et al. 2010; Sullivan et al. 2014). Second, mitigation translocation may not 
always be effective (Fischer & Lindenmayer 2000), as translocated animals may continue 
to come into conflict with humans, either by returning to the original conflict area 
(Cunningham 1996; Linnell et al. 1997; Massei et al. 2010; Sullivan et al. 2014), or by 
moving to new conflict areas after translocation (Linnell et al. 1997; Massei et al. 2010). 
Third, translocated animals may negatively affect conspecifics (or even heterospecifics) 
in the areas they are moved to by introducing disease, disrupting social structure, or 
contributing to outbreeding depression (Burke 1991; Reinert 1991; Chipman et al. 2008; 
Massei et al. 2010; Sullivan et al. 2014).  
These concerns regarding mitigation translocation center largely on the distance 
that the nuisance animal is moved. Animals moved a short distance suffer fewer 
consequences but are more likely to return to areas of conflict, whereas animals moved a 
longer distance are less likely to return but may suffer higher rates of mortality and 
contribute to population-level problems (Massei et al. 2010). Unfortunately, discussion of 
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the merits and concerns of translocation is sometimes confounded by spatial scale, a 
problem arising, in part, because no established terminology exists for translocation 
distance. Some studies arbitrarily define translocation categories relative to the home 
range size of the animal, with short-distance translocation (SDT) being within the 
animal's normal home range, and long-distance translocation (LDT) extending beyond 
the home range but usually within the local breeding population or deme (Hardy et al. 
2001). These distances can vary from several hundred meters for reptiles and small 
mammals (e.g., McGregor et al. 2008) to many kilometers for larger mammals (e.g., 
Athreya et al. 2011). Translocations of much greater distances, beyond the local deme, 
have been referred to as regional or intra-continental translocation (Loss et al. 2011). 
Obviously, the consequences of moving an animal into a neighbor's home range versus a 
distant region can differ dramatically, yet both have come under the rubric of "long-
distance translocation." A more universal terminology, such as alpha- (within the 
individual's home range), beta- (within the local deme), gamma- (beyond the local deme), 
and delta-translocation (to regions unoccupied by the species, including inter-
continental), could help clarify the discussion of problems associated with translocation. 
In this paper, we will use SDT to refer to alpha-translocation and LDT to refer to beta-
translocation, unless otherwise indicated, but we urge researchers to adopt a more 
formalized rubric for the spatial scale of translocation. 
In the United States, venomous snakes often come in conflict with humans 
(Nowak & Riper 1999; Mccrystal & Ivanyi 2008). Even though public perception of the 
risk posed by venomous snakes may be inflated (Hardy et al. 2001; Gibbons & Dorcas 
2002), they do represent a legitimate health risk. Though mortality in the U.S. is low (5–7 
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deaths annually), venomous snakebite is still a significant medical issue, with an 
estimated 2,683–3,858 envenomations annually (Kasturiratne et al. 2008) that incur 
substantial costs and physical and emotional morbidity (Dart et al. 1992; Corneille et al. 
2006; Smith & Bush 2010). Because of this, there is some public support for euthanizing 
nuisance venomous snakes (Braband & Clark 1991).  
However, indiscriminant use of euthanization is problematic. Venomous snake 
are often top-order predators in many of the habitats they occupy; hence, even the loss of 
a few snakes could have significant ecological consequences (Shine & Koenig 2001; 
Estes et al. 2011; Sullivan et al. 2014). Euthanization may also be problematic when the 
nuisance species is endangered or protected. Euthanization may run counter to 
conservation efforts, and may be contrary to legal mandates that require maintenance of 
protected lands and the species they contain (Nowak & Riper 1999).  
Yet the same issues exist with mitigation translocation in venomous snakes as 
with other species, generally including erratic movements and increased mortality. 
Because shorter distances may negate the negative effects of translocation (Massei et al. 
2010), it has been suggested that nuisance rattlesnakes can be effectively managed using 
SDT (Sealy 2002) rather LDT (beta- or gamma-translocation), with the latter often 
employed in an attempt to ensure that the snake will not return to the area of conflict 
(Nowak et al. 2002). Despite one author reporting success with SDT (Sealy 2002), others 
report that SDT snakes often return to conflict areas (Hardy et al. 2001; Brown et al. 
2008; Brown et al. 2009), and therefore may not ultimately solve the problem that 
translocation was intended to resolve.  
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Despite the fact that several studies have examined translocation in rattlesnakes, 
many have methodological weaknesses. Several such studies utilized radiotelemetry to 
monitor venomous snakes that were translocated in order to establish or reestablish 
populations for conservation purposes (Johnson 1993; Hare & McNally 1997; King et al. 
2004; Walker et al. 2009; Harvey et al. 2014). While such studies provide valuable 
information on the behavior of translocated snakes, these studies lacked non-translocated 
control snakes. Other studies have utilized mark/recapture methods (Hardy et al. 2001), 
though these are poorly suited for determining snake mortality and how often snakes 
return undetected to conflict areas. Studies that have utilized radiotelemetry and 
appropriate control groups are summarized in Table 1. Most of these studies show an 
increase in movements and the size of activity ranges in both SDT and LDT (alpha- and 
beta-translocation) snakes. Some studies have further concluded that LDT (beta- and 
gamma-translocation) snakes experience increased mortality (Reinert & Rupert 1999; 
Nowak et al. 2002), whereas others have not (Brown et al. 2008). To date, no studies 
have effectively compared both LDT and SDT snakes within the same study. Brown et al. 
(2008) came close in studying both LDT and SDT Red Diamond Rattlesnakes (Crotalus 
ruber); however, deaths of two of three SDT snakes due to surgical complications 
precluded statistical analysis between these groups.  
Like Brown et al. (2008), we examined the effects of translocation on Red 
Diamond Rattlesnakes in southern California. This snake is a species of special concern 
in the state because of habitat loss due to human development (Jennings & Hayes 1994), 
and has recently received formal protection from collection and possession. As such, 
euthanization may not be desirable as an option for mitigating human-wildlife conflict 
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caused by this species. The aim of this study was to examine the effects of both long- and 
short-distance translocation in this protected species in order to inform future policies for 
dealing with nuisance rattlesnakes. Our study represents, to our knowledge, the only 
study to date that is able to compare LDT, SDT, and untranslocated rattlesnakes within a 
single study.  
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Table 1. Summary of mitigation translocation studies in rattlesnakes that employed radio-telemetry and included a control group.a Effect 
size for survival differences is Cramer's V. Activity range and movement differences relative to controls are indicated as increases ( +) 
or no difference (0). Other effects refer to translocated snakes. 
Species 
Duration 
(months) 
Control Group Translocation Group      
N 
Survival 
(%) Type N 
Survival 
(%) Effect Size 
Activity 
Range Movements Other Effects Source 
C. atrox 28 6 83.3 LDT 7 57.1 0.283 + +  Novak et al. 2002 
C. horridus 48 18 88.9 LDT 11 45.5 0.472 + +  Reinert & Rupert 1999 
C. o. oreganus 18 14 100.0 SDT 14 85.7 0.277 0 +  Brown et al. 2009 
C. o. oreganus 2 14 100.0 SDT 8 100.0 0.000 + 0 
Larger medial 
cortex 
Holding 2011, 2012, 
2014 
C. o. oreganus 1 7 100.0 LDT 7 100.0 0.000 + 0 
Visible more 
often; greater 
levels of 
testosterone 
Heiken 2013b 
C. ruber 60 11 90 SDT/LDT 6 75 0.194 + +  Brown et al. 2008c 
C. ruber 37d 10 60 SDT/LDT 12/10 63/89 0.23 + +  This Studye 
a Deaths due to surgical complications are excluded; survival calculations exclude missing snakes (often due to transmitter failure) as 
mortalities. 
b One mortality that occurred prior to translocation is excluded 
c Two of the three SDT snakes in this study died due to surgical complications, making comparison between LDT and SD snakes 
impossible. 
dMaximum duration a single snake was tracked 
eHuman caused mortality excluded 
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Materials and Methods 
Study Site 
 The study was conducted in the southern portion of Loma Linda, California 
(34°02' N, 117°16' W), within a ca. 500-ha boundary area between human development 
to the north and a largely undeveloped area of rolling hills (ca. 324 km2) that extends 
southeast (Figure 1). The portion containing natural habitat consists largely of non-native 
grassland, though steeper north-facing slopes are covered by coastal sage scrub 
dominated by California Sagebrush (Artemisia californica) and Black Sage (Salvia 
mellifera), and many south-facing slopes are populated by Brittlebush (Encelia farinosa). 
The site lacks the rock outcrops and substantial cactus patches that are generally 
preferred by C. ruber (Dugan et al. 2008; Halama et al. 2008). Human development in 
this area largely consists of a residential area containing homes, sprinkler-irrigated lawns 
and gardens, and non-native tree species.  
The area also contains some small citrus orchards on the eastern end and a large 
cemetery on the western end that includes large trees and a lawn kept green year-round 
by sprinkler irrigation. The site experiences a Mediterranean climate (Cowling et al. 
1996), with much of the ca. 40-cm average annual precipitation occurring during winter 
and spring. Winters are mild, with the mean daily low temperature in January being 
5.6°C, whereas summers are hot and dry, with the mean daily high in July being 35.7°C 
(Western Regional Climate Center n.d.). 
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Figure 1. (A) Study site in Loma Linda, California, USA, showing 100% Minimum 
Convex Polygons for all fixes of all radiotelemetered Red Diamond Rattlesnake (Crotalus 
ruber) in the study. (B) Spatial depiction of a western portion of the study site. 
Radiotelemetry fixes (all snakes pooled) are shown for natural habitat (green circles) versus 
human-modified areas (red circles). Yellow dashes outline a plowed firebreak that snakes 
moved across but never stopped within. 
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Legal Issues 
 The study required cooperation from local residents, who reported snakes to us 
and allowed access to their property. To solicit their help, we distributed fliers to those 
whose property bordered natural habitat. Because our study involved potential liability, 
due largely to the possibility of envenomation from our research subjects, we sought legal 
advice. We recommend that others contemplating similar studies do the same, so we 
briefly share the issues we dealt with. Our university's legal counsel researched three 
risks to the institution, and made the following determinations (with no assurance of legal 
immunity) from California law: (1) liability would be unlikely for injury caused by a 
rattlesnake that researchers captured, tagged, released, monitored, and relocated; (2) 
liability would be unlikely for removal of snakes from an owner's property; and (3) the 
university could be liable if the homeowner was asked to allow a snake to remain on its 
property to benefit the research. Accordingly, we drafted a letter to homeowners, 
approved by legal counsel, which described the study and included a property access 
agreement. The agreement provided options for (1) access to the property (including time 
of day and whether permission would be required each time); (2) notification of radio-
tracked snake presence on property; (3) whether the snake should be left or removed (all 
owners requested removal, and we were forbidden to offer advice); (4) details on 
potentially hostile pets that might be encountered on the property; and (5) release of 
liability from any damage arising from any snake or researcher involved with the study. 
Twenty-eight property owners signed the agreement, of which 27 granted us access to 
their property. We emphasize that our study design was necessarily constrained by these 
liability issues. 
 32 
Radio-telemetry 
Snake collection, radio-transmitter implantation, and tracking commenced in July 
2008 and continued through December 2011. Most snakes were obtained through 
cooperating residents, who contacted us via telephone when they discovered a rattlesnake 
in their yard.  Snakes were also collected opportunistically when discovered in the field, 
especially during the spring mating season (February–April; Dugan et al. 2008) when 
they paired up with telemetered snakes. Once collected, we obtained the snake’s mass 
and total length. Sex was determined by subcaudal scale count (male: ≥24; female: ≤ 23) 
and/or probing using Neosporin-lubricated sexing probes. Total length was determined 
via photography in a press-box (Quinn & Jones 1974), with the floor covered by 1-cm 
graph paper and a clear plastic cover to hold the snake in place. Photographs were 
imported into ImageJ version 1.47q (Rasband 1997) to calculate snake length. 
We used both SI-2 (Holohil Systems Ltd., Ontario, Canada) and SOPB-2190 
(Wildlife Materials Inc., Murphysboro, Illinois, USA) radio-transmitters. These 
transmitters weighed ca. 6 and 9 g, respectively, which always represented <5% of an 
individual snake’s body mass (Hardy & Greene 1999). Surgical procedures followed 
Reinert & Cundall (1982) and Hardy & Greene (1999). Because minimizing time in 
captivity reduces post-surgical mortality (Hardy & Greene 1999), snakes were released 
24–48 hr after surgery. We obtained fixes on each snake’s location 1–2 times weekly 
using a Telonics TR2 receiver (Telonics, Mesa, Arizona, USA) and a generic four- or six-
element yagi antenna. For each fix, we attempted to visually locate the snake and record 
its coordinates using a handheld GPS unit (Magellan Explorist 210; Magellan, Santa 
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Clara, California, USA). If a snake was not visible, we took coordinates as close to the 
source of the radio signal as possible.  
Initial Translocation 
Subsequent to capture and transmitter implantation, snakes were assigned to one 
of three groups. Snakes initially found in natural habitat were released at their site of 
capture and placed in the initially non-translocated control group (NT). Snakes captured 
in or near human-modified areas were always translocated (by landowner request) to 
natural habitat away from the area of conflict, and randomly placed in either the initially 
short-distance translocation group (SDT, <716 m; range 100–600 m) or the long-distance 
translocation group (LDT, >716 m; range 800–5500 m, with one exception detailed 
below). At the onset of our study, we adopted the 716-m criterion used by Brown et al. 
(2008), who distinguished short- and long-distance translocation based on this mean 
value for the maximum straight-line distance between any two locations for non-
translocated C. ruber at a study location not far from ours. We made an exception for one 
female snake which, subsequent to an initial translocation of 519 m, displayed erratic 
movements away from her capture site, overwintered 662 m from her capture site on the 
other side of a large hill, and finally returned to within 200 m of her original capture site 
after 305 days. Given these erratic movements and the fact that female C. ruber have 
significantly smaller home ranges than males (Brown et al. 2008), we interpreted this to 
mean that we had translocated her out of her normal home range, and therefore assigned 
her to the LDT group. 
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Two snakes (1 male and 1 female) in the eastern portion of the study site (where 
we had  access issues) were initially assigned to the SDT group, but were reassigned one 
year later to the LDT group when they were translocated to the western portion of the 
study site. These two snakes, subjected to both SDT and LDT treatments and accounted 
for in the sample sizes noted in Results, were treated as separate snakes in our analyses. 
This treatment, therefore, constituted minor pseudoreplication across but not within 
treatment groups; the latter would be much more problematic. Other investigators have 
made more extensive use in treating movements of the same snake in separate years as 
independent units (e.g. Plummer & Mills 2000; Harvey & Weatherhead 2006; 
DeGregorio et al. 2011). 
Follow-up Translocation 
After implanting transmitters in snakes, and assigning them to a translocation 
group upon release, we disturbed the snakes as little as possible when tracking their 
movements via radiotelemetry. However, because of increased risk of injury to humans 
(and to the snake) as well as for legal reasons, we translocated a short distance (50–400 
m) into suitable natural habitat any telemetered animal found in close proximity to a 
human-modified area. These additional translocations potentially confounded differences 
between treatment groups (NT, SDT, and LDT); however, our statistical analyses (see 
below) allowed us to infer differences between groups independent of the effect of 
follow-up translocations. When snakes near areas of potential human conflict were 
inaccessible (e.g., beneath wooden patios or concrete slabs) or eluded capture, we alerted 
the property owner to the snake’s presence and returned later to recapture the snake if 
still necessary. We did not include sites where snakes were released in our activity range 
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calculations, nor did we include the distance the snake was translocated in our 
calculations of mean daily movement. We attempted to translocate snakes to areas where 
we had observed them previously, resulting in release sites generally within calculated 
activity ranges. Because we used non-parametric methods of activity range calculation 
(see below), which are based on constructing polygons from points at the edge of the 
snake’s activity range, releasing snakes in this way minimized the chances of artificially 
inflating the calculated area of the activity range. 
Activity Range and Movements 
We used R statistical software version 2.15.2 (R Core Team 2014) and the 
package adehabitat version 1.8.12 (Calenge 2006) to calculate several land use and 
movement parameters. Because several of these snakes were long-distance translocated 
outside their normal “home” area, we follow Hare & McNally (1997) in using the term 
“activity range” instead of the more traditional “home range” to describe the area utilized 
by an animal over a particular time period. Because the snakes were generally inactive 
during December and January, we used the calendar year for between-year comparisons.  
We calculated two activity range statistics for each snake during each season per 
calendar year of tracking. To facilitate comparison with previous studies, we computed a 
100% minimum convex polygon (MCP). Because parametric kernel methods of 
calculating activity range area, particularly those using least-squares cross-validation to 
select kernel size, have been shown to be somewhat unreliable for reptiles (Row & 
Blouin-Demers 2006), we chose to use one of the non-parametric kernel methods known 
as local convex hull (LCH; Getz & Wilmers 2004; Getz et al. 2007). This method appears 
to be superior to kernel methods in providing better convergence properties as sample 
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size increases. The LCH is also better able to exclude portions within the activity area 
that animals never occupied due to physical barriers or undesirable habitats. 
Anthropogenic alterations at our study sites that blocked snake access or created 
undesirable habitat included plowed fire breaks and walls erected around some of the 
residential developments. Three LCH methods have been proposed based on the way the 
non-parametric kernels are constructed. The “fixed number of points” method (k-LCH) 
constructs kernels from the k-1 nearest neighbors of a root point, where k is supplied by 
the user; the “fixed sphere of influence” method (r-LCH) constructs kernels based on 
choosing a fixed radius r from each reference point; and the “adaptive sphere of 
influence” method (a-LCH) constructs kernels from all points within a radius a such that 
the distances of all points within the radius to the reference point sum to a value less than 
or equal to a (Getz et al. 2007). Of these three, the a-LCH method is considered superior 
because it provides better area estimates and is more robust to proportional changes in the 
a parameter (Getz et al. 2007), so we chose to use this method. Following the "rule of 
thumb" in Getz et al. (2007), we set the a parameter equal to the range length (RL), 
which was the maximum distance between any two points for each snake in a given year 
(i.e., we used an a value that was unique for each individual snake). We also used RL as a 
relative measure of activity range. 
To determine the minimum acceptable number of fixes to use for calculating 
activity ranges, we bootstrapped 10 randomly-selected activity ranges 100 times each, 
and visually assessed the effect of number of fixes on activity range size. Based on this 
analysis, we excluded activity ranges of any individual snake with fewer than 20 fixes.  
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We also calculated mean daily movement by dividing the distance moved 
between consecutive fixes and the number of days between these fixes (Gregory et al. 
2001). These were averaged per snake over each calendar year to get the mean daily 
movement.  
Distance to Human-Modified Areas 
For each coordinate fix obtained for each snake, we calculated the distance from 
that point to the nearest area with significant human modification (SHM). These areas 
were defined by the presence of buildings, roads, and well maintained gardens and lawns 
(Figure 1). Areas subject to a lesser degree of human modification, such as plowed 
firebreaks and dirt trails, were not included. The UTM coordinates of such areas were 
found using Google Earth software (Google Inc., Mountain View, California, USA), and 
Euclidean distances were calculated using R software.  
Statistical Analyses 
We conducted all statistical tests using SPSS v. 13.0 (SPSS Inc., Chicago, Illinois, 
USA), with alpha set at 0.05. For the analysis of variance (ANOVA) models described 
below, we computed effect sizes as eta-squared (ɳ2) for one-way models and partial ɳ2 for 
factorial models (Green & Salkind 2005). Effect sizes are independent of sample size (in 
contrast to statistical significance) and biologically more meaningful, and can be more 
readily compared among different data sets and different studies (Nakagawa & Cuthill 
2007). Eta-squared can be interpreted as percent of variance explained, though partial ɳ2 
becomes upwardly biased as additional independent variables are added to the model 
(Levine 2002). Values of ~0.01, ~0.06, and ≥0.14 correspond loosely to small, moderate, 
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and large effects, respectively (Cohen 1988). For Chi-square analyses, we computed 
effect size as Cramer’s V, with values of ~0.10, ~0.30, and ≥0.50 corresponding loosely 
to small, moderate, and large effects, respectively (Cohen 1988). 
We analyzed data without regard to environmental differences between years. In 
southern California, one study suggested that Mohave Rattlesnakes (C. scutulatus) moved 
less and occupied smaller home ranges during a dry year compared to two wet years 
(Cardwell 2008). At our study site, where annual precipitation averages 34 cm (National 
Climatic Data Center, 2011), the winter rainfall was less preceding the relatively dry 
2008 and 2009 seasons (July-June rainfall = 27 and 22 cm, respectively) compared to that 
preceding the relatively wet 2010 and 2011 seasons (39 and 53 cm). However, the 
activity ranges and movements of three snakes tracked during both the dry (2008-2009) 
and wet years (2010-2011), each with ≥20 fixes per year, showed surprisingly consistent 
home ranges and movements during each year across this time span (data not presented). 
Activity Range and Movement Analysis  
To examine the effects of initial translocation and sex on annual activity range 
and movement patterns, we utilized a 2 × 3 (sex × treatment group) factorial ANOVA 
(Field 2005) for each dependent variable (100% MCP, 100% a-LCH, mean daily 
movement, RL), and included both sex and translocation group as between-subjects 
factors. We calculated activity range and movement parameters for all snake-year 
combinations, and then the values for snakes tracked during multiple years were averaged 
to avoid pseudoreplication (with the aforementioned exception of two snakes subjected to 
both SDT and LDT). For these analyses, all movement and activity range parameters 
were rank-transformed to meet parametric assumptions.  
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We also examined seasonal differences in mean daily movement between sexes 
using a 2 × 4 repeated-measures ANOVA (Field 2005), with season as a within-subjects 
factor and sex as a between-subjects factor. Seasons were categorized as spring (March–
May), summer (June–August), fall (September–November), and winter (December–
February), and mean daily movement was calculated for each season-year combination 
for each snake. These values were similarly averaged across years for each snake in order 
to obtain a single value for each snake per season, thereby avoiding pseudoreplication. 
Snakes that were not tracked over all four seasons were excluded from analysis. We did 
not transform mean daily movement for this analysis, as parametric assumptions were 
largely met.  
Survival Analysis 
We analyzed snake mortality both considering and omitting mortalities due to 
human causes. Survival rates were calculated using the Kaplan-Meier procedure (Kaplan 
& Meier 1958), following Pollock et al. (1989) and the guidelines of Robertson & 
Westbrooke (2005). The time period used in these calculations was the total number of 
days the snake was tracked. This time period began when the snake was released into the 
field after transmitter implantation, and ended based on the same last fix criteria used in 
the Cox proportional hazard analysis. The number of days a snake was held in captivity 
for surgery or recovery was subtracted from the total time for this analysis. Also, the two 
snakes that died due to surgical complications were excluded from this analysis. The 
Mantel-Cox log-rank method was used to test for differences between sex and 
translocation groups.  
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Distance to Human-Modified Areas by Season 
We considered the effect of season on the distance that the centroid of the activity 
range was from SHM areas. For each snake, we calculated activity range centroids (mean 
of x and y coordinates) for each season, and averaged the corresponding seasonal values 
across years for those snakes tracked for parts of two or more years. We employed two 
ANOVA models: a one-way model considering season as a within-subjects factor, and 
the other a 2 x 3 x 4 (sex × translocation group × season) model including sex and 
translocation group as between-subjects factors, and season as a within-subjects model. 
Centroid distances to SHM areas were rank-transformed, and snakes that were not 
tracked for all four seasons were excluded from analyses. We included in our analysis 
only those snakes with at least one fix <50 m from an SHM area. We expected only those 
snakes familiar with SHM areas, and the resources they may contain, to deliberately 
move toward such areas. 
Risk of Human Conflict and Return to Capture Site after Translocation 
We utilized Cox proportional hazards models (Cox 1972) to address two 
questions related to the potential for conflict with humans: (1) What factors affect 
whether a snake moves near any area of potential human conflict? And (2) if a snake is 
translocated away from human conflict, what factors affect whether or not it returns to 
the place it was originally captured? 
To assess the first question, we used a model that included snake sex and 
translocation group as factors, and the distance from each snake’s initial release point to 
the nearest SHM area as a covariate. The time period used as the dependent variable 
began when the snake was released subsequent to transmitter implantation, and ended the 
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first time that a snake moved within 50 m of any SHM area, or upon the last fix obtained 
for the snake, whether at the end of the study, when found dead in the field, or when 
found ill in the field and subsequently taken into captivity. For snakes lost due to a 
presumed transmitter failure, the final date was calculated as the midpoint between the 
last fix and the subsequent date when looked for but not found (Miller & Johnson 1978).  
To assess the second question, our model looked again at sex and translocation 
group as fixed factors; however, this time we used initial translocation distance as the 
covariate. The time period used began when the snake was released after translocation 
and ended when the snake returned within 50 m of the point it was translocated from or 
to the final location fix for that snake in the study, as defined above. Only snakes that 
underwent at least one SDT from an area <50 m from an SHM area were used in this 
analysis, and only the first such event was considered to prevent pseudoreplication. This 
meant the initial translocation for all snakes in the SDT group was included. Snakes in 
the NT and LDT groups were included if, subsequent to initial release, they moved into 
SHM areas and underwent a follow-up SDT. In such cases only the first follow-up 
translocation events were included. We did not include the initial LDTs of those snakes 
in the LDT group in this analysis because, for several snakes in this group, the position of 
SHM areas (i.e. residential development) blocked, or would have significantly impeded, 
their return to their original capture location in large part because our protocol required 
that snakes that moved into such areas be translocated back towards areas were they been 
observed previously.   
Since Cox proportional hazard models have few underlying assumptions (Mathew 
et al. 1999), no transformations were applied to the data. We confirmed the assumption of 
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proportional hazard by checking log-log survival plots for parallelism between survival 
curves for each group. 
Follow-up Translocations 
Follow-up translocations subsequent to initial assignment of snakes to a 
translocation group (NT, SDT, LDT) were unavoidable given the legal issues that 
impacted our study design. This issue confounded our study design to some extent, 
particularly the distinction between NT and SDT snakes. To assess whether the number 
of follow-up translocations differed among the original translocation group assignments, 
we calculated the number of follow-up translocations per season and per year for each 
snake, and then data for seasons were averaged across years for each snake tracked 
during parts of two or more years. These values were then rank-transformed for the 
following analyses. We used a 2 x 3 factorial ANOVA model that used translocation 
treatment group and sex as independent variables. Because we did not detect a 
relationship between initially assigned translocation group and number of follow-up 
translocations (see Results), we did not control for follow-up translocations in the 
preceding analyses. To assess seasonal variation in the number of follow-up 
translocations, we used a two-way ANOVA model with season as a within-subjects 
factor and sex as a between-subjects factor. Snakes that were not follow-up translocated 
were excluded from this analysis. 
Results 
A total of 30 adult C. ruber provided telemetry data at various periods of time 
between the middle of 2008 and the end of 2011. Two of these snakes (snakes 2 and 11) 
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were originally tracked as SDT snakes, but were then translocated into the western 
portion of the study site and placed in the LDT group, and treated separately for analyses 
(becoming snakes 2.1 and 11.1). This brought the total sample of snakes for analyses to 
32 (Table 2). Median number of days tracked for these snakes was 387.5 days (range: 
11–1148), and a location fix was obtained for each of these snakes on average (± SD) 
every 5.6 ± 3.1 days. Of these snakes, 10 were classed as NT snakes (4 males, 6 females), 
12 were classed as SDT snakes (7 males, 5 females), and 10 were classed as LDT snakes 
(7 males, 3 females).  
Activity Ranges and Movements 
Depending on measure (MCP, LCH, RL), mean activity ranges averaged 38.6–
67.1% larger for male snakes than those of female snakes, and LDT snakes had 20.0–
56.3% larger activity ranges than SDT snakes, which had 77.0–152.9% larger activity 
ranges than NT snakes (Table 3, Figure 2). Results of the ANOVA models (Table 4) 
confirmed this trend; for MCP and LCH, the effects of sex (P = 0.042 and 0.015, 
respectively) and translocation group (P = 0.004 and 0.029, respectively) were both 
significant. Post hoc Tukey tests for both MCP and LCH showed that LDT > SDT = NT. 
For range length, only translocation group was significant (P = 0.003), with Tukey tests 
indicating LDT = SDT > NT; however, the effect of sex approached significance and had 
a large effect size (P = 0.051, partial η2 = 0.17), suggesting that the range length of males 
was larger. No significant effects were detected for mean daily movement; however, the 
large effect size for translocation group (partial η2 = 0.19; Table 4) suggested that  
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Table 2: Study dates, duration, and fate of radio–tracked Red Diamond Rattlesnakes (Crotalus ruber) near 
Loma Linda, California. Group indicates the translocation group of the snake: whether the snake was 
translocated (moved to a new location after transmitter implantation) a short distance (<710m, LDT) or a long 
distance (>710 m, SDT), or not translocated (NT). First date and last date indicate the first and last time 
telemetry data was collected for each snake. 
I.D. Sex Group 
First  
Date 
Last  
Date 
Days 
Tracked 
Total 
Fixes                   Fate 
2 ♀ SDT 8/2/2008 6/10/2009 313 62 Translocated to become snake 2.1 
2.1a ♀ LDT 10/14/2009 10/21/2009 14 5 Died – killed by human action 
3 ♀ SDT 8/3/2008 10/12/2011 1145 180 Transmitter removed, snake released 
4 ♀ NT 8/10/2008 8/23/2009 384 68 Died – found depredated 
5 ♂ SDT 8/27/2008 2/16/2010 539 92 Died – surgery complications 
6 ♂ SDT 8/27/2008 10/12/2011 1121 151 Transmitter removed, snake released 
7 ♀ SDT 9/1/2008 9/15/2009 382 63 Lost  – suspected transmitter failure 
10 ♂ SDT 9/16/2008 12/8/2008 88 3 Died – injury/surgery complications 
11 ♂ SDT 10/9/2008 10/14/2009 350 52 Translocated to become snake 11.1 
11.1a ♂ LDT 10/21/2009 10/18/2011 721 90 Transmitter removed, snake released 
12 ♀ SDT 10/9/2008 5/7/2009 212 34 Lost  – suspected transmitter failure 
13 ♂ SDT 10/21/2008 11/21/2008 36 6 Lost  – suspected transmitter failure 
14 ♂ SDT 1/11/2009 1/27/2009 26 3 Died – suspected depredation 
15 ♀ SDT 1/26/2009 7/31/2009 193 31 Lost  – suspected transmitter failure 
16 ♀ NT 3/13/2009 10/11/2011 929 165 Transmitter removed, snake released 
17 ♀ NT 3/19/2009 1/28/2010 215 42 Died – disease  
18 ♂ NT 3/19/2009 3/27/2009 11 2 Lost  – suspected transmitter failure 
19b ♀ LDT 10/14/2009 10/17/2011 706 131 Transmitter removed, snake released 
20 ♂ NT 10/21/2009 7/26/2011 631 122 Died – killed by human action 
21 ♀ LDT 4/7/2010 10/11/2011 559 80 Transmitter removed, snake released 
22 ♂ LDT 4/7/2010 4/12/2011 382 79 Died – unknown cause 
23 ♂ NT 4/9/2010 8/14/2011 424 78 Transmitter removed, snake released 
24 ♀ NT 5/13/2010 12/1/2010 204 45 Transmitter failed early; found alive 10/21/2013 
25 ♂ LDT 4/27/2010 10/11/2011 516 92 Lost – suspected transmitter failure 
26 ♂ NT 4/27/2010 12/30/2011 608 103 Not recaptured 
27 ♂ SDT 6/10/2010 12/30/2011 550 83 Not recaptured 
28 ♂ LDT 6/10/2010 10/18/2011 480 46 Transmitter removed, snake released 
29 ♀ NT 7/6/2010 6/15/2011 350 65 Lost – suspected transmitter failure 
30 ♀ NT 7/27/2010 8/23/2011 391 68 Transmitter removed, snake released 
31 ♂ LDT 8/5/2010 9/27/2011 423 62 Lost – suspected transmitter failure 
32 ♂ LDT 9/29/2010 9/19/2011 357 53 Lost – suspected killed by human action 
33 ♂ LDT 11/3/2010 10/24/2011 356 54 Transmitter removed, snake released 
aIndicates an LDT snake that was tracked previously as a SDT snake.  
bThis snake was initially translocated 519 m; however, erratic movement patterns suggested she had been translocated outside of 
her normal home range so we assigned her to the LDT group.  
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LDT snakes exhibited more extensive movements than those of the SDT and NT groups  
(Table 3).  
Table 3. Mean (± S.E.) activity range estimates (100% minimum convex polygon, MCP; 
100% adaptive local convex hull, LCH; range length; RL) and movement descriptors 
(autocorrelation; t2/r2; mean daily movement; MDM) by translocation treatment (not 
translocated; NT; short distance translocated; SDT; long distance translocated; LDT) and 
sex. 
Group N MCP (ha) LCH (ha) RL (m) MDM (m) 
Female      
NT 6 1.21 (±0.24) 0.73 (±0.18) 180.08 (±19.76) 7.09 (±1.09) 
SDT 5 2.17 (±0.37) 0.90 (±0.17) 302.03 (±42.35) 6.04 (±1.00) 
LDT 2 4.71 (±0.30) 1.71 (±0.16) 411.57 (±21.17) 9.82 (±1.23) 
Male      
NT 3 2.60 (±0.35) 1.84 (±0.86) 260.86 (±7.99) 9.87 (±2.05) 
SDT 4 3.88 (±1.05) 2.09 (±0.39) 371.94 (±61.30) 8.28 (±1.69) 
LDT 7 7.17 (±1.30) 3.36 (±0.62) 476.17 (±58.24) 13.39 (±2.52) 
 
 
Figure 2. Mean activity range statistics (± SE) for long distance translocated (>716 m), 
initially short distance translocated (<716 m), and initially untranslocated Red Diamond 
Rattlesnakes (Crotalus ruber) of each sex. 100% minimum convex polygon (MCP; left), 
100% adaptive local convex hull (LCH; center), and range length (right) are shown. 
Numbers in parentheses above the SE bars indicate the sample size for each group. 
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Table 4: Summary of analysis of variance (ANOVA) results comparing rank transformed 
estimates of home range (100% minimum convex polygon, MCP; 100% adaptive local 
convex hull, LCH), range length (RL), mean daily movements (MDM), and autocorrelation 
(t2/r2) between translocation treatment groups (no translocation, short-distance 
translocation, and long-distance translocation) and sex in Red Diamond Rattlesnakes 
(Crotalus ruber) in Loma Linda, California. 
Dependent 
Variable 
Sex  Translocation  Interaction 
F1,21 P η2  F2,21 P η2  F2,21 P η2 
MCP 4.71 0.042* 0.18  7.23 0.004* 0.41  0.77 0.476 0.07 
LCH 7.05 0.015* 0.25  4.22 0.029* 0.29  0.43 0.658 0.04 
RL 4.27 0.051 0.17  7.83 0.003* 0.43  0.42 0.663 0.04 
MDM 2.94 0.101 0.12  2.38 0.117 0.19  0.12 0.886 0.01 
t2/r2 0.53 0.477 0.02  1.71 0.205 0.14  1.93 0.170 0.16 
*P < 0.05 
Effect sizes provided as partial η2, and can be loosely interpreted as proportion of variance 
explained by each effect or interaction 
 
 
 
Mean daily movement varied significantly by both season (F3,69 = 18.57, P 
<0.001, partial η2 = 0.45) and sex (F1,23 = 152.68, P = 0.024, partial η2 = 0.20), and had 
large effect sizes. Pairwise least significant difference (LSD) tests revealed that snakes 
moved significantly less during winter compared to all other seasons (P < 0.001 for all), 
and that movements during spring, summer, and fall were similar (P ≥ 0.422 for all). 
Median male movements were 16.7% greater than that of females. The interaction 
between season and sex was nearly significant, with a moderate effect size (F3,69 = 2.65, 
P = 0.056, partial η2 = 0.10). An interaction plot (Figure 3) suggested that males moved 
more than females during the spring mating season. 
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Figure 3. An interaction plot showing mean daily movement by season for male and 
female Red Diamond Rattlesnakes (Crotalus ruber).   
 
Survival 
Based on available evidence, we determined that nine deaths occurred during the 
study, two of which were related to complications from surgery. One of these two (snake 
5) died during transmitter replacement surgery. The other (snake 10) was tracked for 88 
days, but then sustained an injury that reopened the surgical incision and caused tearing, 
exposing a large portion of the coelomic cavity. The snake died four days later in our 
laboratory despite our best efforts to disinfect and close the wound. Of the six remaining 
deaths, two were likely the result of predation. We found the transmitter of snake 4 on 
open ground with unambiguous bite marks, and near a part of the snake’s rattle 
containing the painted segments used for identification. We found the transmitter of 
snake 14 on the ground with probable bite marks, and without snake remains nearby. 
Two deaths resulted from the action of humans. We found the decapitated body of snake 
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2.1 in a plowed firebreak area 30 m from a home and a tennis court. The clean nature of 
the decapitation wound and absence of injury to the remaining body suggested a sharp 
object was used followed by burial of the head (which was not found). Snake 20 was 
buried by heavy earthmoving equipment as part of a landscaping project to expand the 
cemetery in the western portion of the study site. We confirmed this death by digging up 
the snake’s remains. A third presumed case of human-caused mortality resulted when 
snake 32 moved into a large pile of brush and rocks within the area of the cemetery 
landscaping project. The pile was subsequently loaded by heavy equipment into large 
dumpsters and hauled away, presumably taking the snake away as well. In the remaining 
two cases of death, one resulted from apparent disease and the other was from unknown 
causes. We found snake 17 writhing and biting the ground in an area of coastal sage 
scrub, and subsequently euthanized the snake when it deteriorated further in our lab. We 
found the transmitter of snake 22 devoid of marks and in a large brush pile 24 m from a 
house.  
We conducted two Kaplan-Meier analyses classifying each of the snakes above as 
ending in a mortality event. For the first test comparing the three translocation groups, the 
mean (± SE) survival time for all snakes was 853 ± 94 days, with 652 ± 110 days for NT 
snakes, 1033 ± 106 days for SDT snakes, and 575 ± 77 days for LDT snakes. A Mantel-
Cox test showed no statistical difference between the three translocation groups (χ2 = 
0.77, P = 0.68). A separate test comparing males and females also found no significant 
difference (χ2 = 0.01, P = 0.91). Mean survival time was 796 ± 131 days for males and 
894 ± 126 days for females.  
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 We conducted two more Kaplan-Meier analyses similar to the first one except that 
we excluded snakes that died due to human action. In the first model comparing 
translocation groups, the mean (± SE) survival time for all snakes was 973 ± 77 days, 
with 734 ± 116 days for NT snakes, 1033 ± 106 days for SDT snakes, and 677 ± 46 days 
for LDT snakes. Again, the Mantel-Cox test showed no statistical difference between the 
three translocation groups (χ2 = 0.63, P = 0.730). A separate test comparing males and 
females again found no significant difference (χ2 = 0.01, P = 0.923). Mean survival time 
was 961 ± 103 days for males and 962 ± 116 days for females.  
To supplement the Kaplan-Meier analyses, we also compared first-year survival 
(≤365 days of tracking) of snakes in each group, excluding snakes whose eventual death 
involved surgical complications during the first year (snakes 5, 10). We ran two Chi-
square analyses of survival for the three translocation groups, one excluding and the other 
including cases where deaths were attributable to human action. Results are shown in 
Table 5. Most snakes lost during the study without confirmed mortality resulted from 
transmitter failure; thus, mortality could not be determined for these individuals. 
Omitting these lost snakes, there were no differences between groups when human-
caused mortalities were excluded (N = 23, df = 2, χ2 = 1.18, P = 0.553, Cramer’s V = 
0.23) or when they were included (N = 24, df = 2, χ2 = 0.036, P = 0.982, Cramer’s V = 
0.04). Thus, first-year survival rates were comparable for non-translocated (85.7% of N = 
10 snakes) and translocated snakes (both groups combined: 80.0% of 20 snakes 
excluding human-caused mortality, 80.9% of 21 snakes including human-caused 
mortality), with small effect sizes. 
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Table 5. Summary of first-year survival (≤ 365 days of tracking) for radiotransmittered 
snakes in each translocation group (NT, not translocated; SDT, short-distance 
translocation; LDT, long-distance translocation). Survival rate excludes snakes lost during 
the study, presumably from transmitter failure. One snake mortality due to surgical 
complications that occurred during the first year of tracking is omitted. 
Group N 
Survived 
(%) 
Lost 
(%) 
Confirmed 
dead (%) 
Survival 
rate (%) 
Without Human 
Mortality 
     
NT 10 60.0 30.0 10.0 85.7 
SDT 11 63.6 27.3 9.1 87.5 
LDT 9 89.0 11.1 0.0 100.0 
With Human Mortality      
NT 10 60.0 30.0 10.0 85.7 
SDT 11 63.6 27.3 9.1 87.5 
LDT 10 80.0 10.0 10.0 88.9 
 
 
Distance to SHM Areas by Season 
The average distance of snakes from SHM areas varied by season (Figure 4A). 
The one-way repeated-measures ANOVA showed a nearly significant effect of season 
and a moderate effect size (N = 19, F3,54 = 2.52, P = 0.068, η2 = 0.12). The mixed 
factorial ANOVA including season, sex, and translocation group similarly showed season 
to approach significance with a fairly large effect size (N = 19, F3,39 = 2.32, P = 0.090, 
partial η2 = 0.15). Pairwise comparisons using the least significant difference (LSD) 
method showed significant differences, with distance to SHM areas being less in summer 
than in spring or winter (P = 0.032 and 0.048 respectively; Figure 4A). Translocation 
group (F2,13 = 0.14, P = 0.872, partial η2 = 0.02) and sex (F1, 13 = 0.15, P = 0.707, partial 
η2 = 0.01) were not significant, and no significant interactions were detected. 
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Figure 4. (A) Mean (± SE) distance to areas of significant human modification for 19 
snakes across four seasons. (B) Mean (± SE) number of follow-up translocations for 16 
snakes across three seasons. Winter is omitted because no follow-up translocations from 
areas less than 50 m from areas of significant human modification occurred during this 
season. 
 
Risk of Return to Human-modified Areas 
Following transmitter implantation, snakes (including those from all three 
translocation groups) were initially released an average of 152.5 m (range: 25.9–459.5 m) 
away from the nearest SHM area. Omitting two snakes initially released <50 m away 
from SHM areas, 73.3% of all snakes (22 out of 30), regardless of translocation group, 
moved to areas within 50 m of SHM areas subsequent to initial release. Median time for 
these snakes to move to these areas was 48 days (95% CI = 0.00–141.18) based on 
Kaplan-Meier analysis. Cox regression revealed that an increase in distance between a 
snake’s release point and SHM areas reduced the risk of a snake moving near such areas 
by a small but significant amount (hazard ratio [HR] = 0.988, 95% CI = 0.977–0.99, N = 
30, df = 1, Wald = 4.83, P = 0.028). The model suggested that, holding other factors 
constant, for every 1 m increase in distance from the release point to SHM areas, the risk 
of returning to such areas decreased by 1.2% (95% CI = 1.0–2.3%). Translocation group 
 
A B 
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also affected the risk of a snake moving near SHM areas (N = 30, df = 2, Wald = 9.00, P 
= 0.011), with LDT (HR = 5.92, 95% CI = 1.39–25.21, Wald = 5.78, df = 1, P = 0.016) 
and SDT snakes (HR = 10.18, 95% CI = 2.23–46.45.21, Wald = 8.97, df = 1, P = 0.003) 
having a significantly greater risk of moving near SHM areas than NT snakes (Figure 5). 
Sex was not significant (Wald = 3.42, df = 1, P = 0.065).  
 
 
Figure 5. Cumulative incidence of snakes moving within 50 m of an area of significant 
human modification after initial release. A separate curve is shown for each translocation 
group.  
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Risk of Return to Area of Capture after Translocation 
Of the 22 snakes that were short-distance translocated away from SHM areas at 
some point during the course of the study, the first such translocation for these snakes 
averaged 246.2 ± 155.7 m (range 32.2–633 m). Omitting one snake that was translocated 
less than 50 m, 52.4% of these snakes returned to within 50 m of their original location. 
Median time to return was 163 days (95% CI = 11.1–314.9) based on Kaplan-Meier 
analysis. Cox regression again showed a small but significant effect of the distance the 
snake was translocated away from its capture site (N = 21, HR = 0.985, 95% CI = 0.937–
0.998, Wald = 5.07, df = 1, P = 0.024). This model suggested that, keeping other 
variables constant, for every 1 m increase in the translocated distance, the risk of return 
decreased by 1.5% (95% CI = 0.2– 6.3%). Sex (Wald = 1.88, df = 1, P = 0.170) and 
translocation group (Wald = 0.34, df = 2, P = 0.842) were not significant. None of the 
LDT snakes returned to within 50 m of their initial capture sites except for the one female 
(snake 19) which was initially translocated 519 m but was assigned to the LDT group due 
to extensive and erratic movements after translocation. Another LDT snake (snake 33), 
translocated 2573 m from his initial capture site, appeared to make an effort to return. 
Subsequent to initial release on 1 November 2010, this snake moved 681 m in a direction 
toward its capture site until 11 November 2010, when it moved into a residential area and 
on the grounds of an elementary school. It was then translocated 633 m back to its 
original translocated position. The snake again moved 618 m in a direction towards its 
capture site and returned to within 126 m of the same elementary school on 15 December 
2010. At this point, to prevent the snake from returning to the elementary school, we 
broke protocol and again recaptured the snake prior to re-entering an area of potential 
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human conflict (which is why this translocation was excluded from the translocation 
analysis above). We translocated this snake 582 m (straight-line distance) back to the 
point of its initial release. It then overwintered near this release point. The snake did not 
move in the direction of its capture location the following spring, and was found paired 
with a female on 3 March 2011.  
Follow-up Translocations 
Sixteen snakes underwent short-distance follow-up translocation at least once 
during the study, including 4 of the 10 NT snakes (40.0%), 6 of the 12 SDT snakes 
(50.0%), and 6 of the 10 LDT snakes (60.0%). For these snakes, we conducted an 
average of 3.6 (SD = 3.1) translocations per snake per year. The number of follow-up 
translocations per season per year was independent of assigned treatment group (F2,21 = 
1.35, P = 0.28, η2 = 0.11) and sex (F1,21 = 0.02, P = 0.89, η2 = 0.001), and there was no 
significant interaction between sex and treatment group (F2,21 = 2.05, P = 0.153, η2 = 
0.16). 
The number of follow-up translocations varied by season (Figure 4B), with the 
highest frequency in summer and none occurring during winter. The one-way repeated-
measures ANOVA for the three seasons showed a significant effect (N = 16, F2,30 = 3.53, 
P = 0.042, η2 = 0.19), with pairwise LSD comparisons suggesting significantly fewer 
follow-up translocations during spring compared to summer and fall (P = 0.045 and 
0.020 respectively). The mixed factorial ANOVA including season and sex approached 
significance for season and showed a relatively large effect size (N = 16, F2,28 = 3.24, P = 
0.054, η2 = 0.19). Sex (F1,14 = 0.71, P = 0.42, partial η2 = 0.05) was not significant.  
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Discussion 
Mitigation translocation has received increasing attention as an option for dealing 
with nuisance wildlife, including venomous snakes. However, three key concerns have 
been raised: 1) the potential of harm to the translocated snake; 2) return of the snake to 
the original site of human-snake conflict; and 3) population-level effects that result from 
the translocated animal. In this study, we radiotracked three groups of adult rattlesnakes 
to improve our understanding of the first two concerns. If translocation represents a 
successful management tool for reducing human-snake conflict, it should minimally 
impact the translocated snake while reducing the likelihood of the snake returning to a 
site of potential conflict. We sought to learn how distance of nuisance snake translocation 
from human-modified areas would impact their subsequent spatial ecology, movements, 
survival, and, ultimately, their potential for conflict with humans. Because of property 
owner requests and liability issues at our study site, we were compelled to translocate all 
snakes that were initially found in human-modified areas, and those that returned 
subsequently to these areas. In spite of this complication to our study design, we were 
able to assess not only the role of translocation distance in translocation success, but also 
differences between the sexes and among the four seasons.  
Translocation Effects on the Snake 
One major concern about mitigation translocation is the potential for negative 
impacts on the snake. We found the activity ranges (both MCP and LCH) of LDT snakes 
to be 1.5 to 4.0-fold larger than those of SDT and NT snakes. Range lengths for both 
LDT and SDT snakes were also 1.9 to 2.2-fold larger than those of NT snakes. 
Translocation group differences, however, were less evident from mean daily 
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movements, though the relatively large effect size was consistent with the trends for 
activity ranges and range length. These results are consistent with those of most studies 
of rattlesnakes to date, which also have found that translocated snakes exhibit larger 
activity ranges and move greater distances than non-translocated snakes, at least in the 
first year of study (Table 1).  
Males in our study also exhibited 1.4 to 1.7-fold larger activity ranges and 1.2-
fold greater daily movements than females, which is typical of C. ruber (Brown et al. 
2008) and other rattlesnakes (e.g. D. Duvall & Schuett, 1997; Jellen, Shepard, Dreslik, & 
Phillips, 2007; Glaudas & Rodríguez-Robles, 2011). We found no interaction between 
sex and translocation group in home range size and movements, suggesting that both 
sexes responded similarly to the translocation. However, we did find a nearly significant 
interaction between season and sex that may suggest that males move greater distances 
than females in the spring. This is unsurprising, as spring is the mating season for C. 
ruber (Dugan et al. 2008). Rattlesnakes, as with pitvipers generally, exhibit prolonged 
mate searching polygyny in which males search competitively for widely distributed, 
spatially unpredictable, and/or scarce females (Duvall et al. 1992). In the process of 
searching for females, males traverse long distances, potentially in previously unexplored 
areas, and, consequently, garner larger home ranges (Aldridge & Duvall 2002). 
Accordingly, sex-based differences may exist in the behavior of snakes in unfamiliar 
surroundings and, ultimately, in their tolerance to LDT. Because males roam widely 
when searching for females, they may be equipped with behavioral and physiological 
adaptations that enable them to navigate and otherwise cope with being in previously 
unexplored areas, which females, who move much less and have smaller home ranges 
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(Aldridge & Duvall 2002), may lack. The presence of such physiological adaptations has 
been suggested by the findings of Holding et al. (2012, 2014) and Heiken (2013). 
Although only male C. oreganus was used in both studies, snakes repeatedly subject to 
SDT developed larger medial cortexes than controls, presumably in response to increased 
navigational demands (Holding et al. (2012, 2014), and increased testosterone levels in 
LDT snakes may aid in spatial learning and memory (Heiken (2013). Both studies looked 
at levels of the stress hormone corticosterone and found no difference between 
translocated and control snakes. If males are adapted to cope with unfamiliar areas, then 
such a reduced stress response would be expected. 
Although our snakes exhibited increases in space use and movements 
corresponding to distance of translocation, survival (overall and during the first year) was 
similar among the three translocation groups and between sexes. Moreover, survival in 
the first year was similar among groups and between sexes regardless of whether we 
included (87.5% for all snakes) or excluded (91.3% for all snakes) human-caused 
mortalities. Thus, at our study site, translocation of nuisance snakes neither subjected 
them to nor protected them from higher levels of mortality. Effect sizes (Cramer’s V) 
comparing survival between translocation groups of snakes were in the range of 0.04 to 
0.23, depending on whether human-caused mortalities were included, which we interpret 
as small to moderate (Cohen, 1988). With much larger sample sizes, the differences could 
certainly become significant, but effect size has more biological relevance than does 
significance (Nakagawa & Cuthill 2007). 
 Our results were generally consistent with those of previous studies, whose effect 
sizes (Cramer’s V) for longer-term studies ranged from 0.19 to 0.47 (relatively small to 
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large; Table 1). Prior research has shown no differences in mortality for SDT snakes 
compared with controls (Brown et al. 2009; Holding et al. 2012; Holding 2011; Holding 
et al. 2014; Brown et al. 2008). For LDT snakes, however, previous studies offer mixed 
conclusions. Brown et al. (2008), who also examined C. ruber, did not detect a difference 
in mortality between LDT and non-translocated snakes, but other studies of C. atrox and 
C. horridus reported that LDT snakes suffered higher mortality (Reinert & Rupert, 1999; 
Nowak et al., 2002; Heiken [2013] observed no mortality in both control and LDT 
snakes, but the study duration was only one month). The difference between C. ruber and 
other species may be due to differences in habitat and/or dependence upon specific 
hibernacula for overwinter survival. In cooler climates, snakes unable to locate suitable 
locations to brumate (≈ hibernate) are much less likely to survive the winter (Nowak & 
Riper 1999). Indeed, a significant number of mortalities among LDT snakes in Reinert & 
Rupert's (1999) study occurred during the winter, and high winter mortality has been 
reported in repatriated Massasuaga rattlesnakes (Sistrurus catanatus; King et al. 2004; 
Harvy & Lentini 2013). In warmer climates, such as southern California, the need to 
utilize specific or communal hibernacula to escape freezing conditions is reduced (Dugan 
et al. 2008), and hence the inability to find ideal hibernacula may have less of an effect 
on survival. We encourage future researchers to emphasize effect sizes when comparing 
the behavior and survival of translocated snakes to control snakes. Because these studies 
involve radiotelemetry and intense tracking effort, sample sizes are generally small, 
which hampers statistical power. Effect sizes are independent of sample size and can be 
more readily compared among different studies (Nakagawa & Cuthill 2007). 
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Risks Associated with Human-Snake Conflict 
The second major concern of mitigation translocation is whether the snake is less 
likely to return to the area of potential human-snake conflict. We considered three 
measures of potential conflict in relation to snake translocation: 1) average distance of the 
snake from human-modified areas; and 2) whether snakes returned to human-modified 
areas. Prior studies of snake translocation have only considered the latter measure. In 
terms of distance from human-modified areas, seasonality appeared to have the strongest 
influence. Our snakes, regardless of sex or translocation group, moved closer to SHM 
areas and were subject to a greater number of follow-up translocations in summer (and to 
a lesser extent in fall) than during spring or winter (Figure 4B). This seasonal effect 
contrasts with the seasonal occurrence of snake envenomations in southern California, 
which peak in the spring (Parrish et al. 1964; Wingert & Chan 1988; Chapter 4 this 
dissertation). Although a significant proportion of snake envenomations occur at the 
victim’s home (Parrish et al. 1964; Tokish et al. 2001; Minton 1987), human 
envenomations appear to be associated more strongly with seasonal increases in snake 
movement. Indeed, C. ruber shows highest levels of activity during the mating season in 
spring  (T. K. Brown et al., 2008; Dugan et al., 2008; present study), when most human 
envenomations occur. Of course, a snake isn’t a nuisance unless it is discovered (Sealy 
1997; Sealy 2002), and snakes are presumably more likely to be encountered or detected 
by humans when they are moving. Indeed, one study reported that human infants showed 
a differential response to snake images over that of other animals only when shown a 
video of a moving snake (DeLoache & LoBue 2009).  
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The number of snakes requiring follow-up translocation because they returned to 
human-modified areas was most frequent during summer, regardless of sex (Figure 4B). 
A high proportion (73.3% of 30) of snakes moved near SHM areas at some point during 
the study (median of 48 d after initial release), and roughly half of those translocated a 
short distance away from SHM areas (52.4% of 22) returned to within 50 m of their 
original capture site in an SHM area (median of 163 days). Translocated snakes of both 
groups were 5.9 to 10.2-fold more likely to move near SHM areas than were NT snakes, 
regardless of sex. The difference between groups is not surprising, since NT snakes 
tended to have established home ranges that were more distant to SHM areas, whereas 
translocated snakes were classified as such because their home range brought them to 
SHM areas. However, the risk of a snake moving to a SHM area decreased at 
approximately 1.2% per 1 m distance of initial release from a SHM area. For those 
snakes moved a short-distance at some time during the tracking, the probability of 
returning to close proximity (within 50 m) of their initial capture site was independent of 
translocation group and sex. Some snakes in all groups were subjected to this 
translocation, so the lack of differences between translocation groups seems expected. 
But more important, the risk of a snake moving to a SHM area decreased at 
approximately 1.5% per 1 m distance of release from a SHM area. 
Snakes subjected to LDT may nevertheless experience negative impacts. Such 
individuals may take time to orient themselves to the new environment and, as a result, 
increase their movements and exposure to risks as they search for suitable areas to forage, 
bask, shelter, and locate mates. If these snakes exhibit natal habitat preference induction 
and have established natal home ranges that include SHM areas, then such snakes may 
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seek such areas once translocated, and either come into conflict with humans again, or 
move into sub-optimal habitats that the snake perceives to be similar to SHM areas, and 
thereby increase their risk of mortality (Stamps & Swaisgood 2007). In our study, the risk 
of LDT snakes moving near SHM areas was about six fold greater than that of NT 
snakes, and equivalent to SDT snakes. This may be explained in at least three ways. First, 
LDT snakes may have been attempting to navigate back to the area near their point of 
capture, and SHM areas existed between their position and their intended destination. 
This seemed to be the case for snake 33, whose movements suggested deliberate 
navigation toward its capture site. Its movement into an SHM area was likely because 
such areas just happened to be on his intended path. Second, LDT movements into SHM 
areas could have been facilitated by the larger home-ranges and increased movement 
patterns exhibited by these individuals. Third, LDT snakes may actively seek SHM areas 
subsequent to translocation because they have developed a preference for such areas due 
to prior foraging (or mating) success, or even natal habitat preference induction (Stamps 
& Swaisgood 2007). Though little evidence exists of natal habitat preferences in reptiles 
(Germano & Bishop 2009), it has been documented in a wide range of taxa, including 
amphibians, birds, and mammals (Davis & Stamps 2004), so it also likely exists in 
reptiles as well. 
The Effect of Follow-up Translocations 
The obligation from legal counsel to conduct follow-up short-distance 
translocations created the potential that these extra translocations would confound the 
effect of our initial translocation treatment groups. However, several lines of evidence 
suggest that our comparisons of the three treatment groups remain largely valid. First, 
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only the LDT snakes were subjected to a (single) long-distance translocation, which 
maintained this group’s independence from the others. Second, only 50% of the NT 
snakes experienced SDT in the form of follow-up translocation, whereas all of the SDT 
snakes experienced SDT. Although the follow-up translocations likely reduced the 
magnitude of response differences between these two groups, some differences still 
emerged. Third, the mean number of follow-up translocations per season per year was 
statistically similar for the three treatment groups, suggesting an equivalent effect of this 
treatment for all groups.  
Implications for Managing Nuisance Rattlesnakes 
Those who deal with human-wildlife conflict must take into consideration three 
major issues when mitigating situations involving nuisance animals. Our research has 
addressed the first two issues for rattlesnakes, which include the potential negative 
impact to the individual nuisance animal, and the risk to humans (or property) posed by 
the animal. The third issue is the potential negative impact to the population the animal is 
a part of and/or the population it may be moved to if translocated. We will comment on 
each of these as they relate to managing nuisance rattlesnakes. 
With regard to welfare of the nuisance animal, there are three major options for 
dealing with nuisance rattlesnakes: (1) leaving the snake alone, which a property owner 
often objects to; (2) euthanasia, which has the most deleterious impact to the snake, and 
is therefore considered least humane; or (3) removal of the live snake, either by 
translocating it to another area or maintaining it indefinitely in captivity. For 
translocation, a trade-off exists between immediate effects on the snake's behavior, 
including an increased risk of death (the major problem with LDT), versus future return 
 63 
to the area of conflict, which could result once again in human conflict and death of the 
snake (the major problem with SDT). Heretofore, LDT has been strongly criticized as a 
strategy that unacceptably increases the probability of snake death (Reinert & Rupert 
1999; Nowak et al. 2002; Sullivan et al. 2014). However, two studies of C. ruber (ours 
and Brown et al. 2008) suggest that LDT can be a viable option for at least some species, 
or for snakes in certain climates or habitats. Much of the mortality reported for 
translocated snakes of other species has been associated with brumation ≈ hibernation 
(Reinert & Rupert 1999; Harvey et al. 2014), often at communal hibernacula. Repatriated 
snakes (captive-raised prior to release in the wild) have similarly been especially 
vulnerable during the hibernation period (King et al. 2004). The milder climate of 
southern California, where many snakes overwinter individually without strong site 
fidelity (Dugan et al. 2008), may reduce the risk of overwinter mortality in translocated 
snakes. Other factors no doubt contribute to translocation success, including the species' 
biology (C. ruber is a relatively sedentary species; Dugan et al. 2008), snake population 
density, and availability of prey and refugia, At present, we find no compelling evidence 
to recommend against LDT in the southern California region, except at higher altitudes 
where communal overwintering at scarcely-distributed suitable sites may be critical for 
survival. Nevertheless, we certainly agree with Sullivan et al. (2014) that public 
education about tolerating nuisance rattlesnakes would be a viable alternative or 
supplement to mitigation translocation. 
Although LDT may increase the probability of rattlesnake mortality in the short 
term, at least the snakes are given a chance to succeed. Some consider the reduced 
survival rate of LDT (as low as 45.5%; Table 1) unacceptable (Reinert & Rupert 1999; 
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Sullivan et al. 2014); however, all wild snakes will experience death eventually through 
illness, starvation, depredation, and/or senescence, any of which might cause equal levels 
of suffering. Many LDT snakes live beyond the first year of highest vulnerability, and 
thereafter may thrive as successfully as non-translocated snakes (Reinert & Rupert 1999). 
In the absence of studies showing substantially lower levels of survival (well under 50%), 
we see no reason why LDT would be more unethical than euthanasia, particularly in 
areas where SDT is not an option permitted by property owners. 
With regard to risk of the nuisance animal to humans or property, venomous 
snakes actually pose a very low risk to humans in the United States. The most recent 
estimates put the incidence of snake envenoming at 0.79 per 100,000 per year, and the 
incidence of death from such envenomings at 0.001 per 100,000 per year (Kasturiratne et 
al. 2008). Certainly the risk is higher for those people who live in more rural areas, those 
who spend significant time in natural areas for recreational or occupational purposes, and 
those whose health may be somewhat compromised. Yet in many cases human 
envenomings occur because a human deliberately chooses to interact with the snake, 
either to harass, kill, or capture it (see Chapter 3), suggesting that the risk of 
envenomation would be significantly reduced if people would simply choose to leave the 
snakes alone. In spite of the fact that our snakes most frequently approached and entered 
SHM areas during the summer, the majority of human envenomations in our region occur 
during spring (Parrish et al. 1964; Wingert & Chan 1988; Chapter 3 this dissertation). 
This discrepancy suggests that simple proximity to SHM areas may be a poor predictor of 
the overall risk to humans posed by venomous snakes.  
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Although no research has examined the third issue for rattlesnakes, strategies for 
mitigating human-wildlife conflict may have effects at the population level (Burke 1991; 
Reinert 1991; Chipman et al. 2008; Massei et al. 2010; Sullivan et al. 2014). Certainly, 
indiscriminant use of euthanization has the potential to deplete local populations—an 
outcome that can be particularly undesirable if the species in question is protected, as in 
our study, or is a high trophic level consumer (i.e., predator), which can lead potentially 
to profound ecosystem change (Shine & Koenig 2001; Estes et al. 2011; Sullivan et al. 
2014). Moreover, euthanization may alter sex ratios by effecting one sex more than the 
other. Previous studies indicate a male bias in human-caused snake mortality (Bonnet et 
al. 1999; Shepard et al. 2008), and male rattlesnakes may be responsible for more human 
envenomations than females (Cardwell et al. n.d.), suggesting they may be more likely to 
come into conflict with humans.  
Translocations involving substantial distance have the potential to affect both the 
source population (assuming absence of homing to the original location) and the 
population the animal is moved to. In the case of rattlesnakes, individual cases of 
conventional LDT (beta-translocation) involve distances too limited to affect anything 
more than the immediate neighbors of the translocated snake. Given the dynamic nature 
of snake home ranges, which contract and expand seasonally and from year to year, and 
generally overlap widely the ranges of other snakes (Macartney et al. 1988), any impacts 
from the translocation of a few snakes should be fairly negligible. More problematic 
would be removal of an excess number of snakes from a given location, as the local 
population could suffer predator depletion. Sex ratios might also become skewed in both 
the source (female-biased) and receiving (male-biased) populations. These risks are not 
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only dependent on the distance these snakes are moved, but also on the number of 
animals moved. Nuisance snake dumping, involving dozens of individuals at the same 
location, has been described in Arizona (Mccrystal & Ivanyi 2008), and no doubt has 
negative repercussions for the dumped snakes and the local environment. With regional 
translocation beyond the local deme (gamma-translocation), the translocated snake may 
become a vector of disease transmission to the new population, alter the genetic structure 
of the new population, or increase the receiving population beyond carrying capacity 
(Reinert 1991; Shine & Koenig 2001). For rattlesnakes, the consequences of gamma-
translocation have not been examined, but there are compelling reasons to recommend 
against this practice unless it is part of a carefully monitored repatriation program (e.g. 
Harvey et al. 2014 and references therein). 
Conclusions 
This study investigated nuisance snake translocation as a management tool for 
reducing human-snake conflict. Although rattlesnakes translocated beyond their normal 
home range exhibited increased space use and movements, those moved greater distances 
from human-modified areas were less likely to return, and they experienced survival rates 
similar to those moved short distances. Thus, our findings add to the growing body of 
evidence that translocation of nuisance snakes can be a viable approach to reduce human-
snake conflict, at least for some species and/or locations. In spite of accumulating studies 
on the effects of translocation on snakes, this form of mitigation remains a highly 
experimental approach for which generalizations should be made with caution. Studies 
vary substantially in their translocation protocols, duration, and assessments of behavior 
and mortality, and all are constrained by relatively small samples. Standardized 
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terminology for translocation distances, such as the alpha-, beta-, gamma-, and delta-
translocation rubric we introduce here, can reduce the confusion arising from different 
meanings of the terms SDT and LDT among different studies. 
  
 68 
References 
Aldridge, R.D. & Duvall, D.J., 2002. Evolution of the mating season in the pitvipers of 
North America. Herpetological Monographs, 16(1), pp.1–25. 
Athreya, V. et al., 2011. Translocation as a tool for mitigating conflict with leopards in 
human-dominated landscapes of India. Conservation Biology, 25(1), pp.133–141. 
Benn, B. & Herrero, S., 2014. Grizzly bear mortality and human access in Banff and 
Yoho National Parks, 1971-98. Ursus, 13(2002), pp.213–221. 
Bonnet, X., Naulleau, G. & Shine, R., 1999. The dangers of leaving home: dispersal and 
mortality in snakes. Biological Conservation, 89(1), pp.39–50. 
Braband, L. & Clark, K., 1991. Perspectives on wildlife nuisance control: Results of a 
wildlife damage control firm’s customer survey. In Fifth Eastern Wildlife Damage 
Control Conference. pp. 2–6. 
Brown, J.R., Bishop, C.A. & Brooks, R.J., 2009. Effectiveness of short-distance 
translocation and its effects on Western Rattlesnakes. Journal of Wildlife 
Management, 73(3), pp.419–425. 
Brown, T.K. et al., 2008. Spatial ecology, habitat use, and survivorship of resident and 
translocated Red Diamond Rattlesnakes (Crotalus ruber). In W. K. Hayes et al., eds. 
The Biology of Rattlesnakes. Loma Linda, California: Loma Linda University Press, 
pp. 377–394. 
Burke, R.L., 1991. Relocations, repatriations, and translocations of amphibians and 
reptiles: taking a broader view. Herpetologica, 47(3), pp.350–357. 
Calenge, C., 2006. The package “adehabitat” for the R software: A tool for the analysis 
of space and habitat use by animals. Ecological Modelling, 197(3-4), pp.516–519. 
Cardwell, M.D., Bush, S.P., Clark, R.T. & Dugan, E.A., 2005? Males biting males: does 
testosterone shape both sides of the snakebite equation? Unpublished poster 
presentation. 
Cardwell, M.D., 2008. The reproductive ecology of Mohave Rattlesnakes. Journal of 
Zoology, (274), pp.65–76. 
Carter, E.T. et al., 2014. Reducing the potential for human-snake encounters in a 
recreational park. Human–Wildlife Interactions, 8(2), pp.158–167. 
Chipman, R. et al., 2008. Downside risk of wildlife translocation. Developments in 
biologicals, 131, pp.223–32. 
 69 
Cohen, J., 1988. Statistical power analysis for the behavioral sciences 2nd ed., Hillsdale, 
NJ: Lawrence Erlbaum Associates. 
Conover, M.R., 2002. Resolving human-wildlife conflicts: the science of wildlife damage 
management, Boca Raton, Florida: CRC Press. 
Corneille, M.G. et al., 2006. A large single-center experience with treatment of patients 
with crotalid envenomations: outcomes with and evolution of antivenin therapy. 
American Journal of Surgery, 192(6), pp.848–852. 
Cowling, R.M. et al., 1996. Plant diversity in mediterranean-climate regions. Trends in 
Ecology and Evolution, 11(9), pp.362–366. 
Cox, D.R., 1972. Regression models and life-tables. Journal of the Royal Statistical 
Society. Series B (Methodological), 34(2), pp.187–220. 
Craven, S., Barnes, T. & Kania, G., 1998. Toward a professional position on the 
translocation of problem wildlife. Wildlife Society Bulletin, 26(1), pp.171–177. 
Cunningham, A.A., 1996. Translocations of wildlife disease risks. Conservation Biology, 
10(2), pp.349–353. 
Dart, R.C. et al., 1992. The sequelae of pitviper poisoning in the United States. In J. A. 
Campbell & E. D. Brodie, eds. Biology of the Pitvipers. Tyler Texas: Selva, pp. 
395–404. 
Davis, J.M. & Stamps, J. a, 2004. The effect of natal experience on habitat preferences. 
Trends in Ecology & Evolution, 19(8), pp.411–6. 
DeGregorio, B. a et al., 2011. The spatial ecology of the Eastern Massasauga (Sistrurus c. 
catenatus) in northern Michigan. Herpetologica, 67(1), pp.71–79. 
DeLoache, J.S. & LoBue, V., 2009. The narrow fellow in the grass: Human infants 
associate snakes and fear. Developmental Science, 12(1), pp.201–207. 
Dugan, E.A., Figueroa, A. & Hayes, W.K., 2008. Home range size, movements, and 
mating phenology of sympatric Red Diamond (Crotalus ruber) and Southern Pacific 
(C. oreganus helleri) rattlesnakes in southern California. In W. K. Hayes et al., eds. 
The Biology of Rattlesnakes. Loma Linda, California: Loma Linda University Press, 
pp. 353–364. 
Duvall, D. & Schuett, G., 1997. Straight-line movement and competitive mate searching 
in prairie rattlesnakes, Crotalus viridis viridis. Animal Behaviour, 54(2), pp.329–34. 
 70 
Duvall, D.J., Arnold, S.J. & Schuett, G.W., 1992. Pitviper mating systems: ecological 
potential, sexual selection, and microevolution. In J. A. Campbell & E. D. Brodie, 
eds. The Biology of the Pitvipers. Tyler, Texas: Selva Press, pp. 321–336. 
Estes, J. a et al., 2011. Trophic downgrading of planet Earth. Science (New York, N.Y.), 
333(6040), pp.301–306. 
Fernández-Juricic, E., Vaca, R. & Schroeder, N., 2004. Spatial and temporal responses of 
forest birds to human approaches in a protected area and implications for two 
management strategies. Biological Conservation, 117(4), pp.407–416. 
Field, A., 2005. Discovering Statistics Using SPSS 2nd ed., London: SAGE Publications. 
Fischer, J. & Lindenmayer, D.., 2000. An assessment of the published results of animal 
relocations. Biological Conservation, 96(1), pp.1–11. 
Germano, J.M. & Bishop, P.J., 2009. Suitability of amphibians and reptiles for 
translocation. Conservation Biology, 23(1), pp.7–15. 
Getz, W.M. et al., 2007. LoCoH: nonparameteric kernel methods for constructing home 
ranges and utilization distributions. PloS one, 2(2), p.e207. 
Getz, W.M. & Wilmers, C.C., 2004. A local nearest-neighbor convex-hull construction of 
home ranges and utilization distributions. Ecography, 27(4), pp.489–505. 
Gibbons, J.W. & Dorcas, M.E., 2002. Defensive behavior of Cottonmouths (Agkistrodon 
piscivorus) toward humans C. Guyer, ed. Copeia, 2002(1), pp.195–198. 
Glaudas, X. & Rodríguez-Robles, J.A., 2011. Vagabond males and sedentary females: 
spatial ecology and mating system of the speckled rattlesnake (Crotalus mitchellii). 
Biological Journal of the Linnean Society, 103(3), pp.681–695. 
Green, S.B. & Salkind, N.J., 2005. Using SPSS for Windows and Macintosh: Analysing 
and Understanding Data 4th ed., Upper Saddle River, NJ, U.S.A.: Pearson Prentice 
Hall. 
Gregory, P.T., Macartney, J.M. & Larsen, K.W., 2001. Spatial Patterns and Movements. 
In R. A. Seigel, J. T. Collins, & S. S. Novak, eds. Snakes: Ecology and Evolutionary 
Biology. Caldwell, New Jersey: The Blackburn Press, pp. 366–395. 
Griffith, B. et al., 1989. Translocation as a species conservation tool: status and strategy. 
Science, 245(4917), pp.477–80. 
Halama, K.J. et al., 2008. Modeling the landscape niche characteristics of Red Diamond 
Rattlesnakes (Crotalus ruber): implications for biology and conservation. In W. K. 
 71 
Hayes et al., eds. The Biology of Rattlesnakes. Loma Linda, California: Loma Linda 
University Press, pp. 463–472. 
Hardy, D.L. et al., 2001. Relocation of nuisance rattlesnakes : problems using short-
distance translocation in a small rural community. The Newsletter of the Colorado 
Herpetological Society, 28(9), pp.62–63. 
Hardy, D.L. & Greene, H.W., 1999. Surgery on rattlesnakes in the field for implantation 
of transmitters. Sonoran Herpetologist, 12(3), pp.25–27. 
Hare, T. & McNally, J.T., 1997. Evaluation of a rattlesnake relocation program in the 
Tucson, Arizona, area. Sonoran Herpetologist, 85724(May 1996), pp.26–31. 
Harvey, D. & Weatherhead, P.J., 2006. A test of the hierarchical model of habitat 
selection using eastern massasauga rattlesnakes (Sistrurus c. catenatus). Biological 
Conservation, 130(2), pp.206–216. 
Harvey, D.S. et al., 2014. Moving Massasaugas: insight into rattlesnake relocation using 
Sistrurus c. catenatus. Herpetological Conservation and Biology, 9(1), pp.67–75. 
Heiken, K.K., 2013. The behavioral and physiological effects of long-distance 
translocation on Western Rattlesnakes (Crotalus oreganus). California Polytechnic 
State University, San Luis Obispo. 
Holding, M.L. et al., 2012. Experimentally altered navigational demands induce changes 
in the cortical forebrain of free-ranging Northern Pacific Rattlesnakes (Crotalus o. 
oreganus). Brain, Behavior and Evolution, 79(3), pp.144–54. 
Holding, M.L. et al., 2014. Physiological and behavioral effects of repeated handling and 
short-distance translocations on free-ranging Northern Pacific Rattlesnakes 
(Crotalus oreganus oreganus). Journal of Herpetology, 48(2), pp.233–239. 
Holding, M.L., 2011. Short-Distance Translocation of the Northern Pacific Rattlesnake 
(Crotalus o. oreganus): Effects on Volume and Neurogenesis in the Cortical 
Forebrain, Steroid Hormone Concentrations, and Behaviors. M.S. California 
Polytechnic State University. 
IUCN/SSC, 2013. Guidelines for Reintroductions and Other Conservation 
Translocations, Gland, Switzerland. 
Jellen, B.C. et al., 2007. Male movement and body size affect mate acquisition in the 
Eastern Massasauga (Sistrurus Catenatus). Journal of Herpetology, 41(3), pp.451–
457. 
 72 
Jennings, M.R. & Hayes, M.P., 1994. Amphibian and reptile species of special concern 
in California, Rancho Cordova, CA: California Deptartment of Fish and Game, 
Inland Fisheries Division. 
Johnson, B., 1993. Eastern Massasauga rattlesnake conservation program at Metro 
Toronto Zoo. In B. Johnson & V. Menzie, eds. International Symposium and 
Workshop on the Conservation of the Eastern Massassauga Rattlesnake. Toronto 
Zoo. Toronto, Ontario, pp. 89–93. 
Kaplan, E.L. & Meier, P., 1958. Nonparametric estimation from incomplete observations. 
Journal of the American Statistical Association, 53(282), p.457. 
Kasturiratne, A. et al., 2008. The global burden of snakebite: a literature analysis and 
modelling based on regional estimates of envenoming and deaths. PLoS Medicine, 
5(11), p.e218. 
King, R.S., Berg, C. & Hay, B., 2004. A repatriation study of the Eastern Massasauga 
(Sistrurus catenatus catenatus) in Wisconsin. Herpetologica, 60(4), pp.429–437. 
Levine, T.R., 2002. Eta squared, partial eta squared, and misreporting of effect size in 
communication research. Human Communication Research, 28(4), pp.612–625. 
Linnell, J.D.C. et al., 1997. Translocation of carnivores as a method for managing 
problem animals: a review. Biodiversity and Conservation, 6(9), pp.1245–1257. 
Loss, S.R., Terwilliger, L. a. & Peterson, A.C., 2011. Assisted colonization: Integrating 
conservation strategies in the face of climate change. Biological Conservation, 
144(1), pp.92–100. 
Macartney, J.M., Gregory, P.T. & Larsen, K.W., 1988. A tabular survey of data on 
movements and home ranges of snakes. Journal of Herpetology, 22(1), p.61. 
Massei, G. et al., 2010. Can translocations be used to mitigate human–wildlife conflicts? 
Wildlife Research, 37(5), p.428. 
Mathew, a, Pandey, M. & Murthy, N.S., 1999. Survival analysis: caveats and pitfalls. 
European Journal of Surgical Oncology, 25(3), pp.321–9. 
Mccrystal, H.K. & Ivanyi, C.S., 2008. Translocation of venomous reptiles in the 
southwest: A solution–or part of the problem? In W. K. Hayes et al., eds. The 
Biology of Rattlesnakes. Loma Linda, California: Loma Linda University Press, pp. 
395–402. 
McGregor, R.L., Bender, D.J. & Fahrig, L., 2008. Do small mammals avoid roads 
because of the traffic? Journal of Applied Ecology, 45(1), pp.117–123. 
 73 
Miller, H.W. & Johnson, D.H., 1978. Interpreting the results of nesting studies. The 
Journal of Wildlife Management, 42(3), p.471. 
Minton, S.A., 1987. Poisonous snakes and snakebite in the U.S.: A brief review. 
Northwest Science, 61(2), pp.130–136. 
Nakagawa, S. & Cuthill, I.C., 2007. Effect size, confidence interval and statistical 
significance: a practical guide for biologists. Biological Reviews of the Cambridge 
Philosophical Society, 82(4), pp.591–605. 
Nowak, E.M., Hare, T. & McNally, J.T., 2002. Management of “nuisance” effects of 
translocation on Western Diamond-backed Rattlesnakes (Crotalus atrox). In G. W. 
Schuett et al., eds. Biology of the Vipers. Eagle Mountain, UT: Eagle Mountain 
Publishing, LC, pp. 533–560. 
Nowak, E.M. & Riper, C. van, 1999. Effects and effectiveness of rattlesnake relocation at 
Montezuma Castle National Monument, Flagstaff, Arizona. 
Parrish, H.M., Diekroeger, J.L. & Hall, H.K., 1964. Counting California’s snakebites. 
California Medicine, 101, pp.352–7. 
Plummer, M. V. & Mills, N.E., 2000. Spatial ecology and survivorship of resident and 
translocated Hognose Snakes (Heterodon platirhinos). Journal of Herpetology, 
34(4), p.565. 
Pollock, K.H. et al., 1989. Survival analysis in telemetry studies: the staggered entry 
design. The Journal of Wildlife Management, 53(1), p.7. 
Quinn, H. & Jones, J., 1974. Squeeze box technique for measuring snakes. 
Herpetological Review, 5(2), p.35. 
R Core Team, 2014. R: A language and environment for statistical computing. 
Rasband, W.S., 1997. ImageJ. 
Reinert, H.K., 1991. Translocation as a conservation strategy for amphibians and reptiles: 
some comments, concerns, and observation. Herpetologica, 47(3), pp.357–363. 
Reinert, H.K. & Cundall, D., 1982. An improved surgical implantation method for radio-
tracking snakes. Copeia, 1982(3), pp.702–705. 
Reinert, H.K. & Rupert, R.R., 1999. Impacts of translocation on behavior and survival of 
timber rattlesnakes, Crotalus horridus. Journal of Herpetology, 33(1), pp.45–61. 
 74 
Robertson, H.A. & Westbrooke, I.M., 2005. A practical guide to the management and 
analysis of survivorship data from radio-tracking studies, Wellington, New Zealand: 
Science & Technical Publishing, Department of Conservation. 
Rosie Woodroffe, Thirgood, S. & Rabinowitz, A., 2005. The impact of human–wildlife 
conflict on natural systems. In R. Woodroffe, S. Thirgood, & A. Rabinowitz, eds. 
People and Wildlife: Conflict or Coexistence?. Cambridge, UK: Cambridge 
University Press, pp. 1–12. 
Row, J.R. & Blouin-Demers, G., 2006. Kernels are not accurate estimators of home-
range size for herpetofauna. Copeia, 2006(4), pp.797–802. 
Sealy, J.B., 2002. Ecology and behavior of the timber rattlesnake (Crotalus horridus) in 
the upper Piedmont of North Carolina: identified threats and conservation 
recommendations. In G. W. Schuett et al., eds. Biology of the Vipers. Eagle 
Mountain, UT: Eagle Mountain Publishing, LC, pp. 561–578. 
Sealy, J.B., 1997. Short-distance translocations of timber rattlesnakes in a North Carolina 
state park. A successful conservation and management program. Sonoran 
Herpetologist, 10(9), pp.94–99. 
Shepard, D.B. et al., 2008. Reptile road mortality around an oasis in the Illinois corn 
desert with emphasis on the endangered Eastern Massasauga. Copeia, 2008(2), 
pp.350–359. 
Shine, R. & Koenig, J., 2001. Snakes in the garden: an analysis of reptiles “rescued” by 
community-based wildlife carers. Biological Conservation, 102(3), pp.271–283. 
Smith, J. & Bush, S.P., 2010. Envenomations by reptiles in the United States. In S. P. 
Mackessy, ed. Handbook of Venoms and Toxins of Reptiles. Boca Raton, FL: CRC 
Press, pp. 475–490. 
Stamps, J. a. & Swaisgood, R.R., 2007. Someplace like home: experience, habitat 
selection and conservation biology. Applied Animal Behaviour Science, 102(3-4), 
pp.392–409. 
Sullivan, B.K., Nowak, E.M. & Kwiatkowski, M. a., 2014. Problems with mitigation 
translocation of herpetofauna. Conservation Biology, 29(1), pp. 12–18. 
Tokish, J.T., Benjamin, J. & Walter, F.G., 2001. Crotalid envenomation: the southern 
Arizona experience. Journal of Orthopaedic Trauma, 15(1), pp.5–9. 
Walker, M.L. et al., 2009. Successful relocation of a threatened suburban population of 
Timber Rattlesnakes (Crotalus horridus): combining snake ecology, politics, and 
education. IRCF Reptiles & Amphibians, 16(4), pp.210–221. 
 75 
Western Regional Climate Center, San Bernardino, California: NCDC 1981-2010 
Monthly Normals. Available at: http://www.wrcc.dri.edu/cgi-
bin/cliNORMNCDC.pl?ca7723. 
Wingert, W. & Chan, L., 1988. Rattlesnake bites in southern California and rationale for 
recommended treatment. The Western Journal of Medicine, 148(1), pp.37–44. 
 
 76 
CHAPTER THREE 
FACTORS THAT INFLUENCE THE ETIOLOGY AND CLINICAL SEVERITY 
OF VENOMOUS SNAKEBITES IN SOUTHERN CALIFORNIA 
 
Aaron G. Corbit1,2, William K. Hayes2 
 
 
 
 
 
 
 
 
 
1Department of Biology, Southern Adventist University, Collegedale, Tennesee 37315 
USA 
 
 
2Department of Earth and Biological Sciences, Loma Linda University, Loma Linda, 
California 92350 USA 
  
 77 
Abstract 
We retrospectively reviewed 354 cases of venomous snakebite admitted to Loma 
Linda University Medical Center (LLUMC) between 1990 and 2010. Our aims were to 
assess the factors that influence the etiology and clinical severity of rattlesnake bites, and 
to evaluate the clinical effectiveness of current antivenom (CroFab®) in resolving 
symptoms caused by venoms of the seven medically significant snake taxa native to 
southern California. We assessed four measures of snakebite severity: initial snakebite 
severity scores (iSSS) prior to administration of antivenom and at maximum severity 
(mSSS), vials of antivenom administered, and duration of hospitalization. Of the cases 
reviewed, 80.5% were male, 69.2% of bites were to an upper limb, and 88.0% were distal 
to the wrist or ankle. Of 308 cases where a determination could be made, 45.8% were 
illegitimate (provoked bites), and 18.0% involved alcohol or illegal drugs. Most 
snakebites occurred during the spring mating season, followed by another large pulse 
during fall associated with newborn snake emergence. Snakebite severity was positively 
associated with snake size, negatively associated with patient mass, and independent of 
patient age, snake taxon, anatomical location of bite, legitimate versus illegitimate 
(provoked) bites, and time until hospital admission. Male snakebite victims were 2.9, 7.1, 
and 3.1 times more likely than female victims to sustain bites to the upper extremity, 
distal to the ankle or wrist, and via illegitimate provocation, respectively. Those 
admitting to alcohol or drug use were 5.7 times more likely to sustain illegitimate bites, 
which were 111.0- and 7.1-fold more likely than legitimate bites to be to the upper limb 
and distal to the ankle or wrist, respectively. Despite concerns that CroFab is ineffective 
in neutralizing the venom of some snake taxa, especially that of the Southern Pacific 
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Rattlesnake (Crotalus oreganus helleri), we found its clinical effectiveness to be similar 
for all taxa. 
Introduction 
Venomous snakebite represents an important and largely neglected global public 
health issue (Gutiérrez et al. 2006; Harrison et al. 2009; Simpson & Norris 2009). Recent 
estimates suggest that as many as 2.5 million people are envenomed by snakes every 
year, of which as many as 94,000 die (Kasturiratne et al. 2008; Gutiérrez et al. 2010). 
Although mortality is low in the United States (estimated 5–7 deaths annually; 
Kasturiratne et al. 2008), venomous snakebite is still a significant medical issue when it 
occurs. The several thousand people who are envenomated by snakes in the U.S. annually 
(Parrish 1966; Kasturiratne et al. 2008; Smith & Bush 2010) can develop potentially life-
threatening hematotoxicity and neurotoxicity, as well as significant local soft tissue 
damage that can result in long-term physical and emotional morbidity (Dart et al. 1992; 
Smith & Bush 2010; Williams et al. 2011).  
In the U.S., southern California suffers a relatively high rate of venomous 
snakebite. Between 2001 and 2005, Californians reported 1,420 (284 per year) venomous 
bites to the American Association of Poison Control Centers, which was the fourth 
highest of any U.S. state (Seifert et al. 2009). Most cases likely occur in the southern part 
of the state (Parrish et al. 1964). Human population growth and associated urban sprawl 
have spawned development of wilderness areas, bringing humans in conflict with local 
wildlife, including the seven taxa of rattlesnakes which comprise the only venomous 
snakes (apart from the rear-fanged colubrids) native to the area (Campbell & Lamar 
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2004; see Table 1). Bites in southern California may average more severe than those in 
other regions of the U.S., which have Cottonmouths and Copperheads (genus 
Agkistrodon) and Coral Snakes (genera Micrurus and Micruroides) in addition to the 
rattlesnakes (genera Crotalus and Sistrurus) that are more likely to cause major clinical 
effects or death (Langley 2008; Seifert et al. 2009). 
 
Table 1. Bites caused by the seven taxa of southern California rattlesnakes in this study. 
Species of Rattlesnake Number of Bites 
Percent of Total 
Bites 
Southern Pacific (Crotalus oreganus 
helleri) 
95 26.8 
Sidewinder (Crotalus cerastes) 32 9.0 
Mohave (Crotalus scutulatus) 28 7.9 
Red Diamond (Crotalus ruber ruber) 21 5.9 
Speckled (Crotalus mitchellii pyrrhus) 12 3.4 
Western Diamond-backed (Crotalus atrox) 9 2.5 
Northern Pacific (Crotalus oreganus 
oreganus) 
7 2.0 
Unknown 150 42.4 
 
Two important issues relate to venomous snakebite: etiology and clinical severity. 
Understanding etiology informs methods of preventing bites, whereas understanding the 
factors that affect clinical severity informs treatment. When considering etiology, a 
distinction is often made between “illegitimate” and “legitimate” bites. Klauber (1956) 
defined legitimate bites as those “that happen to persons who have no intention of 
indulging in so unnecessary a risk,” whereas Russell (1983), taking a cue from Klauber, 
defined an illegitimate bite as one inflicted on “those who, by their own decision, chose 
to handle snakes, or otherwise expose themselves to risk.” Studies prior to the 1980s 
suggested that the majority of snakebites in the U.S. were legitimate, particularly to 
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children (Hutchison 1929; Parrish 1966; Russell 1983). However, more recent studies 
have yielded somewhat contradictory conclusions. Several studies reported a majority of 
illegitimate bites (e.g. Wingert & Chan 1988; Curry et al. 1989; Morandi & Williams 
1997; Janes et al. 2010), whereas other authors (e.g. Dart et al. 1992; Plowman et al. 
1995) reported a majority of legitimate bites. 
Similar inconsistencies exist in the literature on clinical severity. Several factors 
have been postulated to contribute to the clinical severity of a bite. These factors have 
been partitioned into those associated with the snake and those associated with the human 
victim (Hayes & Mackessy 2010). In terms of the snake, hospital-based studies have 
consistently shown that larger snakes tend to cause more severe bites (Wingert & Chan 
1988; Hayes et al. 2005; Janes et al. 2010; see also Hackett et al. 2002) because they 
inject larger quantities of venom (Hayes 1991; Hayes 2008). However, the idea that more 
provoked snakes deliver more venom, and therefore a more severe bite, has had mixed 
support, especially for rattlesnakes (Herbert 1998; Rehling 2002). Venom composition, 
which varies with ontogeny and among populations and taxa, also affects clinical severity 
(Hayes & Mackessy 2010; Massey et al. 2012). In terms of the human victim, evidence 
supporting the suggestion that smaller patients tend to have more severe bites has also 
been mixed. While some studies have supported this contention (Hayes et al. 2005; Pinho 
et al. 2005), others have failed to detect this relationship (Parrish et al. 1965; Janes et al. 
2010). Bite severity might also be influenced by site of the bite, dictated largely by 
human behavior (Wingert & Chan 1988; Moss et al. 1997; Tanen et al. 2001); presence 
of clothing (Herbert & Hayes 2009); general health (Tanen et al. 2001; Benítez et al. 
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2007; Ribeiro et al. 2008); delay to treatment (Pinho et al. 2005; Michael et al. 2011; Paul 
& Dasgupta 2012; Saravu et al. 2012); and the treatment itself. 
Another issue of importance to clinicians treating venomous snakebites is the 
effectiveness of antivenom at neutralizing venom toxins and resolving symptoms. Some 
controversy surrounds the effectiveness of Crotalidae Polyvalent Immune Fab (Ovine) 
(CroFab®; Protherics, Brentwood, TN, USA, now part of BTG International, London, 
UK) in neutralizing the venom of the Southern Pacific Rattlesnake (Crotalus oreganus 
helleri), a taxon which exhibits substantial geographic variation in venom composition 
(French et al. 2004; Jurado et al. 2007; Salazar et al. 2009; Sunagar et al. 2014). CroFab 
is produced from hyperimmune sera derived from sheep inoculation with four snake 
venoms: C. adamanteus, C. atrox, C. scutulatus, and Agkistrodon piscivorus. Previous 
research suggested that CroFab was much less effective in neutralizing the venom of C. 
o. helleri than that of other U.S. pitviper species (Consroe et al. 1995), though this has 
been tempered by more recent work (Sánchez et al. 2003). The original package insert 
(Protherics Inc. 2008), which provided median effective dose (ED50) comparisons among 
different rattlesnake species, suggested comparatively weak neutralization of C. o. helleri 
venom consistent with Consroe et al. (1995). However, the updated package insert (BTG 
International Inc. 2012) provided very different numbers suggesting comparable 
neutralizing effectiveness for C. o. helleri venom, but nevertheless stated that "higher 
doses may be required based on historical data." In spite of these in vitro assessments, in 
vivo analyses of clinical cases supported the conclusion that CroFab has similar 
effectiveness in treating C. o. helleri bites compared to other southern California species 
(Bush et al. 2002; Janes et al. 2010). Nevertheless, snake enthusiasts (at informal internet 
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forums and meetings) and the media (e.g. Yong 2014) have perpetuated the belief that 
CroFab is ineffective in treating bites from this taxon. 
The purpose of this study was to further elucidate and clarify the factors that 
affect both the etiology and clinical severity of venomous snakebites in southern 
California. The substantial data set also allowed us to compare the effectiveness of 
CroFab in treating envenomations from an unprecedented number of rattlesnake taxa 
(seven), including C. o. helleri. Because snake bite outcomes can be influenced by many 
variables, large sample sizes are required to ascertain which factors are most important 
while simultaneously controlling for potentially confounding variables. This study is 
based on one of the largest samples of snakebite cases collected from a single medical 
facility in the U.S. It also analyzes the largest number of dependent measures (four) and 
potentially explanatory factors (eight) using multivariate statistical models heretofore 
examined in a single study of snakebite severity. 
Materials and Methods 
Study Design 
We retrospectively reviewed 354 medical records of snake bite victims that came 
to the emergency department of Loma Linda University Medical Center (LLUMC). 
Patient records were identified by a database search for records between 1990 and 2010 
that contained the International Classification of Diseases, Ninth Revision (ICD-9), codes 
E905.0 (venomous snake and lizard bites) and 989.5 (toxic effect of venom). Some 
records lacking these codes were undoubtedly missed. We included patients if they were 
bitten by a venomous snake native to Southern California. We excluded patients that 
were bitten by animals other than venomous snakes, those bitten by venomous species 
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not native to Southern California, and those whose envenomation did not result from a 
bite (one patient had an eye splashed by venom). For each patient, data were collected 
that covered the period of time between the bite and initial discharge. Information from 
follow-up visits was not included. The protocol was reviewed by the institutional review 
board and considered exempt from informed consent. 
Data Collection 
Abstractors included one of the investigators (AGC) and four research assistants, 
none of whom were blinded to goals of the study. The four research assistants were 
trained in data collection and calculation of snakebite severity by one of the investigators 
(AGC) via use of a standardized abstraction form. To assess consistency, all five 
abstractors reviewed 10 records and inter-rater reliability was determined using the one-
way, agreement version of the intraclass correlation coefficient (ICC; Shrout & Fleiss 
1979). By convention, ICC values of 0.0–0.20 indicate slight agreement, 0.21–0.40 
indicate fair agreement, 0.41–0.60 indicate moderate agreement, 0.61–0.80 indicate 
substantial agreement, and 0.81–1.00 indicate almost perfect agreement (Landis & Koch 
1977). 
Calculating Snakebite Severity Scores 
We calculated snakebite severity scores (SSS) using the rubric designed by Dart 
et al. (1996). This scoring method, which ranges from 0–20 points, is based on the 
objective evaluation of clinical parameters in six categories: local wound effects, 
hematologic (coagulation) parameters, and symptoms associated with the pulmonary, 
cardiovascular, gastrointestinal, and central nervous systems. The scores for each of these 
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categories, which range from 0–3 or 0–4, were recorded separately and then summed to 
obtain a final score. Higher SSS scores indicate a more severe bite. If the patient record 
included no mention of an organ system abnormality relevant to any category, then that 
system was assumed to be unaffected by the snakebite. Because the SSS criteria 
published by Dart et al. (1996) were designed to assess adults, we adjusted the scoring of 
pulmonary and cardiac categories to account for differences in respiratory rate, heart rate, 
and blood pressure between children and adults (Table 2). These adjustments were based 
on other pediatric medical assessment rubrics and published data on normal values for 
pediatric vital signs (Tepas et al. 1987; Pollack et al. 1997; U.S. Department of Health & 
Human Services 2011; Fleming et al. 2011) in consultation with a pediatric emergency 
medicine specialist. 
 
Table 2. Adjustments made to the pulmonary and cardiac subscores (SSsS) of the snakebite 
severity score (Dart et al. 1996) for pediatric patients; age rangesa are indicated across a 
row.  
  Pulmonary 
Score 
 
Cardiac Score 
  
Respiration Rate  
(rpm) 
 
Heart Rate  
(bpm) 
 Systolic 
Hypertension 
(mmHg) 
 Systolic 
Hypotension 
(mmHg) 
Age Group:  1-5 6-11  1-5 6-11 12-17  < 15  < 15 
SSsS 1  40 23  143 119 106  110+(age×2)   
SSsS 2  46 33  163 150 142     
SSsS 3  60 50  217 212 206    70+(age×2)b 
Most values represent minimum cut-off values for a given level. 
a Years of age 
b For hypotension, scores less than or equal to this value were assigned to SSsS 3 
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We calculated two separate SSS scores for each case. Initial SSS (iSSS) was 
calculated by determining the maximum scores for each symptom category based on 
information recorded from time of the bite until the patient received their first dose of 
antivenom. Maximal SSS (mSSS) was determined by taking the maximum scores for 
each symptom category based on information recorded from the time of the bite until 
initial discharge from the hospital.  
Determining Size of the Snake 
We classified body size of the offending snake in 255 (72.0%) of the 354 cases. 
For many cases (15.3% of the 255), the usual treating physician (Sean P. Bush, SPB) 
recorded the length of the snake if it was brought to the hospital with the patient. In other 
cases (29.8%), the space between fang puncture wounds was recorded (fang spread). A 
formula (Equation 1; from Hayes et al., unpublished data) was applied to this number to 
arrive at an approximate length for the snake.  
 
𝑆𝑛𝑎𝑘𝑒 𝐿𝑒𝑛𝑔𝑡ℎ (𝑐𝑚) =
log10(𝐹𝑎𝑛𝑔 𝑆𝑝𝑟𝑒𝑎𝑑(𝑚𝑚))−0.803
0.006
     (1) 
 
Snake size was then grouped into the following categories based on length: small 
(< 40 cm), medium (40–75 cm), and large (>75 cm). For the remaining cases (54.9%), 
records of qualitative size assessment (e.g., "baby," "small," "large") from observers 
deemed reliable were used to assign these size categories.  
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Determining Species of Snake 
We assigned species of snake for 204 (57.6%) cases. For 104 cases (51.0% of 
species identifications), SPB determined the species of snake that bit the patient from a 
specimen or photograph brought to the hospital with the patient. Otherwise, species 
assignment was based on detailed descriptions provided by reliable observers, as 
recorded in the medical record. The geographical range and preferred habitat of each 
snake species (Stebbins 2003; Campbell & Lamar 2004) were taken into account. If, for 
example, only one venomous species occurred at the geographic location of a bite, that 
species was assigned to the case.  
Vials of Antivenom Administered 
We determined the type and total number of vials of antivenom administered from 
the medical charts. Three kinds of antivenom were given to patients between 1990 and 
2010: the equine-derived Antivenin (Crotalidae) Polyvalent (ACP; Wyeth-Ayerst 
Laboratories, Marietta, Pennsylvania, U.S.A; now part of Pfizer), CroFab (described 
previously), and Polyvalent Equine Anti-viper Serum (Antivipmyn®; Instituto Bioclon, 
Mexico City, Mexico).  
We adjusted the total vials of antivenom to account for differences in the type of 
antivenom used. Most patients receiving Antivipmyn in this study did so as part of a 
multicenter clinical study (Bush et al. 2015) to test its safety and efficacy. Since the 
procedure for this clinical study set the dosage for Antivipmyn to be double that of 
CroFab, the number of Antivipmyn vials was divided by two to generate CroFab-
equivalent vials. Although the median effective doses (ED50) per rattlesnake species for 
Antivipmyn was roughly equivalent to CroFab (Sánchez et al. 2003), one vial of 
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Antivipmyn contained only about half the dry mass of active ingredient (500 mg) 
compared to CroFab (~1 g). We considered the number of vials of ACP and CroFab to be 
equivalent. Despite evidence that CroFab may be five-fold more effective than ACP 
based on ED50 values (Consroe et al. 1995), our analyses (see Results) failed to detect a 
significant difference between these two antivenoms in number of vials given. 
Other Variables 
We extracted several additional variables from each record, including patient 
mass, patient age at the time of the bite, sex of patient, date and time of the bite, time to 
hospital admission (elapsed hours between bite and admission to hospital), hospital 
duration (total hours between patient admission and initial discharge), limb bitten (upper 
or lower extremity), site of bite (distal or proximal to the wrist or ankle), and whether the 
patient had consumed alcohol or drugs just prior to the bite. We also recorded the type of 
interaction the patient had with the snake. If the patient saw the snake and his/her 
deliberate interaction with the snake caused the bite, then the interaction was deemed 
“illegitimate.” If the interaction was not deliberate, and the patient did not see the snake 
prior to the bite, then the interaction was classed as “legitimate.” 
Statistical Analyses 
 We conducted most of the statistical tests described below using SPSS 
13.0 (SPSS Inc., Chicago, IL), with standard defaults. For the one exception, we 
computed inter-rater reliability (ICC) using R 3.0.1 (R Core Team 2014) with the 
package irr (Gamer et al. 2012). We tested for parametric assumptions of normality, 
homoscedasticity, and linearity when appropriate, and applied log10 transformations as 
 88 
needed to better meet assumptions for all continuously-distributed variables except 
patient age. We set alpha at 0.05 for all tests. Following Nakagawa (2004), we chose not 
adjust alpha for multiple tests. Unless otherwise indicated, we report values as mean ± 1 
S.E. 
Effects of Season and Time of Day on Snakebite Occurrence 
 We utilized a one-sample chi-square (χ2) test (Zar 1996) to examine 
seasonal differences in the number of envenomations per season. We categorized seasons 
as spring (March–May), summer (June–August), fall (September–November), and winter 
(December–February), and summed total bites per season across years. We also assessed 
differences in the proportion of snake size classes contributing to bites by season using a 
two-sample χ2 test. The numbers of snakes in each size class were again summed across 
years for each season. We computed Cramer's V as a measure of effect size for these two 
tests, with values of 0.1, 0.3, and 0.5 loosely corresponding to small, medium, and large 
effects, respectively (Cohen 1988). 
 To determine whether time of day when bites occurred varied among 
seasons, we employed a Cochran-Mantel-Haenszel linear-by-linear association test 
(Mantel & Haenszel 1959). Seasons were categorized as mentioned above. The winter 
season was omitted from this analysis because few bites (N = 12) occurred during this 
season, and including it created four cells with expected values of less than five. Bite 
times were standardized to Pacific Standard Time, and then categorized as night (000–
600 hours), morning (600–1200 hours), afternoon (1200–1800 hours), and evening 
(1800–2400 hours). We computed Pearson’s r as a measure of effect size for this test, 
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with values of 0.1, 0.3, and 0.5 loosely corresponding to small, medium, and large effects 
(Cohen 1988). 
Antivenom Effectiveness 
 We employed an analysis of covariance (ANCOVA; Mertler & Vannatta 
2004) model to compare the number of vials of ACP and CroFab administered to 
patients. This model used number of vials of antivenom (log10-transformed) as the 
dependent variable, antivenom type as the independent variable, and mSSS (log10-
transformed) as the covariate. We used another ANCOVA model to test for differences in 
total vials of CroFab used among species. For this analysis, we only considered cases 
where CroFab was the sole antivenom administered to the patient and the species of 
envenomating snake was known. The model controlled for snake size as a fixed factor 
and patient mass (log10-transformed) and mSSS as covariates.  We computed ANCOVA 
effect sizes as partial ɳ2, with values of ~0.01, ~0.06, and > 0.14 loosely regarded as 
small, medium, and large effects, respectively (Cohen 1988). Although partial ɳ2 values 
tend to be upward biased (Pierce et al. 2004), the main effects and interactions never 
summed to more than 1.0 in our models, and therefore were not adjusted. 
Factors Affecting Snakebite Severity 
We relied on five multiple analysis of covariance (MANCOVA) models (Mertler 
& Vannatta 2004) to determine which factors affected the severity of a bite. We had to 
use multiple models because a single omnibus model that included all independent 
variables of interest resulted in too many empty cells. For each of these models, we used 
iSSS, mSSS, total vials of antivenom, and hospital duration (all log10-transformed) as 
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dependent variables. Cases in which patients received more than one type of antivenom 
were excluded from this analysis. From prior research (Wingert & Chan 1988; Blaylock 
2004; Hayes et al. 2005; Benítez et al. 2007; Janes et al. 2010) and our own exploratory 
analyses, we controlled for three primary predictors in all five models: snake size (as a 
fixed factor), patient mass (covariate, not transformed), and patient age (covariate, not 
transformed). The remaining five secondary predictors entered into the models included: 
snake species, limb bitten (upper or lower), site of bite (proximity to wrist or ankle), 
interaction with snake (legitimate or illegitimate), and time to hospital admission (the 
first four as fixed factors, the latter as a covariate). To maximize sample size and 
statistical power, each of the secondary predictors was entered into a separate model with 
the three primary predictors, except that one model included only the primary predictors, 
and two variables (limb bitten and site of bite) were entered together in another model. 
We tested the assumption of homogeneity of regression slopes using separate 
MANCOVA models that included all interactions between the covariates and other 
predictors. No significant interactions were found, so we omitted interactions involving 
the covariates from our final models. We computed effect sizes as multivariate ɳ2, with 
values interpreted similar to those of ɳ2 (described previously). 
Factors Affecting Site of Bite and Interaction with the Snake 
We used binary logistic regression (Mertler & Vannatta 2004) to examine the 
influence of several factors on which limb was bitten (upper or lower), which site on the 
limb was bitten (proximal or distal to the ankle or wrist), and whether the bite was 
legitimate or illegitimate. To assess the factors associated with limb bitten and site of 
bite, we included snake size, patient sex, patient age, and whether or not the bite was 
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illegitimate as predictors in a separate model for each dependent variable. To examine the 
factors associated with bite legitimacy, we included patient sex, patient age, alcohol or 
drug use, and size of snake as predictors. Odds ratios derived from the logistic regression 
models were calculated as measures of effect size.  
Results 
Demographics and Bite Characteristics 
Of the 354 cases that were reviewed, 285 (80.5%) involved male patients and 69 
(19.5%) were females. The median age was 34.4 (range: 1 to 81) years. Ninety-seven 
patients (27.4%) were under age 18, while 33 patients (9.3%) were over age 60. We were 
able to determine the anatomical location of the bite for all cases, and found that 245 
(69.2%) were to an upper limb, and 311 (88.0%) were distal to the wrist or ankle. No 
bites were delivered to the head or trunk. Of the 308 cases for which a determination 
could be made, 45.8% were classed as illegitimate. Sixty-four (18.0%) of the patients 
admitted to using alcohol or drugs just prior to the bite. Median time between the time of 
the bite and hospital admission was 1 hr (range: 4.8 min to 42 hr). The average hospital 
duration was 50.9 hr (95% CI: 46.4 to 55.5 hr). The mean iSSS and mSSS were 4.6 (95% 
CI: 4.3-4.9; range: 0–18) and 7.0 (95% CI: 6.6–7.3), respectively. There were three 
recorded deaths (0.8% of all cases). Seven rattlesnake taxa inflicted bites (Table 1), with 
the majority (26.8%) caused by Southern Pacific Rattlesnakes.  
Effects of Season and Time of Day on Snakebite Occurrence 
The frequency of bites differed among seasons (χ2 = 103.52, df = 3, P < 0.001), 
with the majority (335, 95%) occurring from March to October, during the active season 
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of southern California's rattlesnakes (Fig. 1). The proportion of snakes of different size 
classes delivering bites also varied among seasons (χ2 = 37.66, df = 6, P < 0.001, 
Cramer's V = 0.27). There was a large pulse of bites during spring, of which 55.6% 
resulted from small snakes and 44.4% from medium and large snakes. Another pulse 
occurred in fall, which included a substantial proportion of bites from newly born and 
other small snakes (81.6%), and a much smaller proportion of medium and large snakes 
(18.3%). 
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Figure 1.  Rattlesnake envenomation cases by month and snake size. Total number of 
rattlesnake snakebite cases per month presenting at the Loma Linda University Medical 
Center between 1990 and 2010, and proportions of bites from three snake length classes 
(small: < 40 cm; medium: 40–75 cm; large: >75 cm). 
 
The frequency of bites differed by time of day (χ2 = 130.52, df = 3, P < 0.001). 
Most bites happened during the afternoon (168, 47.7%), fewer bites occurred during the 
morning (94, 26.7%), still fewer bites occurred in the evening (71, 20.2%), and the fewest 
bites happened at night (19, 5.4%). There was a significant association between the time 
of day a bite occurred and season (omitting winter [see above]; Mantel-Haenszel χ2 = 
7.91, df = 1, P = 0.005, n = 340). Pearson’s r (0.15) suggested a direct relationship, with 
more bites happening later in the day as the year progressed from spring to fall.  
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Antivenom Effectiveness 
Table 3 provides information on the amount of antivenom used. The majority of 
patients (244, 68.9%) received CroFab. Seventy-one patients (20.1%) received ACP, 
which was the only FDA-approved antivenom for North American pitvipers prior to 
October 2000, when CroFab received FDA approval. Ten patients (2.8%) received 
Antivipmyn as part of the aforementioned clinical study. Eleven patients (3.1%) received 
both ACP and CroFab during the period between 2001 and 2003, when CroFab was 
replacing ACP in the market. One patient received both CroFab and Antivipmyn on an 
experimental basis to treat a severe envenomation. Twelve patients (3.4%) received no 
antivenom due to minimal or no envenomation. The remaining five patients (1.4%) were 
enrolled in the Antivipmyn clinical study, but information was not released regarding the 
type of antivenom they received. We found no significant difference in number of vials 
of ACP and CroFab administered to patients (F2,333 = 0.21, P = 0.82, partial η2 = 0.001, n 
= 337; note the miniscule effect size). 
 
Table 3. Vials of antivenom administered, by type, to snakebite patients. 
Antivenom Type 
 
N 
Mean Number of 
Vials (±SE) Range 
Antivenin Crotalidae Polyvalent 
(ACP) 
71 18.55 (±2.04) 1–100 
CroFab 244 14.4 (±0.54) 2–66 
Antivipmyn 10 22.4 (±3.51) 10–46 
Multiple Typesa 12 — — 
None 12 — — 
Unknownb 5 — — 
a Values not informative 
b Enrolled in blind study 
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Table 4 provides the unadjusted and estimated marginal mean (adjusted for snake 
size, patient mass, relative bite severity) vials of CroFab for each species. The species 
with lowest unadjusted means was C. cerastes, which averages substantially smaller in 
body size than all other taxa (Klauber 1956; Campbell & Lamar 2004). When controlling 
for snake size, patient mass, and mSSS in the ANCOVA model, mSSS exerted the largest 
effect on number of antivenom vials (F1,108 = 34.34, p < 0.001, partial η2 = 0.241), as 
expected. The main effect of species approached significance with a moderate effect size 
(F6,108 = 2.06, p = 0.064, partial η2 = 0.10), whereas snake size was significant in spite of 
the smaller effect size (F2,108 = 3.19, p = 0.045, partial η2 = 0.06) due to fewer degrees-of-
freedom. In general, bites from larger snakes required more vials of CroFab, but the 
interaction between species and snake size (n = 130, F11,108 = 2.22, p = 0.018, partial η2 = 
0.18) indicated that the relationship between snake size and number of antivenom vials 
was stronger for some snake taxa than others (data not shown). The species with the 
lowest marginal means (C. atrox and C. scutulatus) were two of the four species whose 
venom is used to produce CroFab. Bites inflicted by C. o. helleri required antivenom 
quantities similar to those of other species. Patient mass was not significant in this model 
(F1,108 = 2.49, p = 0.117, η2 = 0.02).    
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Table 4. Mean and estimated marginal mean number of vials of CroFab (antivenom) 
administered for each species. 
 Mean Vials 
of Antivenom 
 
 
Estimated  
Marginal Means 
Species N Mean 95% CI  N Mean 95% CI 
Mohave Rattlesnake 21 13.10 9.36–16.83 18 10.49 8.31–13.17 
Northern Pacific Rattlesnake 4 12.50 -1.58–26.58 4 14.79 9.27–23.28 
Red Diamond Rattlesnake 16 17.13 12.07–22.18 13 14.27 10.1–19.99 
Sidewinder Rattlesnake 19 9.32 7.21–11.42 15 12.69 9.03–17.69 
Southern Pacific Rattlesnake 75 15.52 13.14–17.90 64 12.71 11.34–14.23 
Speckled Rattlesnake 10 19.50 14.46–24.54 9 17.44 12.91–23.46 
Western Diamondback 
Rattlesnake 
8 11.25 5.60–16.90 7 8.81 5.85–13.04 
Estimated marginal means are based on an ANCOVA model (with type IV sum of squares 
due to no data in one cell) that controlled for snake size as a fixed factor, and log10-
transformed patient mass and maximal snakebite severity score (mSSS) as covariates. 
Marginal means computed at the following log10-transformed values: patient mass = 1.83, 
maximal SSS = 0.89. Main effects were significant for snake size and mSSS, and 
approached significance for snake species, but a significant interaction existed between 
species and snake size (see text for further details). 
 
Inter-rater Reliability for Calculating SSS 
Inter-rater reliability (ICC) values for total antivenom (ICC = 0.93, 95% CI: 0.84–
0.98) and hospital duration (ICC = 0.97, 95% CI: 0.92–0.99) showed almost perfect 
agreement between abstractors. Corresponding values for iSSS (ICC = 0.64, 95% CI: 
0.37–0.88) and mSSS (ICC = 0.65, 95% CI: 0.40–0.89) were lower, but still showed 
substantial agreement.  
Factors Affecting SSS 
Of the eight independent variables and cofactors used among the five 
MANCOVA models (snake size, snake species, patient age, patient mass, limb bitten, site 
of bite, interaction with snake, time to hospital admission), only snake size and patient 
mass showed significance (Table 5). Snake size was significant in Models 1, 3, 4, and 5 
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(Model 1: Wilks’ Λ = 0.78, F8,480 = 7.87, P < 0.001, multivariate η2 = 0.12; Model 3: 
Wilks’ Λ = 0.933, F8,462 = 2.03, P = 0.034, multivariate η2 = 0.03; Model 4: Wilks’ Λ = 
0.859, F8,474 = 4.69, P < 0.001, multivariate η2 = 0.07; Model 5: Wilks’ Λ = 0.785, F8,478 
= 7.67, P < 0.001, multivariate η2 = 0.11), but only approached significance in Model 2 
when species of snake was included as a factor (Wilks’ Λ = 0.90, F8,276 = 1.85, P = 0.067, 
multivariate η2 = 0.05). Patient mass was significant in all five models (Model 1: Wilks’ 
Λ = 0.91, F4,240 = 5.77, P < 0.001, multivariate η2 = 0.09; Model 2: Λ = 0.90, F4,138 = 
3.97, P = 0.004, multivariate η2 =  0.10; Model 3: Λ = 0.92, F4,231 = 4.93, P < 0.001, 
multivariate η2 = 0.08; Model 4: Λ = 0.91, F4,209 = 5.29, P < 0.001, multivariate η2 = 0.09; 
Model 5: Λ = 0.91, F4,239 = 5.69, P < 0.001, multivariate η2 = 0.09). 
Follow-up univariate ANCOVA results for model 1 confirmed the importance of 
snake size and patient mass. Snake size significantly affected all four dependent variables 
(iSSS: F2,243 = 7.20, P = 0.001, partial η2 = 0.06; mSSS: F2,243 = 17.40, P < 0.001, partial 
η2 = 0.13; total antivenom: F2,243 = 18.54, P < 0.001, partial η2 = 0.13; hospital duration: 
F2,243 = 14.69, P < 0.001, partial η2 = 0.11). Patient mass significantly influenced mSSS 
(F1,243 = 4.77, P = 0.030, partial η2 = 0.02), total antivenom (F1,243 = 3.92, P = 0.049, 
partial η2 = 0.02), and time to hospital admission (F1,243 = 7.75, P = 0.006, partial η2 = 
0.03), but not iSSS (F1,243 = 0.99, P = 0.32, partial η2 = 0.004). In each model, snake size 
explained substantially more variance (effect sizes 0.06–0.13) than patient mass (effect 
sizes ≤0.03). Figure 2 illustrates the positive relationship between snake size and 
snakebite severity, and the inverse relationship between patient mass and snakebite 
severity (note that no significant interactions existed between snake size and patient 
mass). 
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Table 5. Results (P-values and multivariate ɳ2 effect sizes) of multivariate analysis of covariance (MANCOVA) models for measures 
of clinical severity resulting from rattlesnake bites in southern California. Values in bold font are significant. 
Independent variables Model 1 
(N = 248) 
 Model 2 
(N = 163)a 
 Model 3 
(N = 248) 
 Model 4 
(N = 220) 
 Model 5 
(N = 248) 
P ɳ2  P ɳ2  P ɳ2  P ɳ2  P ɳ2 
Snake size <0.001 0.12  0.067 0.05  0.042 0.03  <0.001 0.07  <0.001 0.11 
Patient mass <0.001 0.09  0.004 0.10  0.001 0.08  <0.001 0.09  <0.001 0.09 
Patient age 0.281 0.02  0.192 0.04  0.137 0.03  0.480 0.01  0.314 0.02 
Snake species – –  0.750 0.03  – –  – –  – – 
   Snake species × snake size – –  0.226 0.08  – –  – –  – – 
Upper vs. lower limb – –  – –  0.533 0.01  – –  – – 
Proximal vs. distal bite – –  – –  0.515 0.01  – –  – – 
   Proximal or distal bite × snake size – –  – –  0.709 0.01  – –  – – 
   Upper or lower limb × snake size – –  – –  0.085 0.03  – –  – – 
   Proximal or distal × upper or  lower limb – –  – –  0.323 0.02  – –  – – 
   Proximal or distal × upper or  lower limb ×  
      snake size 
– –  – –  0.298 0.02  – –  – – 
Interact with snake – –  – –  – –  0.477 0.01  – – 
    Interact × snake size – –  – –  – –  0.275 0.02  – – 
Time to hospital admission – –  – –  – –  – –  0.617 0.01 
Dependent variables: initial snakebite severity score (iSSS), maximal snakebite severity score (mSSS), vials of antivenom, hospital 
duration (all were log10-transformed). 
Independent variables: all treated as fixed factors except that patient mass and patient age (both covariates) 
a Type IV sum of squares model due to one empty cell (similar to results from type III sum of squares model).   
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Figure 2. Relationship of snakebite severity to snake size and patient mass. Relationships 
between four measures of rattlesnake snakebite severity (snakebite severity score [SSS] at 
initial presentation and at maximal severity, number of vials of antivenom, hospital 
duration), snake size, and patient mass. Note the log10-transformed measures. Analysis of 
covariance (ANCOVA) models indicated that snake size was positively associated with all 
four measures of snakebite severity (all P ≤ 0.001, partial ɳ2 = 0.06–0.13). Patient mass 
was independent of initial SSS (P = 0.32, partial ɳ2 = 0.004), but negatively associated with 
the other three measures of snakebite severity (P = 0.006–0.049, partial ɳ2 = 0.02–0.03). N 
= 249–252 for each model. 
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Factors Affecting Location of Bite and Interaction with Snake 
Bites to Upper vs. Lower Extremities 
The logistic regression model significantly distinguished between bites to upper 
and lower limbs (69.2% and 30.8% of all cases, respectively; P < 0.001, Table 6). This 
model successfully predicted which type of limb was bitten with moderate success 
(78.9% of cases). Two predictors were significant: sex of the patient (P = 0.012) and 
interacting with the snake (i.e., legitimacy of bite; P < 0.001). Odds ratios derived from 
the logistic regression model indicated that males were 2.9 times more likely to sustain 
bites to the upper limb than females (75.1% and 44.9% of cases, respectively), and that 
illegitimate bites were 111 times more likely than legitimate bites to be to the upper 
rather than the lower limb (97.9% and 46.1% of cases, respectively). The limb that was 
bitten was independent of size of snake and age of patient. 
Proximal vs. Distal Bites 
This logistic regression model significantly distinguished between bites to the 
proximal and distal portions of the limbs (12.1% and 87.9% of all cases, respectively; P < 
0.001, Table 6). The model predicted site of bite with excellent success (87.2% of cases). 
Again, two predictors were significant: size of the snake (P = 0.002) and interacting with 
the snake (i.e., legitimacy of bite; P = 0.001). A cross-tabulation revealed that 58.4%, 
19.9%, and 21.7% of distal bites were from small, medium, and large snakes, 
respectively, whereas 17.2%, 31.0%, and 51.7% of proximal bites were from small, 
medium, and large snakes, respectively. A Mantel-Haenszel χ2 test for trend proved 
significant (𝜒1
2 = 18.380, P < 0.001), suggesting that smaller snakes were more likely to 
deliver distal bites, whereas larger snakes were more likely to deliver proximal bites.  
  
1
0
1
 
 
 
 
 
Table 6. Results of logistic regression models examining factors predicting bites to upper versus lower limb, bites distal or proximal to 
the wrist or ankle, and whether the bite was incidental (legitimate) or involved deliberate interaction with the snake (illegitimate).a 
Predictors B SE Wald P Exp(B) 
Upper vs. Lower Limb      
Snake size - - 4.557 0.102 - 
Patient sexb  1.070 0.426 6.308 0.012 2.915 
Patient age -0.004 0.009 0.174 0.676 0.996 
Illegitimate vs. legitimate bitec 4.710 1.027 21.049 <0.001 111.004 
Distal vs. Proximal       
Snake size - - 12.196 0.002 - 
Patient sexb -0.817 0.600 1.852 0.174 0.442 
Patient age -0.004 0.011 0.153 0.695 0.996 
Illegitimate vs. legitimate bitec 1.963 0.575 11.638 0.001 7.143 
Illegitimate vs. Legitimate       
Snake size - - 1.052 0.591 - 
Patient sexb 1.124 0.389 8.348 0.004 3.076 
Patient age 0.012 0.008 2.420 0.120 1.012 
Alcohol or drug usec 1.733 0.460 14.224 <0.001 5.660 
a Upper vs. lower limb (coded as one and zero, respectively): 𝜒5
2 = 105.320, P < 0.001,  -2 log likelihood = 173.521, Nagelkerke R2 = 
0.525, 78.9% predicted correctly. Proximal vs. distal (coded as one and zero, respectively): 𝜒5
2 = 33.476, P < 0.001, -2 log likelihood = 
139.995, Nagelkerke R2 = 0.257, 87.2% predicted correctly. Illegitimate vs. legitimate (coded as one and zero, respectively): 𝜒5
2 = 
32.476, P < 0.001, -2 log likelihood = 279.879, Nagelkerke R2 = 0.178, 66.1% predicted correctly. 
b Males coded as one, females as zero 
c Illegitimate bites coded as one, legitimate bites as zero 
d Alcohol or drugs use coded as one, no alcohol or drug use coded as zero
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Odds ratios derived from the logistic regression model indicated that illegitimate bites 
were 7.1 times more likely than legitimate bites to occur distal to the ankle or wrist rather 
than more proximally (95.7% and 80.8% of cases, respectively). Site of the bite was 
independent of sex and age of the patient.  
Legitimate vs. Illegitimate Bites 
This final logistic regression model provided significant discrimination between 
legitimate and illegitimate bites (54.2% and 45.8% of 308 cases, respectively; P < 0.001, 
Table 6). However, its prediction success was more moderate (66.1%). This model 
revealed that sex of the patient (P = 0.004) and alcohol or drug use (P < 0.001) were 
significant predictors. Odds ratios derived from the logistic regression model showed that 
males had a 3.1-fold greater chance of sustaining an illegitimate bite than females (52.8% 
and 21.3% of cases, respectively), and those patients who admitted using alcohol or drugs 
prior to the bite were 5.7 times more likely to experience an illegitimate bite than a 
legitimate bite (84.9% and 37.6% of cases, respectively). Interacting with the snake was 
independent of snake size and patient age. 
Discussion 
We conducted this study, in large part, to identify and better manage the risks 
associated with venomous snakebite in a heavily populated region of the U.S. Norris and 
Bush (2007) remarked that a common clinical profile for a snakebite victim in the U.S. is 
a “young, intoxicated male bitten on the hand while intentionally interacting with the 
snake.” Our study largely supports this contention by showing that being male and being 
intoxicated significantly increase one’s risk of sustaining an illegitimate bite, and that 
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illegitimate bites are more likely to be to the upper limb and distal to the ankle or wrist. 
Our findings also indicate that the major factors that affect the clinical severity of a 
venomous snakebite are size of the snake, with larger snakes causing more severe bites, 
and mass of the victim, with greater mass mitigating bite severity. Here, we discuss both 
the etiology of venomous snakebite, particularly in relation to legitimate and illegitimate 
bites, and the diverse factors that influence the clinical severity of venomous snakebite. 
Etiology 
The etiological profile of snakebite victims in the U.S. seems to have changed 
since the beginning of the twentieth century. The earliest studies, which sought to 
characterize venomous snakebites for the entire U.S., suggested that most bites were 
accidental and with fewer than half of bites being to the upper limb. Willson (1908) 
reported 42.7% of U.S. bites being to the upper limb. Likewise, Hutchison (1930) 
reported 42.9% of bites being to the upper limb and only 6.3% of bites resulting from 
catching venomous snakes or handling captive ones. Later on, Parrish (1966), in a large 
study characterizing 3,367 bites which occurred between 1958–1959 from the entire U.S., 
reported 38% of bites being to the upper limbs. However, other studies conducted by 
Parrish covering the same time period indicate some regions where the majority of bites 
were to the upper limbs. In New England, 8 of 12 cases (66.7%) involved bites to the 
upper limb (Parrish et al. 1960), and 95 of 146 snakebites in California (65%) were to the 
upper extremities, with 23 (15.7%) of all bites occurring when people were handling a 
venomous snake (Parrish et al. 1964). Later, Russell (1980) estimated that 25% of bites in 
the U.S. were illegitimate.   
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With few exceptions (Dart et al. 1992; Forrester & Stanley 2004; Correa et al. 
2014; Gerardo et al. 2015), more recent studies report a greater percentage of illegitimate 
bites and a majority of bites to the upper limb. Most are from individual hospitals in 
regions of the U.S. where snakebites are relatively common, particularly the east 
(Rudolph et al. 1995; Morandi & Williams 1997; Thorson et al. 2003) and southwest 
(Wingert & Chan 1988; Curry et al. 1989; Downey et al. 1991; White & Weber 1991; 
Plowman et al. 1995; Tokish et al. 2001; Tanen et al. 2001; Janes et al. 2010; Spano et al. 
2013), though one covers cases across the entire U.S. (O’Neil et al. 2007). In a study of 
30 cases from West Virginia, Morandi & Williams (1997) found that 70% of bites were 
to upper limbs and 67% of bites were illegitimate (40% of these were from rattlesnake 
round-ups). This study also found that 95% of illegitimate bites were to the upper 
extremities. Similarly, Curry et al. (1989), in a study of 85 cases from Arizona, found that 
74.4% were to upper limbs and 56.7% of cases were illegitimate. This study further 
found that only 73% of bites to upper extremities were illegitimate, whereas all bites to 
the lower extremity were legitimate. Studies from Southern California are similar. 
Wingert & Chan (1988) found that, of 282 cases, 87% were to upper limbs and 57% were 
illegitimate, and Janes et al. (2010), using 142 cases (also from LLUMC), found that 70% 
of bites were to upper limbs and 67% of bites were illegitimate. The current study is 
consistent with the recent trend of bites resulting from interactions with snakes. We found 
that 69.2% of cases involved bites to the upper limb, and though we found a smaller 
proportion of illegitimate bites (45.7% of classifiable cases), it is much higher than that 
reported for the earliest studies. Consistent with other studies (Curry et al. 1989; Morandi 
& Williams 1997; O’Neil et al. 2007), we also found a significant relationship between 
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bites to the upper limbs and illegitimate bites, with illegitimate bites being 111.0 times 
more likely to be to upper limbs.  
One bite characteristic that has changed little since the early 1900s is whether a 
bite was inflicted proximal or distal to the ankle or wrist. All previous literature has 
reported a majority of distal bites. Among the earlier reports, Willson (1908) reported 
76.3% distal bites, and Hutchison (1929) reported 77.8% distal bites. More recently, 
LoVecchio & DeBus (2001) reported that 67% of the children in his study sustained 
distal bites, and Thorson et al. (2003) reported that 88% of Copperhead (Agkistrodon 
contortrix) bites in the Carolinas were to distal portions of the extremities. The latter 
study uncovered a relationship between more distal bites and those received illegitimately 
that we confirmed in ours. 
Another trend that has not changed is the proportion of males that are 
envenomated. The earliest study reporting this (Willson 1908) found that 74.5% of 740 
cases were to males. With the exception of one study in which 47% of victims were male 
(Gerardo et al. 2015), more recent studies continue to show a majority of male victims, 
with proportions ranging between 54–93% (Christopher & Rodning 1986; Wingert & 
Chan 1988; Curry et al. 1989; Downey et al. 1991; White & Weber 1991; Plowman et al. 
1995; Rudolph et al. 1995; Morandi & Williams 1997; LoVecchio & DeBus 2001; Tanen 
et al. 2001; Tokish et al. 2001; Thorson et al. 2003; Forrester & Stanley 2004; Corneille 
et al. 2006; O’Neil et al. 2007; Seifert et al. 2009; Janes et al. 2010; Lavonas et al. 2011; 
Spano et al. 2013). Our value of 80.5% is within this range. Our finding that males are 
more likely than females to sustain illegitimate bites is consistent with Curry et al. (Curry 
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et al. 1989), who found that 97.9% of illegitimate bites were sustained by males 
compared to 72.2% of legitimate bites.  
The proportion of snakebite cases associated with intoxication is inconsistent in 
the literature. Our study found that intoxication (alcohol or drugs) was involved in 18.0% 
of cases. This proportion is similar to that of several prior U.S. studies (13.9%, Downey 
et al. 1991; 17.2%, Janes et al. 2010). However, others have reported higher levels of 
alcohol use: Wingert & Chan (1988) reported 28% of cases from Southern California, 
Curry et al. (1989) 38.6% from Arizona, and Morandi & Williams (1997) 40% from 
West Virginia. In stark contrast, one central California study reported 7% (of 46 cases; 
Spano et al. 2013). Some variation may result from different methods used to ascertain 
intoxication. Our finding that intoxicated individuals are 5.6 times more likely to sustain 
an illegitimate bite is consistent with Curry et al. (1989), who found that 56.5% of 
illegitimate bite cases were under the influence of alcohol compared to 16.7% of 
legitimate bites. 
The low frequency of dry bites and/or minimal envenomation (3.6%), which can 
be difficult to differentiate, contrasts with the higher percentages reported elsewhere for 
rattlesnakes (see Hayes et al. 2002 and Hayes 2008 for reviews). However, many patients 
represented in our dataset were transferred to LLUMC from other medical facilities. 
Since, these facilities were unlikely to transfer patients that did not show symptoms of 
envenomation, our percentage should not be considered representative of the actual rate 
of dry bites in southern California.    
Our study further suggests that most rattlesnake bites in southern California occur 
during the afternoon hours of the spring and fall. Our finding that most bites occur in the 
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afternoon is consistent with previous studies (Parrish et al. 1964; Parrish 1966; Curry et 
al. 1989; Plowman et al. 1995). Our finding that bites tend to occur later in the day as the 
season progresses has not been reported before, and may be related to the increase in day-
length and ambient temperature as one moves from spring into summer. However, why 
the trend should continue into fall, when day-length is decreasing, remains unclear. Our 
finding that envenomations peak in spring and fall is at odds with most of the literature. 
Several studies from various regions of the U.S. (Ennik 1980; Downey et al. 1991; 
Plowman et al. 1995; Rudolph et al. 1995; Spano et al. 2013) and two large 
epidemiological studies covering the entire U.S. (Parrish 1966; Seifert et al. 2009) 
reported venomous snakebite incidence peaking in the summer (June and July). However, 
two studies from Arizona found that bite incidence peaked in the fall (September and 
October; LoVecchio & DeBus 2001; Hardy 1986), and another epidemiological study 
from Texas reported that bites peak in the spring (May; Forrester & Stanley 2004). The 
study most relevant to ours is that of Parrish et al. (1964), which documented two 
snakebite peaks in California, with one in the spring (May) and the second at the end of 
the summer (August). These seasonal differences in the incidence of venomous snakebite 
are likely related to substantial seasonal variation among rattlesnake species in movement 
patterns associated with the timing of the reproductive cycle (Aldridge & Duvall 2002; 
Schuett et al. 2002), and seasonal shifts in snake activity from diurnal to nocturnal in the 
hotter regions of the U.S. Most medically significant venomous snakes in the U.S. are pit 
vipers, which exhibit prolonged mate searching polygyny in which males significantly 
increase their movements in search of females (Duvall et al. 1992; Aldridge & Duvall 
2002), and in the process may be more likely to encounter humans. Indeed, some 
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evidence suggests that male rattlesnakes cause the majority of human envenomations 
(Cardwell et al. n.d.). Some species mate during just one season, either in spring or late 
summer/early fall, whereas other species mate in both seasons (Aldridge & Duvall 2002; 
Schuett et al. 2002). The somewhat unique seasonal distribution of snake bites in our 
study likely results from most rattlesnake species in southern California mating during 
both spring and late summer/fall (Aldridge & Duvall 2002; Cardwell 2008; Dugan et al. 
2008; Brown et al. 2009; Dugan 2011; Chapter 2 this dissertation), including the species 
causing the most bites in our study, the Southern Pacific Rattlesnake (C. o. helleri; Dugan 
et al. 2008), and the extreme summer temperatures that shift snake activity to nocturnal 
hours when humans are less likely to encounter them. Parturition in U.S. pitviper species, 
including southern California species, also happens during the fall (Aldridge & Duvall 
2002), and the dispersal of young snakes after this event likely explains the high 
proportion of bites (81.6%) attributed to small snakes during this period.  
Effectiveness of CroFab in Treating Southern California Rattlesnake Bites 
Our analysis did not detect statistically significant species differences in the 
number of vials of CroFab needed to resolve rattlesnake envenomation. However, the 
moderate effect size that approached significance for estimated marginal means of 
species (Table 4) suggests that CroFab may be most effective against the venoms of the 
two southern California species that are used in the manufacture of CroFab (C. atrox and 
C. scutulatus). 
Our results do not support the ongoing contention of amateur herpetologists (on 
internet discussion groups) and the media (Yong 2014) that CroFab is comparatively 
ineffective at treating bites from C. o. helleri. This contention was fueled in part by a 
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prior study of CroFab's constituents showing exceptionally high ED50 values for C. o. 
helleri relative to nine other North American crotaline taxa (Consroe et al. 1995). 
However, a later study (Sánchez et al. 2003) determined that CroFab had moderate 
effectiveness against C. o. helleri compared to 16 other North American taxa. The 
original product insert by Protherics provided an ED50 of 122 mg antivenom/mg venom 
for C. o. helleri, compared to 8 and 15, respectively for C. adamanteus and C. scutulatus 
(two species used in the production of CroFab; Protherics Inc. 2008). More recently, the 
package insert was changed, inexplicably, to provide ED50 values of 6 for C. o. helleri 
and 18 for both C. adamanteus and C. scutulatus (BTG International Inc. 2012). 
Regardless, our results suggest that CroFab is equally effective at treating C. o. helleri 
envenomations compared to other southern California rattlesnakes. Earlier, Bush et al. 
(2002) demonstrated efficacy of CroFab against C. o. helleri venom in a clinical setting, 
but with a much smaller sample. 
Factors Influencing Clinical Severity 
This study addresses many of the factors thought to influence the severity of bites 
from venomous snakes. These factors have been divided into two categories: factors 
related to the snake and factors related to the human victim (Hayes & Mackessy 2010). 
The two major factors associated with the snake include the amount of venom injected 
and the toxicity of the venom. The amount of venom injected is, in turn, thought to be 
influenced by several things, including amount of venom present in the snake’s glands 
and the level of threat it perceives. Despite a persistent myth in the U.S. that baby 
rattlesnakes inject more venom and inflict more severe bites (Hayes et al. 2002), evidence 
strongly supports the notion that the major factor determining the amount of venom 
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present in the glands of a snake is its size. As a rattlesnake grows, the amount of venom 
in its gland increases exponentially (Glenn & Straight 1982; Hayes 1991; Mackessy et al. 
2003). Because larger snakes have more venom, it would be expected that they inject 
more venom and subsequently cause more severe bites. Our findings support this 
hypothesis and are consistent with other studies (Wingert & Chan 1988; Thomas et al. 
1998; Hayes et al. 2005; Janes et al. 2010). In fact, snake size was the single most 
important predictor of snakebite severity, explaining roughly 6–13% of the variation in 
SSS. 
Evidence further suggests that venomous snakes are able to meter their venom, 
regulating the amount they inject depending on context (Hayes 2008). One context that 
may trigger a snake to inject more venom is when it perceives a significant threat. Indeed, 
studies show that some snake species will inject more venom when grasped by a human 
than when unrestrained (Hayes et al. 2002). Although one might expect illegitimate bites 
to be more severe than legitimate ones due to potentially greater provocation of the 
snake, all bites result from contact with the snake or the threat of close proximity, so it's 
not surprising—from the snake’s perspective—that the current study found no differences 
in severity of legitimate and illegitimate bites (see also Janes et al. 2010). The limited 
data for rattlesnakes suggests that they do not inject more venom when grasped (Herbert 
1998; Rehling 2002). 
 Considerable research has examined differences in venom composition among 
venomous snakes in the U.S. Venom variation has been documented taxonomically, 
geographically, and ontogenetically (Chippaux et al. 1991).  However, much less work 
has been done looking at the clinical significance of these venom variations (Janes et al. 
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2010; Massey et al. 2012). Despite the wide range of toxicities in the venoms of the 
different species of rattlesnakes native to southern California (intravenous mouse LD50: 
C. scutulatus ~0.14 mg/kg, C. ruber ~3.51 mg/kg; Glenn & Straight 1982), we detected 
no differences in snakebite severity (SSS) among species in this study (see also Hayes et 
al. 2005; Janes et al. 2010). The reason for this remains unclear, but it does call into 
question the relevance of overall toxicity (LD50 values in mice) in the clinical severity of 
rattlesnake bites. Currently, we are investigating whether the six clinical symptoms 
(snakebite severity subscores) differ among taxa to determine whether interspecific 
venom differences produce different clinical syndromes, which might necessitate 
different treatment algorithms (Appendix 1).  
In terms of factors related to the human victim, we found a small but significant 
effect of patient mass (explaining <3% of variation in SSS), with larger patents 
experiencing less severe bites. This outcome differs from some (Wingert & Chan 1988; 
Janes et al. 2010) but not all (Hayes et al. 2005) southern California data sets. The 
conclusions of studies outside of southern California have also been mixed. Pinho et al. 
(2005) found that those envenomated by the South American rattlesnake (C. durissus) 
were more likely to experience acute renal failure if they had a small body surface, 
whereas Parrish et al. (Parrish et al. 1965) concluded that there were no real differences 
in bite severity among patient age groups (a factor closely related to patient mass) in his 
study of snakebite victims from 10 U.S. states. Small effect size may help explain why 
some previous studies have failed to detect this relationship, yet these studies also have 
other limitations. Wingert & Chan (1988) did not utilize statistical models that accounted 
for potentially confounding variables such as snake size, whereas Janes et al. (2010) did 
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not adjust their use of the Dart et al. (1996) snakebite severity score when considering 
pediatric patients. One significant limitation of Parrish et al. (1965) is that their 
conclusion was not based on any statistical test. In fact, a re-analysis of the data they 
presented leads to a different conclusion. We applied a Mantel-Haenszel linear-by-linear 
χ2 test to the data in table V of Parrish et al. (1965) showing the number of snakebite 
cases cross-tabulated by bite severity grade and age group. Omitting cases wherein the 
severity grade was omitted, our analysis yielded a significant result (Mantel-Haenszel χ2= 
4.66, df = 1, P = 0.031). The associated negative Pearson’s r (-0.06) suggested an inverse 
relationship between age group and bite severity, which is consistent with the results of 
our study. Because our results match what might be expected theoretically (Russell 
1983), and are based on methodologies which overcome the limitations of previous 
studies that have failed to detect this relationship, we are confident in our conclusions. 
Moreover, the negative relationship between patient size and snakebite severity has 
implications for the dosing of antivenom in pediatric patients (Chapter 4 this 
dissertation). 
Another potential contributing factor to snakebite severity is the anatomical 
location of the bite. Moss et al. (1997) presented evidence that bites distal to the first 
interphalangeal joint of the fingers or toes tend to be less severe than bites proximal to 
these joints, and attributed the difference to the distal digit’s smaller volume and reduced 
blood supply. However, the authors did not consider snake size in their analysis. Gerardo 
et al. (2015) reported a difference in the amount of antivenom needed to treat bites to 
upper vs. lower extremities. However the authors did not report which extremities need 
more antivenom and, as with the previous study, did not consider snake size in their 
 113 
analysis. Our results revealed that bites to the distal limbs are more likely to be caused by 
small snakes than large snakes, which might account for the difference reported by Moss 
et al. (1997). Our methodology allowed us to control for multiple variables 
simultaneously, including the most important factor influencing snakebite severity—
snake size—which corresponds to the mass of venom injected. 
How quickly a rattlesnake bite victim gets medical care after the bite may also 
influence bite severity, with longer lag times tending to result in greater clinical severity 
(Silveira & De Andrade Nishioka 1992; Pinho et al. 2005). However, consistent other 
studies (Bucaretchi et al. 2002; Gerardo et al. 2015), our results did not show this 
relationship. This may be because the vast majority of patients in our study received 
medical care very quickly. Half of our patients arrived at a medical facility within 1 hr, 
and 90% arrived within 3 hr. This may have rendered the relationship undetectable. The 
only other study that has examined time to treatment for CroFab (Gerardo et al. 2015) 
failed to detect an effect on antivenom use when comparing time to antivenom treatment 
of greater than 6 hours to less than six hours. However, this study may not be directly 
comparable since the majority of cases were Copperhead envenomations, which 
generally give less severe bites. The effects of increased time until treatment may also 
result in long-term or permanent tissue damage that can only be assessed after initial 
discharge from the hospital—a timeframe outside the scope of this study.  
Limitations 
Despite our attempt to maintain the highest possible methodological rigor, several 
possible shortcomings are common to studies based on retrospective chart reviews. First, 
bias may exist in the type and extent of missing data. More complete data may have been 
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collected for patients with more severe bites because these cases were likely to have 
received more attention from a greater number of clinicians, including a well-informed 
snakebite specialist (SPB). Also, charts did not specify whether recorded patient mass 
was measured or estimated. Since it may be more difficult to measure the mass of 
patients confined to a bed, a greater proportion of estimated masses may have been 
recorded for patients with more severe envenomations. Second, possible error existed in 
the information we used to determine the size and species of the snake. For information 
on the size and species of the snake, determinations based on photographs, specimens 
brought to the hospital, or measurement of fang-spread, especially those evaluated by 
SPB, were considered to be of high accuracy. However, we also based determinations on 
descriptions provided by other medical personnel (e.g., first responders) and the patients 
themselves, and these were likely to be less accurate. Cross-referencing the geographic 
location where the bite occurred with the known geographic ranges of southern California 
rattlesnakes provided some error mitigation for species determinations. Third, veracity of 
the patients comprised another potential source of error, particularly with respect to 
assigning bite legitimacy. Patients may have felt ashamed if their own lack of judgement 
had resulted in the bite, or may have worried about legal ramifications, especially if they 
were keeping the snake in captivity, and therefore may have given inaccurate information 
about how the bite occurred. In one case where a male patient was transferred to LLUMC 
from another medical facility, we found contradictory information surrounding the 
circumstances of the bite. This patient reportedly told LLUMC medical personnel that a 
snake had come out of the bushes and bit him on the finger while he was sitting outside at 
a friend’s house. However, the story reported by the outside facility was that he was 
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bitten on the finger by a rattlesnake his friend was keeping as a “pet.” Such reluctance to 
admit to an illegitimate bite suggests that our finding that 45.8% of classifiable cases 
were illegitimate may be an underestimate.  
Conclusions 
Our results support several conclusions that may be of use by clinicians treating 
venomous snakebite in southern California. First, most snakebites occur during the 
spring, but another large group of snakebites occur in the fall, primarily from a pulse of 
newborn snakes. Clinicians and pharmacologists should be aware of this, and prepare 
accordingly. Second, envenomations delivered by larger snakes and to smaller patients 
tend to be more severe. Clinicians should therefore treat such cases more aggressively, 
and should seek information about the size of the snake upon initial presentation of a 
patient to a medical facility. Third, CroFab is efficacious against all southern California 
rattlesnake venoms, including that of C. o. helleri. When controlling for snake size and 
patient body mass, we found no significant differences in CroFab effectiveness among 
species. However, recent study suggests that the clinical syndrome can vary substantially 
among snake species (Appendix 1), and therefore ascertainment of offending snake 
species may be valuable to anticipating and managing the course of treatment.  
Our results further suggest that at least 45.8% of venomous snakebites in southern 
California are illegitimate, and therefore preventable. Males and intoxicated individuals 
are at greatest risk of sustaining bites. Education initiatives that promote leaving the 
snake alone may help to reduce the number of snakebites in southern California and 
elsewhere. 
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Abstract 
Despite low mortality in the U.S., venomous snakebite constitutes a potentially 
life-threatening medical emergency that often results in a high financial cost to victims in 
large part due to the cost of antivenom (CroFab). To improve decisions by physicians 
treating snake envenomation in southern California, we assessed several factors currently 
omitted from snakebite treatment algorithms for their potential usefulness as predictors of 
maximal snakebite severity score (mSSS, based on the sum of six clinical symptom 
subscores, SSsS), symptom progression from initial assessment, and antivenom use. The 
factors included initial SSS (iSSS), size of the envenoming snake, mass of the patient, 
snake species, anatomical location of bite, whether the bite was provoked (illegitimate) or 
not (legitimate), and the time until hospital admission. We found initial snakebite severity 
score (iSSS), the size of the envenoming snake, and patient mass to be significant 
predictors of overall bite severity, symptom progression, and antivenom use. Initial SSS 
proved to be the most effective predictor of overall severity, explaining ~70% of the 
variance. Snake size best predicted symptom progression, with larger snakes inflicting 
greater symptom progression. Patient mass and iSSS also significantly predicted 
symptom progression, with smaller patients and those with lower iSSSs experiencing 
greater symptom progression. Snake size was also the most important factor predicting 
antivenom use, with large snakes requiring, on average, seven more vials of CroFab than 
medium or small snakes. We further evaluated whether each of the six symptoms upon 
admission (iSSS subscores for cardiovascular, gastric, hematological, local wound, 
neurological, and pulmonary symptoms) influenced overall SSS, symptom progression, 
and antivenom use. All six subscores significantly predicted overall severity, but 
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hematological, neurological, and cardiovascular subscores were most salient. Local 
wound score was the only significant predictor of symptom progression. Gastric, 
neurological, and hematological symptoms significantly influenced antivenom use, but 
the gastric subscore showed an unexpected inverse relationship to antivenom use. Based 
on our analyses, we suggest that iSSS, snake size, and patient mass are especially useful 
to clinicians for anticipating antivenom needs. We further suggest several rules of thumb 
that could be added to the current snakebite treatment algorithm to help clinicians 
anticipate antivenom needs.  
Introduction 
Several thousand human envenomations from venomous snakes occur in the 
United States every year (estimated at 2,683–3,858; Kasturiratne et al. 2008), with the 
vast majority of these being caused by pitvipers (family Viperidae, subfamily Crotalinae; 
Seifert et al. 2009). Despite a low mortality rate (5–7 deaths annually; Kasturiratne et al., 
2008), venomous snakebite in the United States constitutes a potentially life-threatening 
medical emergency. Non-fatal envenomations can still result in significant 
hematotoxicity, neurotoxicity, and local soft tissue damage, and can lead to long-term 
physical and emotional morbidity (Dart et al. 1992; Smith & Bush 2010; Williams et al. 
2011).The financial costs to victims of snakebite can also be high. The most definitive 
treatment for snake envenomation remains antivenom infusion (Smith & Bush 2010). 
Currently, Crotalidae Polyvalent Immune Fab (Ovine) (CroFab®; Protherics, Brentwood, 
TN, USA, now part of BTG International, London, UK) is the only FDA-approved 
antivenom to treat pitviper bites in the U.S., and wholesales at more than $1000 per vial 
(Corneille et al. 2006; Lavonas et al. 2011). Given the average of 14 vials of CroFab 
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needed to resolve envenomations in southern California (Chapter 3), the cost to patients 
or insurers from antivenom alone can add up very quickly. With a more than two-fold 
mark-up in cost, antivenom may comprise more than 70% of the total hospital bill 
(Corneille et al. 2006). Cases wherein hospitals have billed patients $20,000 or more per 
vial have been reported in the popular media (Marcinko 2014; Rhodan 2014). The high 
rate of symptom recurrence (Boyer et al. 1999; Boyer et al. 2001; O’Brien et al. 2009; 
Lavonas et al. 2014) and low rate of hypersensitivity reactions (Dart & McNally 2001; 
Cannon et al. 2008) also drive a tendency toward overuse, which may exacerbate patient 
costs. Indeed, one study has documented a significant increase in the use of antivenom 
since CroFab was introduced in 2001 (Spiller et al. 2010), and Lavonas et al. (2011) 
noted that inexperienced health care providers may administer large doses to treat clinical 
effects that do not respond to antivenom therapy, and could be safely observed without 
further treatment.  
The need to maximize patient benefits while reducing the risks and costs of 
antivenom use requires the standardization of care via an evidence-based treatment 
algorithm. Such an algorithm has been developed for the treatment of pit viper bites in 
the United States (Lavonas et al. 2011). However, this algorithm does not make use of 
grading scales for assessing the severity of crotaline envenomations, preferring instead to 
make use of continuous assessment of specific venom effects in order to inform treatment 
decisions. This approach was taken because the validity, reliability, and utility of such 
grading scales have yet to be demonstrated in a clinical setting. However, such grading 
scales, coupled with other baseline information obtained during initial clinical 
assessment, could prove useful if they could help predict overall severity and determine 
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which patients were most likely to show symptom progression. This information, 
therefore, could help medical professionals anticipate complications and improve patient 
outcomes.  
Several key factors affect bite severity and the clinical symptoms observed; these 
include the size and species of snake, as well as the body size and general health of the 
patient (Hayes & Mackessy 2010). Recent research suggests that the most important of 
these factors are snake size and patient mass (Chapter 3). Although snake species often 
differ in venom composition, their bites generally elicit different symptoms but result in 
similar overall severity (Chapter 3 and Appendix 1; Hayes et al. 2005; Janes et al. 2010). 
However, much of the research exploring these relationships has been general in nature, 
and has not focused on specific clinical application. 
The aim of this research was to examine the potential clinical usefulness of a 
standardized snake envenomation grading scale, the snakebite severity score (SSS; Dart, 
Hurlbut, Garcia, & Boren, 1996). In particular, we sought to determine whether the 
assessment of SSS and other relevant factors at the initial presentation of a snakebite 
victim at the hospital could help predict (1) the overall severity of envenomation, (2) the 
progression of symptoms following initial presentation, and (3) the total vials of CroFab 
antivenom used in treatment.  
Materials and Methods 
Study Design 
We analyzed data retrospectively abstracted from 243 medical records of 
venomous snakebite victims admitted between 2001 and 2010 to the Emergency 
Department of the Loma Linda University Medical Center (LLUMC). Our dataset was a 
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subset of a larger dataset of 354 cases (see Chapter 3), but included only those patients 
treated exclusively with CroFab. For the larger, original dataset, cases were identified by 
a database search for records between 1990 and 2010 that contained the International 
Classification of Diseases, Ninth Revision (ICD-9), codes E905.0 (venomous snake and 
lizard bites) and 989.5 (toxic effect of venom). Some records lacking these codes were 
undoubtedly missed. We included patients if they were bitten by a venomous snake 
native to southern California. We excluded patients that were bitten by animals other than 
venomous snakes, those bitten by venomous species not native to Southern California, 
and those whose envenomation did not result from a bite (one patient had an eye splashed 
by venom). For each patient, data were collected that covered the period of time between 
the bite and initial discharge. Information from follow-up visits was not considered. The 
protocol was reviewed by the institutional review board and considered exempt from 
informed consent.  
Data Collection 
Abstractors included one of the investigators (AGC) and four research assistants, 
none of whom were blinded to the goals of the study. The four research assistants were 
trained in data collection and calculation of snakebite severity by one of the investigators 
(AGC) via use of a standardized abstraction form. Inter-rater reliability was assessed and 
showed substantial agreement between abstractors (see Chapter 3). 
Calculating Snakebite Severity Scores 
We calculated snakebite severity scores (SSS) using the rubric designed by Dart 
et al. (1996). This scoring method, which ranges from 0–20 points, is based on the 
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objective evaluation of clinical parameters in six categories or subscores (SSsS): local 
wound effects, hematologic (coagulation) parameters, and symptoms associated with the 
pulmonary, cardiovascular, gastrointestinal, and central nervous systems. The subscores 
for each of these categories, which ranged from 0–3 or 0–4, were recorded separately and 
then summed to obtain a final SSS. Higher SSS scores indicate a more severe bite. If the 
patient record included no mention of an organ system abnormality relevant to any 
category, then that system was assumed to be unaffected by the snakebite. Because the 
SSS criteria published by Dart et al. (1996) were designed to assess adult patients, we 
adjusted the scoring of pulmonary and cardiac categories to account for differences in 
respiratory rate, heart rate, and blood pressure between children and adults (see Chapter 
3). These adjustments were based on other pediatric medical assessment rubrics and 
published data on normal values for pediatric vital signs (Tepas et al. 1987; Pollack et al. 
1997; Fleming et al. 2011; U.S. Department of Health & Human Services 2011) in 
consultation with a pediatric emergency medicine specialist. 
We calculated two separate SSS scores for each case. Initial SSS (iSSS) was 
calculated by determining the maximum scores for each category based on information 
recorded from time of the bite until the patient received their first dose of antivenom. 
Maximal SSS (mSSS) was determined by taking the maximum scores for each category 
based on information recorded from the time of the bite until initial discharge from the 
hospital. To assess the progression of snakebite symptoms once victims were in the care 
of medical professionals, we calculated the increase in SSS (incSSS) by subtracting iSSS 
from mSSS. 
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Determining Size of the Snake 
For 186 (76.5%) of the 243 cases used for this analysis, we categorized snake size 
as small (< 40 cm snout-vent length), medium (40–75 cm), or large (>75 cm), following 
the methods of Chapter 3. Briefly, we relied on three approaches for judging body size: 
1) the treating physician measured the length of the snake if it was brought to the hospital 
with the patient; 2) we used a regression model to estimate snake length based on the 
space between fang puncture wounds; and 3) we recorded a qualitative size assessment 
(e.g., "baby," "small," "large") from observers deemed reliable.  
Determining Species of Snake 
Seven taxa of rattlesnakes occur in southern California, including Crotalus atrox, 
C. cerastes, C. mitchellii pyrrhus, C. oreganus helleri, C. oreganus oreganus, C. ruber 
ruber, and C. scutulatus scutulatus. Because C. oreganus is represented by two 
subspecies in this region, we use the generic term "snake species" without implying 
anything about the taxonomic relationship within this clade. Of the 243 cases analyzed in 
this study, we were able to determine the envenoming species in 152 (62.6%) of them. 
Species were assigned to cases as described in Chapter 3. To summarize, the majority of 
species identifications were made by SPB based on a specimen or photograph brought to 
the hospital with the patient. Otherwise, species assignment was based on detailed 
descriptions when provided by reliable observers, as recorded in the medical record. 
Species assignments were checked against the geographical range and preferred habitat 
of each snake species (Stebbins 2003; Campbell & Lamar 2004). 
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Other Variables 
We analyzed several additional variables extracted from each record, including 
the number of vials of CroFab administered, patient mass, time to hospital admission 
(elapsed hours between bite and admission to hospital), limb bitten (upper or lower 
extremity), site of bite (distal or proximal to the wrist or ankle), and the type of 
interaction the patient had with the snake. Following the definitions provided by Klauber 
(1956) and Russell (1983), we classified the interactions as “legitimate” or “illegitimate.” 
If the patient saw the snake, and his/her deliberate interaction with the snake caused the 
bite, then the interaction was deemed “illegitimate.” If the interaction was not deliberate, 
and the patient did not see the snake prior to the bite, then the interaction was classed as 
“legitimate.” 
Statistical Analyses 
We conducted statistical analyses using SPSS 13.0 (SPSS Inc., Chicago, IL) and 
R version 3.1.2 (R Core Team 2014). All hypothesis testing was done using SPSS 13.0 
with standard defaults and alpha set at 0.05, whereas R version 3.1.2 was used to 
calculate Cook’s D for all analyses involving linear models (see below). Following 
Nakagawa (2004), we chose not adjust alpha for multiple tests. Unless otherwise 
indicated, we report values as mean ± 1 S.E. 
Factors Predicting Maximal Severity 
We relied on five analysis of covariance (ANCOVA) models (Mertler & Vannatta 
2004) and post-hoc multiple comparisons (least significant difference, LSD) to determine 
which of several factors affected mSSS as the dependent variable. We had to use multiple 
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models because a single omnibus model that included all independent variables of 
interest resulted in too many empty cells, as many cases lacked information on snake 
species, snake size, and/or type of patient interaction with the snake. For each of these 
models, we used mSSS as the dependent variable. Based on prior research (Wingert & 
Chan 1988; Blaylock 2004; Hayes et al. 2005; Benítez et al. 2007; Janes et al. 2010; 
Chapter 3 of this dissertation), we controlled for two primary predictors in all five 
models: snake size (as a fixed factor) and patient mass (as a covariate). We also included 
iSSS (covariate) in all models as a third primary predictor. The remaining five secondary 
predictors entered into the models included: snake species, limb bitten (upper or lower), 
site of bite (proximity to wrist or ankle), interaction with snake (legitimate or 
illegitimate), and time to hospital admission, with the first four variables treated as fixed 
factors, and the latter as a covariate. To maximize sample size and statistical power, each 
of the secondary predictors was entered into a separate model with the three primary 
predictors, except that one model included only the primary predictors, and two 
predictors (limb bitten and site of bite) were included together in another single model. 
Since the data largely conformed to parametric assumptions, none of the variables were 
transformed. For each model, we identified outliers using Cook’s D (Cook 1977), with 
cases being omitted as outliers if D exceeded 4/n (Bollen & Jackman 1990).  
We subsequently used a sixth ANCOVA model to analyze the contribution of 
each iSSS subscore (local wound effects, hematologic = coagulation parameters, and 
symptoms associated with the pulmonary, cardiovascular, gastrointestinal, and central 
nervous systems) to mSSS while controlling for snake size and patient mass, as indicated 
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by results of the first five ANCOVA models. This analysis allowed us to infer which 
initial symptoms were most predictive of overall snakebite severity. 
Factors Predicting Symptom Progression  
To assess the factors that predict the relative symptom progression following 
assessment of iSSS, we utilized another five ANCOVA models, making use of the same 
factors and covariates as for the previous analyses. However, we used incSSS as the 
dependent variable rather than mSSS, and we rank-transformed both incSSS and iSSS to 
better meet parametric assumptions. As with mSSS, we also utilized a sixth ANCOVA 
model to analyze the contribution of each iSSS subscore to relative symptom progression. 
Based on the results of the first five ANCOVA models, this model also included snake 
size and patient mass.  
Progression of Specific Symptom Types 
To assess which specific snakebite severity subscores (SSsS) showed progression 
in patients during the course of treatment, we compared initial and maximal values for 
each SSsS. Progression was deemed present if there was a difference. Cochran’s Q 
(Cochran 1950) was used to test for differences in the proportion of cases that showed 
progression among the six subscores. 
Factors Predicting Amount of Antivenom Used 
To assess the factors that predict the amount of antivenom used, we utilized 
another five ANCOVA models making use of the same factors and covariates as for the 
previous analyses. However, the total number of vials of antivenom was used as the 
dependent variable instead of mSSS or incSSS. For these analyses, we did not transform 
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vials of antivenom or iSSS so as to make the analysis more directly applicable for clinical 
application and because the data largely conformed to parametric assumptions after 
omitting outliers utilizing the aforementioned criteria. As with mSSS and incSSS, we also 
utilized a sixth ANCOVA model to analyze the contribution of each iSSS subscore to the 
amount of antivenom used. Again, this model also included snake size and patient mass.  
Assumptions and Effect Sizes 
For all ANCOVA models, we tested the assumption of homogeneity of regression 
slopes using separate ANCOVA models that included all interactions between the 
covariates and other predictors. No significant interactions were found, so we omitted 
interactions involving the covariates from our final models. We computed the coefficients 
(β) of the underlying regression model for each covariate to aid interpretation. We 
computed effect sizes as partial eta-squared (ɳ2), with values of ~0.01, ~0.06, and >0.14 
loosely regarded as small, medium, and large effects, respectively (Cohen 1988). 
Although partial ɳ2 values become upward biased as more independent variables are 
added to the model (Pierce et al. 2004), they never summed to >1 in the models tested, 
and therefore were not adjusted. 
Results 
Factors Predicting Maximal Snakebite Severity 
Mean mSSS for all cases was 7.12 ± 0.22. Of the eight independent variables and 
cofactors used among the five ANCOVA models (snake size, snake species, iSSS, patient 
mass, limb bitten, site of bite, interaction with snake, time to hospital admission), only 
snake size (all P ≤ 0.031; partial ɳ2 = 0.07–0.13), patient mass (all P ≤ 0.001; partial ɳ2 = 
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0.10–0.15), and  iSSS (all P < 0.001; partial ɳ2 = 0.67–0.70) were significant, and these 
were significant in all five models (Table 1). Estimated marginal means for mSSS were 
calculated for each snake size class based on Model 1, and were 6.66 ± 0.17, 6.69 ± 0.24, 
and 8.11 ± 0.25 for small, medium, and large snakes, respectively. Post-hoc (LSD) 
comparisons for model 1 (the model containing only the significant independent 
variables) showed that bites from large snakes had higher mSSSs than those from small 
and medium snakes (P < 0.001 for both), whereas the mSSS for bites of small and 
medium snakes was similar (P = 0.916). Initial SSS was negatively associated with 
patient mass (β = -0.02 to -0.03) and positively associated with iSSS (β = 0.79–0.89). 
The sixth ANCOVA model examining the effects of each iSSS subscore on mSSS 
is reported in Table 2. All six subscores (cardiovascular, gastric, hematological, 
pulmonary, neurological, and local wound) were found to be significant predictors of 
mSSS, with the regression coefficients suggesting a direct relationship for each subscore. 
Effect sizes (partial η2) suggested the following ranking for each subscore’s impact on 
mSSS: hematological > neurological > cardiovascular > pulmonary > gastric > local 
wound.  
  
1
3
9
 
 
 
 
 
 
Table 1. Results (P-values and partial ɳ2 effect sizes) of analysis of covariance (ANCOVA) models for maximal evenomation severity 
(mSSS) resulting from bites from seven rattlesnake species in southern California. 
Independent variables 
Model 1 
(N = 178) 
Model 2 
(N = 117)a 
Model 3 
(N = 171) a 
Model 4 
(N = 159) 
Model 5 
(N = 174) 
P ɳ2 P ɳ2 P ɳ2 P ɳ2 P ɳ2 
Snake size  <0.001 0.13 0.031 0.07 0.001 0.08 <0.001 0.10 <0.001 0.13 
Patient mass  <0.001 0.15 0.001 0.10 <0.001 0.10 <0.001 0.15 <0.001 0.11 
iSSS <0.001 0.70 <0.001 0.70 <0.001 0.67 0.001 0.70 <0.001 0.69 
Snake species – – 0.648 0.03 – – – – – – 
Snake species × snake size – – 0.303 0.08 – – – – – – 
Upper vs. lower limb – – – – 0.982 <0.01 – – – – 
Proximal vs. distal bite – – – – 0.242 0.01 – – – – 
Proximal or distal bite × snake size – – – – 0.591 <0.01 – – – – 
Upper or lower limb × snake size – – – – 0.887 <0.01 – – – – 
Proximal or distal × upper or  lower 
limb 
– – – – 0.099 0.02 – – – – 
Proximal or distal × upper or  lower 
limb × snake size 
– – – – 0.999 <0.01 – – – – 
Interact with snake – – – – – – 0.664 0.00 – – 
Interact × snake size – – – – – – 0.182 0.02 – – 
Time to hospital admission – – – – – – – – 0.881 <0.01 
aType IV sum of squares used due to empty cells 
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Table 2. Results of ANOVA model with maximal snakebite severity scores (mSSS) as the 
dependent variable, and each SSS subscore (shown), rank of patient mass (not shown), and 
size of snake (not shown) treated as independent factors. Regression coefficients (β) and 
effect sizes (partial η2) are also included. Subscores are ordered by effect size. 
SSS Subscore F 1,156 P β Partial η2 
Hematological 57.07 <0.001 0.95 0.27 
Neurological 39.80 <0.001 0.96 0.20 
Cardiovasular 26.92 <0.001 0.95 0.15 
Pulmonary 13.72 <0.001 0.78 0.08 
Gastric 9.37 0.003 0.68 0.06 
Local Wound 5.62 0.019 0.39 0.04 
 
Factors Predicting Symptom Progression  
Mean incSSS was 2.40 ± 0.133. Of the eight independent variables and cofactors 
used among the five ANCOVA models (snake size, snake species, iSSS, patient mass, 
limb bitten, site of bite, interaction with snake, time to hospital admission), only snake 
size (all P ≤ 0.010; partial ɳ2 = 0.06–0.16), patient mass (all P ≤ 0.001; partial ɳ2 = 0.10–
0.14), and iSSS (all P ≤ 0.008; partial ɳ2 = 0.07–0.11) were significant, and these were 
significant in all five models (Table 3). Post-hoc analysis of model 1 (the model 
containing only the significant independent variables) showed that bites from large 
snakes had more symptom progression than bites from both small and medium snakes (P 
< 0.001 for both), whereas progression of symptoms from the bites of small and medium 
snakes was similar (P = 0.512). Increase in SSS was negatively associated with both 
patient mass (β = -0.72 to -0.99) and iSSS (β = -0.18 to -0.21).The sixth ANCOVA 
model examining the effects of each iSSS subscore on incSSS is reported in Table 4. Of 
the six subscores (cardiovascular, gastric, hematological, pulmonary, neurological, and 
local wound), only the local wound subscore was found to significantly predict incSSS. 
The regression coefficient (β = -26.23) suggested an inverse relationship between this 
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subscore and incSSS; in other words, higher initial local wound subscores predicted less 
progression of symptoms.  
Progression of Specific Symptom Types 
Some snakebite severity subscores were more likely than others to show 
progression of symptoms (Cochran’s Q = 180.90, df = 5, p < 0.001; Figure. 1). The 
proportion of cases in which symptom progression occurred showed the following 
rankings for each symptom category: local wound > hematological > cardiovascular > 
pulmonary > neurological > gastric. 
Factors Predicting Antivenom Usage 
Median vials of CroFab used for all cases was 12.0 (range 2–66). Of the eight 
independent variables and cofactors used among the five ANCOVA models (snake size, 
snake species, patient mass, limb bitten, site of bite, interaction with snake, time to 
hospital admission), the main effects of the primary predictors snake size, patient mass, 
and iSSS were significant for all models except model 2 (Table 5; for models 1, 3 ,4 and 
5, snake size: all P < 0.001, partial ɳ2 = 0.11–0.20; patient mass: all P ≤ 0.019, partial ɳ2 
= 0.03–0.08; iSSS: all P ≤ 0.024, partial ɳ2 = 0.03–0.06). Estimated marginal means for 
total vials of antivenom were calculated for each snake size class based on Model 1, and 
were 12.14 ± 0.61, 11.67 ± 0.89, and 18.42 ± 0.95 for small, medium, and large snakes, 
respectively. Post-hoc pair-wise comparisons showed significant differences between 
large snakes and both medium and small snakes (P < 0.001 for both), whereas small and 
medium snakes were similar in antivenom dosage (P = 0.676).  
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Table 3. Results (P-values and partial ɳ2 effect sizes) of analysis of covariance (ANCOVA) models for increase in envenomation 
severity (incSSS) between initial (iSSS) and maximal (mSSS) measures of snakebite severity resulting from bites from seven rattlesnake 
taxa in southern California. 
Independent variables 
Model 1 
(N = 178) 
Model 2 
(N = 117)a 
Model 3 
(N = 171)a 
Model 4 
(N = 159) 
Model 5 
(N = 174) 
P ɳ2 P ɳ2 P ɳ2 P ɳ2 P ɳ2 
Snake size  <0.001 0.16 0.010 0.09 0.003 0.06 <0.001 0.12 <0.001 0.12 
Patient mass  <0.001 0.14 <0.001 0.11 <0.001 0.10 <0.001 0.14 <0.001 0.12 
iSSS <0.001 0.08 0.008 0.07 <0.001 0.11 0.001 0.07 <0.001 0.07 
Snake species – – 0.847 0.02 – – – – – – 
Snake species × snake size – – 0.113 0.10 – – – – – – 
Upper vs. lower limb – – – – 0.649 <0.01 – – – – 
Proximal vs. distal bite – – – – 0.945 <0.01 – – – – 
Proximal or distal bite × snake size – – – – 0.947 <0.01 – – – – 
Upper or lower limb × snake size – – – – 0.734 <0.01 – – – – 
Proximal or distal × upper or  lower 
limb 
– – – – 0.153 0.01 – – – – 
Proximal or distal × upper or  lower 
limb × snake size 
– – – – 0.999 <0.01 – – – – 
Interact with snake – – – – – – 0.780 0.00 – – 
Interact × snake size – – – – – – 0.438 0.01 – – 
Time to hospital admission – – – – – – – – 0.517 <0.01 
Independent variables: Patient age, patient mass, and time to hospital all rank transformed and treated as covariates. All others treated as fixed factors. 
aType IV sum of squares used due to one empty cell 
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Table 4. Results of ANOVA model with rank of increase in snakebite severity scores 
(incSSS) as the dependent variable, and each SSS subscore (shown), rank of patient mass 
(not shown), and size of snake (not shown) treated as independent factors. Regression 
coefficients (β) and effect sizes (partial η2) are also included. Subscores are ordered by 
effect size. 
SSS Subscore F1,157 P β Partial η2 
Local Wound 18.82 <0.001 -26.23 0.10 
Hematological 0.98 0.324 -4.56 0.01 
Gastric 0.66 0.420 -6.68 <0.01 
Pulmonary 0.51 0.477 -5.55 <0.01 
Cardiovasular 0.31 0.578 -3.97 <0.01 
Neurological 0.12 0.735 1.89 <0.01 
 
 
Figure 1: Percent of snake bite cases (out of 243) showing increases in snakebite severity 
between initial presentation and maximal severity for the six snakebite severity subscores 
corresponding to specific clinical symptoms. 
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Table 5. Results (P-values and partial ɳ2 effect sizes) of analysis of covariance (ANCOVA) models for antivenom usage resulting 
from rattlesnake bites in southern California 
Independent variables Model 1 
(N = 170) 
Model 2 
(N = 117)a 
Model 3 
(N = 168) 
Model 4 
(N = 155) 
Model 5 
(N = 168) 
P ɳ2 P ɳ2 P ɳ2 P ɳ2 P ɳ2 
Snake size  <0.001 0.18 0.361 0.02 <0.001 0.20 <0.001 0.11 <0.001 0.16 
Patient mass  0.019 0.03 0.077 0.03 0.009 0.04 0.001 0.08 0.015 0.04 
iSSS 0.021 0.03 0.055 0.04 0.001 0.06 0.024 0.03 0.007 0.04 
Snake species – – 0.093 0.09 – – – – – – 
Snake species × snake size – – 0.122 0.11 – – – – – – 
Upper vs. lower limb – – – – 0.417 <0.01 – – – – 
Proximal vs. distal bite – – – – 0.739 <0.01 – – – – 
Proximal or distal bite × 
snake size 
– – – – 0.863 <0.01 – – – – 
Upper or lower limb ×  
snake size 
– – – – 0.001 0.09 – – – – 
Proximal or distal ×  
upper or  lower limb 
– – – – 0.952 <0.01 – – – – 
Proximal or distal ×  
upper or  lower limb ×  
snake size 
– – – – 0.999 <0.01 – – – – 
Interact with snake – – – – – – 0.969 <0.01 – – 
Interact × snake size – – – – – – 0.008 0.06 – – 
Time to hospital admission – – – – – – – – 0.990 <0.01 
Independent variables: Patient age, patient mass, and time to hospital all rank transformed and treated as covariates; all others treated 
as fixed factors. 
aType IV sum of squares used due to one empty cell 
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Number of vials of CroFab used was negatively associated with patient mass (β = -0.04 
to -0.07) and positively associated with iSSS (β = 0.42–0.54 
None of the main effects of the secondary predictors (snake species, upper versus 
lower limb, proximal versus distal bite, interaction with the snake, time to hospital 
admission) were significant in these models. However, a significant interaction existed 
between snake size and upper vs. lower limb (F1,156 = 7.35, P = 0.001, partial ɳ2 = 0.09) 
in model 3. An interaction plot (Figure 2A) suggested that patients with bites from large 
snakes to the lower extremity were given more antivenom than similar bites to the upper 
limb, whereas similar quantities of antivenom were given regardless of site of bite for 
small and medium snakes. Model 4 also revealed a significant interaction between snake 
size and whether the bite was legitimate or illegitimate (F2,147 = 5.00, P = 0.008, partial ɳ2 
= 0.06). An interaction plot (Figure 4) suggested that patients who sustained legitimate 
bites from large snakes were given more antivenom on average than those receiving 
illegitimate bites, but this pattern was reversed for medium snakes. 
The sixth ANCOVA model examining the effects of each iSSS subscore on 
antivenom usage is reported in Table 6. Gastric, neurological, and hematological 
subscores were significant predictors of antivenom administration (in this order; P ≤ 
0.044, partial ɳ2 = 0.03–0.06), whereas local wound, cardiovascular, and pulmonary 
subscores were not. Regression coefficients suggested an inverse relationship between 
the gastric subscore and antivenom use (β = -2.77), and a direct relationship for the 
neurological and hematological scores (β = 1.33 and 1.06, respectively). Effect sizes 
(partial η2) suggested the following ranking for each significant subscore’s impact on 
antivenom use: gastric > neurological > hematological.  
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Figure 2: Interaction plots showing the effect of snake size (small: < 40 cm; medium: 40–75 cm; and large: >75 cm) and (A) 
whether the bite was to the upper vs. lower extremity, or (B) whether the bite was provoked (illegitimate) or not (legitimate), on 
the estimated marginal means of CroFab vials needed to treat the envenomation. Panel A is based on model 3 and panel B is 
based on model 4 from Table 5. Patient mass and initial snakebite severity (iSSS) were held constant (Panel A: 69.35 kg and 4.51, 
respectively; Panel B: 75.79 kg and 4.77, respectively). Error bars represent 95% confidence intervals. 
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Table 6. Results of ANOVA model that with vials of CroFab as the dependent variable, 
and each initial subscore (shown), rank of patient mass (not shown), and size of snake (not 
shown) as independent variables. Regression coefficients (β) and effect sizes (partial η2) 
are also included. Subscores are ordered by effect size.  
SSS Subscores F 1,154 P β Partial η2 
Gastric 9.14 0.003 -2.77 0.06 
Neurological 5.08 0.026 1.33 0.03 
Hematological 4.13 0.044 1.06 0.03 
Local Wound 2.01 0.158 0.89 0.01 
Cardiovascular 1.95 0.165 0.993 0.01 
Pulmonary 1.28 0.259 -0.961 0.01 
 
Discussion 
In this study, we sought to identify the salient factors that could help a physician 
anticipate how severe a snakebite might become subsequent to the initial presentation. 
Based on a substantial clinical data set and several measures of the well-established SSS 
rubric, we used multivariate models to evaluate the potential predictors of 1) maximal 
snakebite severity, 2) specific symptom profession, and 3) antivenom usage. Based on 
our findings, we offer several recommendations for treating physicians. 
Factors Predicting Maximal Severity 
We found that snake size and patient mass were significant predictors of overall 
snakebite severity, with each generally having a moderate to large effect size. Our 
analyses showed that large snakes were responsible for greater overall envenomation 
severity than medium or small snakes, which is consistent with previous research (Hayes 
et al. 2005; Hayes & Mackessy 2010; Janes et al. 2010); Chapter 3 of this dissertation). 
Also consistent with previous research is the finding of an inverse relationship between 
patient mass and mSSS (Hayes et al., 2005; Hayes & Mackessy, 2010; Chapter 3 this 
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dissertation). We further found iSSS to be a very significant predictor that showed a 
strong positive relationship to mSSS, explaining ~70% of the variance (partial η2 value; 
Table 1) This very large effect size may be explained by the fact that a majority of our 
cases didn’t show a significant increase in symptomology beyond initial assessment. 
Indeed, median increase in severity was just two SSS points, and 90.1% of cases showed 
an increase of just five or less. These findings suggest that the majority of the 
envenomation severity is captured by iSSS, and that substantial progression of symptoms 
beyond those seen at the initial assessment may be relatively rare.  
All iSSS subscores were significant predictors of mSSS. However, the 
hematological, neurological, and cardiovascular subscores showed large effect sizes, 
whereas the pulmonary, gastric, and local wound subcores showed small to moderate 
effect sizes. This finding is consistent with Yin et al., (2011) who found that 
thrombocytopenia, bleeding, neurologic effects, and bite severity were associated with 
difficulty in achieving initial control with antivenom administration.   
Factors Predicting Symptom Progression 
Our results suggest that the major factors that predict the progression of 
symptoms beyond the initial clinical assessment are the size of the envenoming snake, the 
mass of the patient, and the iSSS. Of these factors, the one with the greatest predictive 
value was the size of the snake, which in our analysis explained ~16% of the variance 
(Table 2), with larger snakes more likely to cause greater symptom progression. Patient 
mass explained ~14% of the variance, with smaller patients showing significantly greater 
symptom progression. Surprisingly, our statistical models suggested an inverse 
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relationship between iSSS and severity progression, with higher iSSS scores predicting a 
reduction in the amount of symptom progression. 
In analyzing the prediction of symptom progression based on iSSS subscores, 
only the local wound subscore was significant, explaining ~10% of the variance. The 
other five subscores (hematological, gastric, pulmonary, cardiovascular, and 
neurological) were not significant. This result may be explained by differences in the rate 
at which various symptoms progress. The symptoms associated with the local wound 
subscore generally progress more slowly, causing this subscore to reach peak severity 
much later than the other subscores. This finding further suggests that the majority of 
symptom progression after iSSS assessment may be due to progression of local wound 
symptoms. 
Our analyses found no evidence that the anatomical location of the bite or the 
nature of interaction with the snake (legitimate or illegitimate) affected symptom 
progression. Our analyses further found no evidence that symptom progression varied 
among snake species. This latter result was somewhat unexpected considering the 
differences in venom composition and clinical symptoms among the seven venomous 
snake taxa in southern California (Appendix 2).  
Factors Predicting Antivenom Usage 
The median number of vials of CroFab needed to resolve envenomations in our 
study was 12, which corresponds to a standard six vial initial dose and three maintenance 
doses of two vials each, according to the current dosing recommendation for CroFab 
(BTG International Inc. 2012; Lavonas et al. 2011). Our results are consistent with other 
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research wherein the median number of vials needed for initial control was six (Lavonas 
et al. 2009).   
The results of our analyses predicting antivenom use were similar to our analyses 
of overall severity and symptom progression, with snake size, patient mass, and iSSS all 
being significant predictors of antivenom use. These three variables were significant in 
four of our five ANCOVA models. None of these variables were significant in the model 
that tested for differences between snake species (model 2, Table 3), presumably because 
snake species explains some of the variation in snake size (see Chapter 2). Our analyses 
further suggest that length of the envenoming snake is the most important predictor of 
antivenom use, explaining ~18% of the variance (model 1), whereas patient mass and 
snake size had small to moderate effect sizes. In general, our statistical model (model 1; 
Table 5) showed that, on average (holding other factors constant), bites from large snakes 
required approximately 7 more vials of antivenom than those from small or medium 
snakes. Though effect sizes were small, the nature of the relationship between patient 
mass and iSSS was also described by our statistical models. Based on model 1 (Table 5), 
the coefficients of the underlying regression models suggested that, holding other factors 
constant, every 1 kg increase in patient mass was associated with a decrease in antivenom 
use by 0.04 vials. Likewise, every one point increase in iSSS was associated with an 
increase in antivenom use by 0.44 vials.  
The two interactions (one in model 3 and one in model 4; Table 5) suggest some 
effect of the anatomical location of the bite and whether the bite was legitimate or not. 
The interaction plots (Figure 2) suggest that legitimate bites and bites to the lower limb 
by large snakes may require more antivenom. These two factors may be related, as more 
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legitimate bites tend to happen to the lower extremities (Chapter 3). The ultimate reason 
for these relationships, however, remains unclear. Despite the moderate effect sizes of 
these interactions, the results may be statistical anomalies.  
Three subscores of iSSS predicted antivenom dosage. Of these, the gastric 
subscore was the most predictive, though its effect size was only moderate. The statistical 
model suggested that, holding other factors constant, a one point increase in gastric 
subscore predicted a decrease in antivenom use by 2.77 vials. This finding differs from 
other research that found no relationship between gastrointestinal symptoms and bite 
severity (Thornton et al. 2012). It remains unclear why higher initial gastric subscores 
would predict a reduction in antivenom use, but gastrointestinal subscores are highest in 
bites from the Mohave rattlesnake (C. scutulatus), for which lower local wound scores 
could predispose physicians to prescribe less antivenom (Appendix 1). The neurological 
and hematological subscores had small effect sizes, with the statistical model showing 
that a one point increase in the neurological and hematological subscores resulted in a 
1.33 and 1.06 vial increase in antivenom usage, respectively. We expected stronger 
relationships between initial local wound and initial hematological subscores and 
antivenom use, because these two symptoms, especially the former, are largely relied 
upon by physicians for antibody dosing. 
Clinical Recommendations 
Several conclusions can be drawn from our analyses that can be of use for 
clinicians in anticipating the overall severity of a bite, the degree of symptom 
progression, and the quantities of CroFab needed. In terms of overall severity and 
symptom progression, this study suggests that iSSS captures the vast majority of the 
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variation in overall snakebite severity, and further suggests that, while most cases will 
show some symptom progression beyond initial assessment, such progression is unlikely 
to be extreme and will likely result from local wound symptoms. Further, we found that 
higher iSSS scores predict a reduced progression of symptoms, suggesting that clinicians 
be more vigilant in monitoring symptom progression in patients with lower severity 
scores.  
Of greatest interest to clinicians may be our results related to the number of vials 
of CroFab needed to resolve symptoms, which may suggest changes to the way CroFab is 
currently administered. In our study, the factor with the greatest effect size was the length 
of the envenoming snake. We found that bites from large snakes (> 75 cm in length) 
required ~7 more vials of CroFab than bites from medium or small snakes. This roughly 
corresponds to the six-vial initial dose in the current dosing recommendations for CroFab 
(BTG International Inc. 2012; Lavonas et al. 2011). Therefore, clinicians may need to 
anticipate giving a second initial dose of six vials if it can be determined that the 
envenoming snake was greater than 75 cm in length.  
Though the effect size was small, patient mass was also significantly related to the 
number of vials of CroFab needed, with smaller patients needing more vials of 
antivenom. This may suggest a need to re-examine the current treatment algorithm that 
advocates using the same dosing regimen for both pediatric and adult cases (BTG 
International Inc. 2012; Lavonas et al. 2011). A rule of thumb that might be suggested 
based on the regression coefficients in our statistical models would be that, for every 20 
kg reduction in body mass, one extra vial of CroFab should be added to the first initial 
dose. Since the median patient mass for this study was about 75 kg, this would mean 
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adding one extra vial for patients less than 55 kg, two vials for patients less than 35 kg, 
and three extra vials for pediatric patients less than 15 kg.  
Initial snakebite severity (iSSS) was also significantly related to total vials of 
CroFab, though the effect size was rather small. In general, the regression coefficients 
from our statistical models suggested the need for an extra ~0.5 vials for every one point 
increase in iSSS. This may make the calculation of iSSS useful for clinicians seeking to 
determine whether a second initial dose is indicated. After the initial dose is 
administered, an iSSS of 8 or more may suggest that a second initial dose of four vials is 
warranted, whereas an iSSS of 12 or more may suggest a second initial dose of six vials 
may be indicated.  
Limitations 
One limitation of the conclusions of this study is its limited scope. We only 
collected data based on information recorded from the time of the envenomation until 
initial discharge from the hospital. Accordingly, our analyses do not inform prediction or 
treatment of potential further complications related to envenomation that may be 
manifested after initial discharge from the hospital. Potential complications following 
discharge include the recurrence of envenomation symptoms, which has been 
documented with the use of CroFab (Boyer et al. 1999; Boyer et al. 2001; O’Brien et al. 
2009; Lavonas et al. 2014), and other long term physical and emotional morbidities (Dart 
et al. 1992; Smith & Bush 2010; Williams et al. 2011). 
Despite our attempt to maintain the highest possible methodological rigor, several 
sources of bias are common to studies based on retrospective chart reviews. Bias may 
exist, for example, in the type and extent of missing data. More complete data may have 
 154 
been collected for patients with more severe bites, because these cases were likely to 
have received more attention from a greater number of clinicians, including one of our 
investigators (SPB). Also, charts did not specify whether recorded patient mass was 
measured or estimated. Since it may be more difficult to measure the mass of patients 
confined to a bed, a greater proportion of estimated masses may have been recorded for 
patients with more severe envenomations. Possible error existed in the information we 
relied on to determine size and species of the offending snake, and legitimacy of the bite. 
For information on the size and species of the snake, determinations based on 
photographs, specimens brought to the hospital, or measurement of fang-spread, 
especially those evaluated by SPB, were considered to be of high accuracy. 
Determinations from descriptions provided by other medical personnel (e.g. first 
responders), and the patients themselves, were likely to be less accurate. Cross-
referencing the geographic location where the bite occurred with the known geographic 
ranges of southern California rattlesnakes provided some error mitigation for species 
determinations. Veracity of the patients was another potential source of error, particularly 
with respect to assigning bite legitimacy. Patients may have felt ashamed if their own 
lack of judgement resulted in the bite, or may have worried about legal ramifications, 
especially if they were keeping the snake in captivity, and, hence, may have given 
inaccurate information about how the bite occurred. In one case where a male patient was 
transferred to LLUMC from another medical facility, we found contradictory information 
surrounding the circumstances of the bite.  
  
 155 
References 
Benítez, J.A., Rifakis, P.M., Vargas, J.A., Cabaniel, G., et al., 2007. Trends in fatal 
snakebites in Venezuela, 1995-2002. Wilderness & Environmental Medicine, 18(3), 
pp.209–213. 
Blaylock, R.S., 2004. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South 
Africa. Toxicon, 43(2), pp.159–166. 
Bollen, K.A. & Jackman, R.W., 1990. Regression diagnostics: An expository treatment 
of outliers and influential cases. In J. Fox & J. S. Long, eds. Modern Methods of 
Data Analysis. Newbury Park, CA: SAGE Publications, pp. 257–291. 
Boyer, L. V., Seifert, S. A. & Cain, J.S., 2001. Recurrence phenomena after 
immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical 
management with crotaline Fab antivenom. Annals of Emergency Medicine, 37(2), 
pp.196–201. 
Boyer, L. V., Seifert, S.A., Clark, R.F., McNally, J.T., et al., 1999. Recurrent and 
persistent coagulopathy following pit viper envenomation. Archives of Iinternal 
Medicine, 159(7), pp.706–10. 
BTG International Inc., 2012. Highlights of perscribing information for CroFab. 
Campbell, J.A. & Lamar, W.W., 2004. Venomous reptiles of the western hemisphere, 
Ithaca, NY: Cornell University Press. 
Cannon, R., Ruha, A.-M. & Kashani, J., 2008. Acute hypersensitivity reactions 
associated with administration of crotalidae polyvalent immune Fab antivenom. 
Annals of Emergency Medicine, 51(4), pp.407–11. 
Cochran, W.G., 1950. The comparison of percentages in matched samples. Biometrika, 
37(3), pp.256–266. 
Cohen, J., 1988. Statistical power analysis for the behavioral sciences 2nd ed., Hillsdale, 
NJ: Lawrence Erlbaum Associates. 
Cook, R.D., 1977. Detection of Influential Observation in Linear Regression. 
Technometrics, 19(1), pp.15–18. 
Corneille, M.G., Larson, S., Stewart, R.M., Dent, D., et al., 2006. A large single-center 
experience with treatment of patients with crotalid envenomations: outcomes with 
and evolution of antivenin therapy. American Journal of Surgery, 192(6), pp.848–
852. 
 156 
Dart, R.C., Hurlbut, K.M., Garcia, R. & Boren, J., 1996. Validation of a severity score for 
the assessment of crotalid snakebite. Annals of Emergency Medicine, 27(3), pp.321–
326. 
Dart, R.C. & McNally, J.T., 2001. Efficacy, safety, and use of snake antivenoms in the 
United States. Annals of Emergency Medicine, 37(2), pp.181–8. 
Dart, R.C., McNally, J.T., Spaite, D.W. & Gustafson, R., 1992. The sequelae of pitviper 
poisoning in the United States. In J. A. Campbell & E. D. Brodie, eds. Biology of the 
Pitvipers. Tyler Texas: Selva, pp. 395–404. 
Fleming, S., Thompson, M., Stevens, R., Heneghan, C., et al., 2011. Normal ranges of 
heart rate and respiratory rate in children from birth to 18 years of age: a systematic 
review of observational studies. Lancet, 377(9770), pp.1011–1018. 
Hayes, W.K., Herbert, S.S., Bush, S.P., Rehling, G.C., et al., 2005. Defensive bites by 
rattlesnakes (Genus Crotalus): Venom expenditure, envenomation severity, and the 
importance of snake size. In Program and Abstracts of the Biology of the 
Rattlesnakes Symposium. Loma Linda, California: Loma Linda University, p. 31. 
Hayes, W.K. & Mackessy, S.P., 2010. Sensationalistic journalism and tales of snakebite: 
Are rattlesnakes rapidly evolving more toxic venom? Wilderness & Environmental 
Medicine, 21(1), pp.35–45. 
Janes, D.N., Bush, S.P. & Kolluru, G.R., 2010. Large snake size suggests increased 
snakebite severity in patients bitten by rattlesnakes in southern California. 
Wilderness & Environmental Medicine, 21(2), pp.120–126. 
Kasturiratne, A., Wickremasinghe, A.R., de Silva, N., Gunawardena, N.K., et al., 2008. 
The global burden of snakebite: a literature analysis and modelling based on 
regional estimates of envenoming and deaths. PLoS Medicine, 5(11), p.e218. 
Klauber, L.M., 1956. Rattlesnakes: their habits, life histories and influence on mankind 
2nd ed., Berkeley: University of California Press. 
Lavonas, E.J., Khatri, V., Daugherty, C., Bucher-Bartelson, B., et al., 2014. Medically 
significant late bleeding after treated crotaline envenomation: a systematic review. 
Annals of Emergency Medicine, 63(1), pp.71–78.e1. 
Lavonas, E.J., Ruha, A.-M., Banner, W., Bebarta, V., et al., 2011. Unified treatment 
algorithm for the management of crotaline snakebite in the United States: results of 
an evidence-informed consensus workshop. BMC Emergency Medicine, 11(1), p.2. 
Lavonas, E.J., Schaeffer, T.H., Kokko, J., Mlynarchek, S.L., et al., 2009. Crotaline Fab 
antivenom appears to be effective in cases of severe North American pit viper 
envenomation: an integrative review. BMC Emergency Medicine, 9, p.13. 
 157 
Marcinko, T., 2014. Poison pill: Inflated antivenom bills shed light on high drug costs. 
Aljazeera America. Available at: 
http://america.aljazeera.com/articles/2014/3/17/poison-pill-
inflatedantivenombillsshedlightonhighdrugcosts.html [Accessed December 30, 
2014]. 
Mertler, C.A. & Vannatta, R.A., 2004. Advanced and multivariate statistical methods: 
practical application and interpretation 3rd ed., Los Angeles, CA: Pyrczak 
Publishing. 
Nakagawa, S., 2004. A farewell to Bonferroni: the problems of low statistical power and 
publication bias. Behavioral Ecology, 15(6), pp.1044–1045. 
O’Brien, N.F., DeMott, M.C., Suchard, J.R., Clark, R.F., et al., 2009. Recurrent 
coagulopathy with delayed significant bleeding after crotaline envenomation. 
Pediatric Emergency Care, 25(7), pp.457–9. 
Pierce, C.A., Block, R.A. & Aguinis, H., 2004. Cautionary note on reporting eta-squared 
values from multifactor ANOVA designs. Educational and Psychological 
Measurement, 64(6), pp.916–924. 
Pollack, M.M., Patel, K.M. & Ruttimann, U.E., 1997. The pediatric risk of mortality III--
Acute physiology score (PRISM III-APS): A method of assessing physiologic 
instability for pediatric intensive care unit patients. The Journal of Pediatrics, 
131(4), pp.575–581. 
R Core Team, 2014. R: A language and environment for statistical computing. 
Rhodan, M., 2014. Snake Bite Costs North Carolina Couple $89,000 Hospital Bill. 
Time.com. Available at: http://time.com/2897/north-carolina-hospital-bill-snake-
bite/ [Accessed November 3, 2015]. 
Russell, F.E., 1983. Snake venom poisoning, Great Neck, New York: Scholium 
International Inc. 
Seifert, S.A., Boyer, L. V, Benson, B.E. & Rogers, J.J., 2009. AAPCC database 
characterization of native U.S. venomous snake exposures, 2001-2005. Clinical 
Toxicology, 47(4), pp.327–335. 
Smith, J. & Bush, S.P., 2010. Envenomations by reptiles in the United States. In S. P. 
Mackessy, ed. Handbook of Venoms and Toxins of Reptiles. Boca Raton, FL: CRC 
Press, pp. 475–490. 
Spiller, H. a., Bosse, G.M. & Ryan, M.L., 2010. Use of antivenom for snakebites reported 
to United States poison centers. American Journal of Emergency Medicine, 28(7), 
pp.780–785. 
 158 
Stebbins, R.C., 2003. Peterson field guides: western reptiles and amphibians 3rd ed., 
New York, NY: Houghton Mifflin Compancy. 
Tepas, J.J., Mollitt, D.L., Talbert, J.L. & Bryant, M., 1987. The pediatric trauma score as 
a predictor of injury severity in the injured child. Journal of Pediatric Surgery, 
22(1), pp.14–18. 
Thornton, S.L., Nguyen, K.T., Shenn, S.K., Castillo, E.M., et al., 2012. A retrospective 
review of early gastrointestinal symptoms in the prediction of crotaline 
envenomation severity. Wilderness & Environmental Medicine, 23(4), pp.360–2. 
U.S. Department of Health & Human Services, 2011. Pediatric basic and advanced life 
support. Available at: http://chemm.nlm.nih.gov/pals.htm [Accessed June 7, 2014]. 
Williams, S.S., Wijesinghe, C.A., Jayamanne, S.F., Buckley, N.A., et al., 2011. Delayed 
psychological morbidity associated with snakebite envenoming. PLoS Neglected 
Tropical Diseases, 5(8), p.e1255. 
Wingert, W. & Chan, L., 1988. Rattlesnake bites in southern California and rationale for 
recommended treatment. The Western Journal of Medicine, 148(1), pp.37–44. 
Yin, S., Kokko, J., Lavonas, E.J., Mlynarchek, S., et al., 2011. Factors associated with 
difficulty achieving initial control with crotalidae polyvalent immune fab antivenom 
in snakebite patients. Academic Emergency Medicine, 18(1), pp.46–52. 
 
 159 
CHAPTER FIVE 
CONCLUSIONS 
In this dissertation, I examined several aspects of human-rattlesnake conflict in 
southern California. I addressed the risks this conflict poses to both parties: the 
rattlesnakes and the humans. In this chapter, I will revisit the major findings in each study 
and suggest avenues for future research.  
In Chapter 2, I investigated the impact of short-distance translocation (SDT) and 
long-distance translocation (LDT) on Red Diamond Rattlesnakes (Crotalus ruber) 
located near residential development in southern California. Depending on the metric 
measured (minimum convex polygon, local convex hull, range length), activity ranges of 
LDT snakes were 38.6–67.1% larger than those of SDT snakes, which, in turn, had 
activity ranges that were 77.0–152.9% larger than non-translocated (NT) snakes. Snakes 
moved closer to human modified areas during summer, and were translocated most often 
during that season at the behest of property owners. Both SDT and LDT snakes were 
more likely to move into human-modified areas subsequent to translocation than NT 
snakes. The distance a snake was translocated affected its risk of movement into human 
modified areas and its risk of returning to its site of capture, with every 1 m increase in 
distance resulting in a 1.2% decreased risk of moving into a human-modified area, and a 
1.5% decreased risk of returning to the site of capture. We found no differences in the 
survival rate between translocated snakes (LDT and SDT) and NT snakes.  
Based on these findings, I suggest that translocation may be a viable approach to 
reduce human-snake conflict. However, the success of this approach may depend on the 
local ecology and the biology of the rattlesnake species. I proposed that snakes which 
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rely on specific (typically communal) hibernacula will be placed at greatest peril with 
translocation, as these snakes may experience difficulty locating a suitable site for 
overwintering. Snakes that do not rely on specific hibernacula for brumation (≈ 
hibernation), such as those included in our study, may be less effected by translocation. 
In Chapter 3, I investigated the effects of a number of factors on the etiology and 
severity of envenomations among victims of rattlesnake envenomations in southern 
California. I conducted a retrospective review of 354 cases of venomous snakebite 
admitted to Loma Linda University Medical Center (LLUMC) between 1990 and 2010. 
In terms of etiology, I found that 80.5% of snakebite cases were male victims, 69.2% of 
bites were to an upper limb, and 88.0% were distal to the wrist or ankle. Of 308 cases 
where a determination could be made, 45.8% were illegitimate (i.e., bites provoked by 
the human interacting with the snake). Most snakebites occurred during the spring mating 
season, followed by another large pulse during fall associated with newborn snake 
emergence. Males snakebite victims were 2.9, 7.1, and 3.1 times more likely to sustain 
bites to the upper extremity, distal to the ankle or wrist, and via illegitimate provocation, 
respectively, than female victims. Those admitting to alcohol or drug use were 5.7 times 
more likely to sustain illegitimate bites, which were 111.0- and 7.1-fold more likely to be 
to the upper limb and distal to the ankle or wrist, respectively. Snakebite severity was 
positively associated with snake size, negatively associated with patient mass, and 
independent of patient age, snake taxon, anatomical location of bite, legitimate versus 
illegitimate (provoked) bites, and time until hospital admission. The effectiveness of 
CroFab antivenom against each of the seven southern California rattlesnake taxa was also 
assessed. Despite concerns that CroFab is ineffective in neutralizing the venom of some 
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snake taxa, especially that of the Southern Pacific Rattlesnake (Crotalus oreganus helleri; 
Consroe et al., 1995; Sánchez et al., 2003), we found its clinical effectiveness to be 
similar for all taxa. 
In Chapter 4, I further investigated rattlesnake envenomations in southern 
California from the perspective of a clinician, assessing several factors currently omitted 
from snakebite treatment algorithms (Lavonas et al. 2011) for their potential usefulness 
as predictors of overall snakebite severity score, symptom progression from initial 
assessment, and antivenom use. The factors were the same as those for the previous 
chapter. I found initial snakebite severity score (iSSS), the size of the envenoming snake, 
and patient mass to be significant predictors of overall bite severity, symptom 
progression, and antivenom use. Initial SSS proved to be the most effective predictor of 
overall severity, explaining ~70% of the variance. Snake size best predicted symptom 
progression, with larger snakes inflicting greater symptom progression. Patient mass and 
iSSS also significantly predicted symptom progression, with smaller patients and those 
with lower iSSSs experiencing greater symptom progression. Snake size was also the 
most important factor predicting antivenom use, with large snakes requiring, on average, 
seven more vials of CroFab than medium or small snakes. I further evaluated whether 
scores of each of six symptom classes assessed upon admission (iSSS subscores for 
cardiovascular, gastric, hematological, local wound, neurological, and pulmonary 
symptoms) influenced overall SSS, symptom progression, and antivenom use. All six 
subscores significantly predicted overall severity, but hematological, neurological, and 
cardiovascular subscores were most salient. Local wound score was the only significant 
predictor of symptom progression. Gastric, neurological, and hematological symptoms 
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were significantly associated with antivenom use, but the gastric subscore showed an 
unexpected inverse relationship to antivenom use. Based on our analyses, we suggest that 
iSSS, snake size, and patient mass are especially useful to clinicians for anticipating 
antivenom needs. I also suggested several potential rules of thumb that could be added to 
the current snakebite treatment algorithm to help clinicians anticipate antivenom needs. 
Future Directions 
 In Chapter 2, I examined the effect of long- and short-distance translocation in 
Red Diamond Rattlesnakes in southern California. While this study represents one of the 
most complete studies to date on translocation in a rattlesnake species, substantially more 
research is needed to improve our understanding of the impacts of mitigation 
translocation on snakes. In spite of accumulating studies on the effects of translocation on 
rattlesnakes (see Table 1, Chapter 2), this form of mitigation remains a highly 
experimental approach for which generalizations should be made with caution. Studies 
vary substantially in their translocation protocols, duration, and assessments of behavior 
and mortality, and all are constrained by relatively small samples, including mine.  
Comparing the low mortality in my study with the higher mortality seen in other 
studies (e.g. Reinert & Rupert, 1999; Nowak, Hare, & McNally, 2002) suggests that 
environmental and ecological conditions play an important role in mortality due to 
translocation, and failure to account for this may influence our assessment of the viability 
of mitigation translocation in rattlesnakes. Clearly, more studies of this kind are needed 
from a wide variety of species and habitats.  
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My results from the snakebite studies of Chapters 4 and 5 also suggest avenues 
for future research. The conclusions drawn from these studies were made on the basis of 
a retrospective review of medical records. The conclusions we derived have yet to be 
tested in a prospective study. Such studies are needed to test the validity of my 
conclusions and to determine the utility of the potential rules of thumb I suggest to help 
clinicians anticipate antivenom needs. The approaches I used to assess snakebite severity 
and its amelioration can be adapted to future studies in North America and other regions, 
and studies of new antivenoms and novel treatments as they emerge.  
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APPENDIX A 
FROM VENOME TO SYNDROME: CORRESPONDENCE OF RATTLESNAKE 
VENOM COMPOSITION AND CLINICAL SYMPTOMS OF SNAKEBITE 
 
Aaron G. Corbit and William K. Hayes 
 
Abstract 
Rattlesnakes possess highly variable venoms that cause severe systemic and local 
tissue effects in human snakebite victims. We sought to determine the degree to which 
different clinical symptoms could be attributed to variation in the venom composition of 
seven southern California rattlesnake taxa. To compare species differences in clinical 
symptoms resulting from bites, we assigned snakebite severity subscores (SSsS) to 204 
envenomated patients presenting at the LLU Medical Center. This sample included only 
cases with positive identification of the offending snake species. We quantified SSsS 
using a standard scale that included effects on local tissue, cardiovascular, respiratory, 
gastrointestinal, hematological, and neurological systems. Discriminant function analysis 
using equal probabilities for group assignments and controlling for snake size yielded a 
highly significant model (Λ = 0.39, χ242 = 148.63, P < 0.001; N = 166 cases with 
complete data). Overall, 50.0% of cases were correctly classified to snake species, which 
greatly exceeded that expected from random (14.3%). To characterize venom variation, 
we subjected at least one sample from each rattlesnake taxon to high-pressure liquid 
chromatography (HPLC) fractionation, which allowed us to identify the relative 
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composition of major toxin families. Major species differences in SSsS corresponded to 
obvious differences in the venom composition. As examples, (1) the high neurological 
subscores of Crotalus oreganus helleri bites corresponded to high levels of myotoxins in 
their venom that caused frequent muscle fasciculations and/or myokymia; (2) the high 
pulmonary, cardiovascular, and gastrointestinal subscores of C. scutulatus corresponded 
to high levels of Mojave toxin, a presynaptic neurotoxin; (3) the high local wound scores 
of C. mitchellii and C. o. oreganus bites probably corresponded to high levels of snake 
venom serine proteases (SVSPs) and cysteine-rich secretory proteins (CRiSPs); and (3) 
the high hematological subscores of C. atrox and C. ruber bites corresponded to high 
levels of metalloproteases. We further documented flaccid paralysis and 
fasciculations/myokymia—symptoms expected of bites from C. scutulatus and C. o. 
helleri that are known to possess neurotoxins in their venoms—in occasional bites from 
several taxa that presumably lack neurotoxins. Collectively, these findings offer valuable 
insights on how venom composition influences clinical symptoms, and can inform the 
design of more effective antivenoms and treatment algorithms for rattlesnake bites. 
Introduction 
Rattlesnakes possess highly variable venoms that can cause a variety of severe 
local tissue, hematological, and neurological effects (White et al. 2003; Boyer et al. 
2015). Seven rattlesnake taxa occur in southern California (see Chapter 3), including two, 
the Southern Pacific Rattlesnake (Crotalus oreganus helleri) and the Mohave Rattlesnake 
(Crotalus scutulatus), that are known to cause neurotoxic symptoms. However the 
neurological effects of these two taxa differ. Crotalus o. helleri envenomations cause 
muscle fasciculations and/or myokymia (Wingert & Chan 1988; Bush & Siedenburg 
 167 
1999), whereas those of C. scutulatus often cause flaccid paralysis due to the action of a 
well characterized dimeric, presynaptic, phospholipase A2 neurotoxin known as Mojave 
toxin (Farstad et al. 1997; Massey et al. 2012). A population of C. o. helleri around 
Mount San Jacinto possesses a homologous phospholipase A2 neurotoxin (French et al. 
2004; Sunagar et al. 2014), but other than a case report for a dog bitten in the San Jacinto 
Mountains (Hoggan et al. 2011) and a case of possible flaccid paralysis in a Caracal 
(Caracal caracal; Singleton et al. 2009), no flaccid paralysis resulting from C. o. helleri 
envenomation has been documented. 
Whereas a growing body of research characterizes the differences in venom 
composition among rattlesnake taxa (Calvete et al. 2010; Mackessy 2010; Massey et al. 
2012; Sunagar et al. 2014), much less work has been done to document differences in the 
clinical syndrome that can be attributed to variation in venom composition. We can 
expect that venom components present in the largest quantities of a given venom will 
elicit the most severe clinical symptoms. Thus, if a snake has a large component of 
neurotoxin in its venom, then we would expect the clinical presentation to feature 
substantial symptoms related to neurotoxicity. Prior studies from southern California 
suggest that the overall snakebite severity score (SSS) does not differ among rattlesnake 
taxa (Janes et al. 2010; Chapter 3 of this dissertation). However, some differences in 
specific clinical symptoms (snakebite severity subscores) have been documented among a 
few of these same taxa (Janes et al. 2010), and even among venom phenotypes of a single 
species (Massey et al. 2012). 
The purposes of this study were to (1) examine the extent to which clinical 
symptoms differ among seven rattlesnake taxa in southern California, and (2) to identify 
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candidate toxin families largely responsible for these differences. This preliminary report 
represents the largest and most comprehensive study to date in attributing the clinical 
syndrome of rattlesnake envenomation (i.e., the specific set of clinical symptoms) to 
venom composition. We are currently expanding the study to include detailed proteomic 
analyses of a much larger set of venom samples. 
Materials and Methods 
Snakebite Severity Subscores 
We utilized a subset of 204 cases from the retrospective dataset of 354 cases used 
in Chapters 3 and 4 wherein the taxon of the envenoming snake was known. Seven 
rattlesnake taxa were represented: Western Diamondback (C. atrox), Sidewinder (C. 
cerastes), Southwestern Speckled Rattlesnake (C. mitchellii pyrrhus), Northern Pacific 
Rattlesnake (C. o. oreganus), Southern Pacific Rattlesnake (C. o. helleri), Red Diamond 
Rattlesnake (C. ruber), and Mojave Rattlesnake (C. scutulatus). Besides snake taxa, we 
included information about the size of the snake that bit each patient, as well as the 
snakebite severity scores following the rubric designed by Dart et al. (1996) for adults 
and an adjusted rubric for pediatric patients (see Chapter 3). This scoring method, which 
ranges from 0–20 points (higher scores indicating more severe bites), is based on the 
objective evaluation of clinical parameters in six categories: local wound effects, 
hematologic (coagulation) parameters, and symptoms associated with the pulmonary, 
cardiovascular, gastrointestinal, and central nervous systems. Snakebite severity 
subscores (SSsS) for each of these categories, which range from 0–3 or 0–4, were 
recorded in this dataset as well as a summed total score. Two sets of these scores were 
recorded in the dataset. Initial scores were calculated by determining the maximum 
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scores for each symptom category based on information recorded from time of the bite 
until the patient received their first dose of antivenom. Maximal scores were determined 
by taking the maximum scores for each symptom category based on information recorded 
from the time of the bite until initial discharge from the hospital. However, we only 
report analyses based on maximal SSsS here. 
The dataset also characterized the presence or absence of flaccid paralysis and 
fasciculations/myokymia. The presence of flaccid paralysis was assigned if case 
documentation noted muscle weakness, ptosis, slurred speech, or other signs of motor 
impairment due to loss of muscle tone. The presence of fasciculations/myokymia was 
assigned if any mention of uncontrolled muscle twitching was made in the medical 
record. Symptoms were assumed to be absent if undocumented. Some researchers 
distinguish between fasciculations and myokymia (Gutmann & Gutmann 2004) both of 
which manifest as spontaneous, fine, involuntary undulating waves or ripples of muscle 
fibers that are often visible beneath the skin; however, it may be difficult to distinguish 
these clinically (LoVecchio et al. 2005), and the distinction remains unclear in the 
snakebite literature. 
Venom Composition 
 We created a representative chromatogram for each snake taxon by fractionating a 
venom sample using reversed-phase high-pressure liquid chromatography (RP-HPLC). 
Methods are described elsewhere (Sunagar et al. 2014; Gren 2015). This preliminary 
work involved a single venom sample for most of the taxa, but we are currently running 
additional venom samples to obtain a better understanding of geographic variation within 
each taxon. All venom samples analyzed here were obtained within the same geographic 
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region where snakebites occurred. Venom composition can be inferred from the 
chromatograms, with several major toxin families appearing in distinct portions of the 
chromatogram. Most notably, small basic proteins comprising myotoxins (β-defensins) 
appear with the early eluents (roughly 56-65 mL), Mojave toxin appears as two peak sets 
(for the two subunits) within the 78–95 mL region, serine and numerous other proteases 
and toxins emerge within the 95–123 mL region, and snake venom metalloproteinases 
dominate beyond 123 mL (Fig. 1). 
 
 
 
 
Figure 1. Composite RP-HPLC chromatogram, combining peaks from several Crotalus 
oreganus helleri venom samples to illustrate major toxin protein families. Presence and 
order of elution of proteins can vary substantially among some toxin families, particularly 
within the range of 95–120 mL. BPP = bradykinin potentiating peptide; SBP = small basic 
peptides comprising myotoxins; VEGF = vascular endothelial growth factor; PLA2 = 
phospholipases A2, including Mojave toxin (MT), a dimeric presynaptic neurotoxin with 
acidic (MTa) and basic (MTb) subunits; CRiSP = cysteine-rich secretory protein; SVSP = 
snake venom serine protease; LAO = L-amino acid oxidase; SVMP = snake venom 
metalloproteinase. Figure modified from Gren (2015). The three entities most reliably 
identified by position are SBP, MT, and SVMP. 
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Statistical Analyses 
We performed discriminant function analysis (DFA) on the SSsS for each case to 
examine whether there were differences in the clinical symptomology among snake 
species. Prior to analysis, we screened the data to assure they largely met parametric 
assumptions. We based our analyses and conclusions on a DFA model that assumed 
equal prior probabilities for each group. DFA models that use equal prior probabilities are 
known to be less biased (Mertler & Vannatta 2004); however, we also conducted DFAs 
using prior probabilities computed from group sample sizes for comparison and obtained 
similar results. We included size of the snake in the model to increase the predictive 
success of the model and to control for species differences in snake size. Cases wherein 
the size of the snake could not be determined were omitted, leaving a final sample of 166 
cases for this analysis. Similar multinomial logistic regression models using each species 
as a reference were also performed. These models had somewhat better prediction 
success; however, the DFA yielded similar results and provided a canonical plot of 
discriminant scores to visualize species differences. Only the DFA results are reported 
here. We standardized the SSsS values for graphical presentation to illustrate species 
differences relative to all snakebites. These standardized values do not control for snake 
size. 
We further tested for differences in the incidence of flaccid paralysis and 
fasciculations/myokymia among species using Fisher exact tests due to small sample 
sizes for some species. We conducted the DFA using SPSS 13.0 (SPSS Inc., Chicago, 
IL), and Fisher exact tests via R 3.2.1 (R Core Team 2014). Alpha was set to 0.05. We 
present results as means ± 1 S.E. 
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Results 
Standardized means for each SSsS for each species are shown in Figure 2. For 
some taxa, one or several clinical symptoms averaged much higher subscores relative to 
the average snakebite. Again, these values are not adjusted for snake size. 
 
 
Figure 2. RP-HPLC chromatograms of venom samples paired with standardized SSsS 
(mean ±1 SE) of clinical symptoms from each of seven rattlesnake taxa. Colored ellipses 
indicate correspondence between elution peaks and clinical symptoms. For SSsS, n = 7 to 
74 for each taxon. 
 
 
 
Wilks’ lambda for the DFA model was significant (Λ = 0.390, χ242 = 148.633, n = 
166, P < 0.001), indicating that SSsSs differed among the snake taxa. Separation of snake 
species based on the first two functions is depicted in Figure 3. The first function (43.2% 
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of variance) was positively associated with the hematological (standardized coefficient = 
0.910) and local wound (0.303) components. It was negatively associated with the 
pulmonary (-0.454), cardiac (-0.382), and gastric (-0.279) components. This function did 
well separating C. atrox and C. ruber, which tended to cause significant hematologic and 
local wound symptoms, from C. scutulatus, which tended to cause more pulmonary and 
cardiac symptoms. The second function (34.2% of variance) was strongly and positively 
associated with the neurological component (1.090) and negatively associated with the 
cardiac (-0.279) and pulmonary (-0.264) components. The second function separated out 
C. o. helleri, which tended to cause more significant neurological symptoms, and C. 
cerastes, which had the lowest subscores. 
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Figure 3. Canonical plot of discriminant scores for snakebite severity subscores (SSsSs) 
from each of seven rattlesnake (genus Crotalus) taxa. Function 1 (48.6% of variance) and 
Function 2 (29.6% of variance) were comprised primarily of hematological and 
neurological subscores, respectively. 
 
 
 
Classification results for the DFA model indicated that 50.0% of the snakebite cases 
were classified correctly to snake species, and somewhat fewer (44.6%) were cross-
validated using leave-one-out. Accuracy for each species was C. atrox 87.5%, C. cerastes 
80.8%, C. mitchellii pyrrhus 33.3%, C. o. helleri 44.2%, C. o. oreganus 14.3%, C. ruber 
33.3%, and C. scutulatus 52.4%. Classifications greatly exceeded those expected from 
random, which was 14.3% based on the assumption that prior probabilities were equal for 
all species. The only exception was for C. o. oreganus, for which model accuracy was 
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equal to what was expected by chance. When the DFA was run using prior probabilities 
computed from group sizes, classification success improved to 60.0% and 52.4% for 
original and cross-validated cases, respectively.  
Major species differences in SSsSs corresponded to obvious differences in venom 
composition (Fig. 2). As examples, (1) the high neurological subscores of C. o. helleri bites 
corresponded to high levels of myotoxins in the venom; (2) the high pulmonary, 
cardiovascular, and gastrointestinal subscores of C. scutulatus corresponded to high levels 
of Mojave toxin in the venom; (3) the high local wound scores of C. mitchellii and C. o. 
oreganus bites probably corresponded to high levels of snake venom serine proteases 
(SVSPs) and cysteine-rich secretory proteins (CRiSPs), and (4) the high hematological 
subscores of C. atrox and C. ruber bites corresponded to high levels of metalloproteases in 
the venom. 
The number of cases showing symptoms consistent with venom-induced flaccid 
paralysis and muscle fasciculations/myokymia for each rattlesnake species is shown in 
Table 1. Fisher exact tests showed significant differences among species for both flaccid 
paralysis (P = 0.022) and fasciculations/myokymia (P < 0.001). Envenomations from only 
two taxa showed symptoms indicative of flaccid paralysis. These were C. scutulatus and 
C. o. helleri, with 21.4% and 3.2% of cases showing these symptoms, respectively. 
Fasciculations/myokymia were documented in four taxa, with C. o. helleri having the 
highest proportion of cases exhibiting these symptoms (45.3%).  Other taxa showing 
fasciculations/myokymia were C. scutulatus (14.3%), C. ruber (9.5%), and C. mitchellii 
pyrrhus (8.3%).  
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Table 1. Envenomation cases showing either flaccid paralysis or fasciculations/myokymia 
by envenoming rattlesnake species in southern California 
Note: We cannot verify that all cases showing these symptoms were caused by the effects 
of the venom 
 
 
Discussion 
Rattlesnake venoms contain a variety of protein-based toxins, and these can vary 
substantially among and within different taxa. Chromatograms from this preliminary 
analysis represent the first proteomic assessment for a number of species examined (C. 
cerastes, C. o. oreganus, C. mitchellii, C. ruber), and confirm the substantial differences 
in venom composition among southern California rattlesnake taxa. Although geographic 
venom composition has been documented in several of the remaining taxa (C. scutulatus: 
Massey et al., 2012; C. o. helleri: Gren, 2015), our ongoing analyses of additional venom 
samples from each taxon suggest that the chromatograms portrayed in Fig. 2 are largely 
representative for southern California specimens. Whereas previous studies showed that 
the overall severity of rattlesnake envenomation does not differ among southern 
California rattlesnake species (Janes et al. 2010; Chapter 3), this study revealed 
Rattlesnake Species Total Cases 
Flaccid Paralysis 
(%) 
Fasciculations 
(%) 
Mohave Rattlesnake  28 6  (21.4) 4 (14.3) 
Northern Pacific Rattlesnake 7 0 (0) 0 (0) 
Red Diamond Rattlesnake 21 0 (0) 2 (9.5) 
Sidewinder Rattlesnake 32 0 (0) 0 (0) 
Southern Pacific Rattlesnake 95 3 (3.2) 43 (45.3) 
Speckled Rattlesnake 12 0 (0) 1 (8.3) 
Western Diamondback 
Rattlesnake 
9 0 (0) 0 (0) 
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significant differences in envenomation symptomology among these species, which we 
can attribute, in part, to venom composition differences.  
Correspondence of Venom Composition and Clinical Symptoms 
Perhaps the most surprising finding of the study was the high level of symptoms 
heretofore attributed largely to neurotoxicity (Ranawaka et al. 2013) that accompanied 
bites from C. o. helleri. Indeed, the neurological subscores of C.o. helleri exceeded those 
of C. scutulatus. This difference was unexpected because the only documented 
presynaptic neurotoxin within the genus, Mojave toxin and its homologues (Werman 
2008), is believed to be present throughout the range of C. scutulatus in California, but 
only in one small portion of the range of C. o. helleri (the San Jacinto Mountains; French 
et al. 2004; Gren 2015). Most of the bites from C. o. helleri in this study were from 
regions lacking this neurotoxin. The high neurological subscores resulted because of the 
high frequency of fasciculations/myokymia, which are scored as neurotoxicity in the 
original SSS rubric (Dart et al. 1996). Fasciculations/myokymia occurred in 45.3% of all 
bites by this taxon, and were associated with the relatively high proportion of small basic 
myotoxins in the venom. Heretofore, the toxins that cause fasciculations/myokymia in 
rattlesnake bites have not been clearly identified (Vohra et al. 2008), though Ranawaka et 
al. (2013) suggested the involvement of crotamine, which occurs among the small basic 
myotoxins present in C. o. helleri venom (Sunagar et al. 2014; Gren 2015; see also 
Salazar et al. 2009). Our study strongly implicates a role for myotoxins in causing these 
symptoms. Although some of these myotoxins may also be neurotoxins (Gren 2015), the 
myotoxins may be causing fasciculations/myokymia independent of neurotoxicity.  
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The low level of overtly neurotoxic symptoms documented for C. scutulatus was 
also surprising (only 21.4% of cases). Mojave toxin is absent from the venom of C. 
scutulatus from south-central Arizona (Massey et al. 2012), but occurs in the venom 
elsewhere within the species’ range, including southern California (Ho & Lee 1981; 
Glenn & Straight 1989). Accordingly, previous literature characterizes the envenomation 
symptomology associated with C. scutulatus as largely neurotoxic symptoms such as 
paresthesia of the face and limbs, respiratory arrest, lethargy, diplopia, ataxia, seizures, 
and altered consciousness though edema, ecchymosis, and pain, with rhabdomyolysis, 
myoglobinuria, and renal failure also documented (Jansen et al. 1992; Farstad et al. 
1997). However, our analyses portray a more distinct envenomation syndrome for 
specimens possessing Mojave toxin that is largely lacking from the literature, with 
unremarkable neurotoxic symptoms as scored by SSS, relatively severe pulmonary, 
cardiovascular, and gastrointestinal symptoms, and relatively mild local wound and 
hematological symptoms compared to other rattlesnake taxa. The low levels of 
neurotoxic symptoms documented in our study may simply be the result of clinicians 
failing to detect or document the neurotoxic effects of Mojave toxin. While clinicians are 
likely to detect extreme neurotoxic symptoms associated with severe envenomations from 
this species, the effects of this toxin in moderate or mild envenomations may be less 
obvious, especially in patients lying relatively motionless in hospital beds. In prior 
studies, Farstad et al. (1997) detected neurotoxic symptoms in 69.2% of 13 presumed C. 
scutulatus bites in California, whereas Massey et al. (2012) reported neurotoxicity in only 
9.3% of 75 bites from C. scutulatus in a region of Arizona where they possess Mojave 
toxin. The fact we detected more severe pulmonary and cardiac symptoms in C. 
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scutulatus envenomations is consistent with the neurotoxic effects of Mojave toxin, as 
partial paralysis of the diaphragm would be expected to cause shallow, rapid respirations 
and tachycardia. 
Minimal and even delayed local tissue injury from C. scutulatus specimens 
having Mojave toxin have been noted previously (Russell 1969; Glenn et al. 1983; 
Wingert & Chan 1988), which could lead to under-treatment with antivenom (Jansen et 
al. 1992). Current treatment recommendations and algorithms for rattlesnake bite require 
monitoring of local wound effects—notably swelling—and blood abnormalities for 
dosing decisions regarding antivenom (Lavonas et al. 2011). Our results confirm the need 
for practitioners to recognize the very distinct envenomation syndrome of bites resulting 
from venoms having Mojave toxin or its homologues, as failure to recognize the 
symptoms of severe envenomation could lead to under-treatment. 
The relatively high hematological subscores of C. atrox and C. ruber can be 
attributed to the high metalloproteinase content of their venoms (Fig. 2; see also Calvete 
et al. 2009). Snake venom metalloproteinases (SVMPs) have well-documented 
hemorrhagic activities that disrupt cardiovascular function and impair hemostasis 
(Takeda et al., 2012; Markland and Swensen, 2013; Casewell et al., 2015). These two 
taxa appear to have the highest proportions of SVMPs present in the venoms of the seven 
snake taxa we examined. The strong correspondence between SVMP presence and 
bleeding abnormalities suggests a major role of SVMPs in hemostasis disruption of 
human snakebite victims. 
Our results largely fit the trend seen in rattlesnakes (genus Sistrurus and Crotalus) 
wherein venoms are either highly coagulopathic and tissue destructive, and have lower 
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overall toxicity (type I venoms), or are highly toxic (often due to the presence of Mojave 
toxin or its analogs) and have less coagulopathic and tissue destructive properties (type II 
venoms; Mackessy 2008; Mackessy 2010). Consistent with Mackessy (2008), our 
analysis suggests that C. atrox, C. mitchellii, C. o. oreganus, and C. ruber have 
envenomation symptomologies that would be expected for a type I venom. 
Envenomations from C. cerastes showed substantially reduced standardized subscores 
compared southern California taxa. This probably resulted more from snake size than 
anything else, as the species averages smaller in body size than all other southern 
California rattlesnakes (Klauber 1972; Campbell & Lamar 2004). The lack of neurotoxic 
symptoms documented for this species would suggest that it has venom more consistent 
with the type I profile, which has been confirmed by Mackessy (2008).  
Our study revealed several cases where the envenoming taxon was associated 
with uncharacteristic neurotoxic symptoms. These include three cases of bites attributed 
to C. o helleri causing flaccid paralysis in areas distant from San Jacinto area, the only 
known region where snakes of this subspecies contain the Mojave toxin analog. We also 
documented fasciculations/myokymia in four cases of bites attributed to C. scutulatus, 
two cases attributed to C. ruber, and one attributed to C. mitchellii. Russell (1960) 
reported occurrences in some bites from C. atrox in southern California. While these 
cases are interesting, they must be interpreted with caution. First, while many snake 
identifications in this study were made by reputable individuals (see Chapter 3), there is 
the possibility that some of the envenoming snakes were misidentified. Second, given the 
nature of this study, we cannot say with certainty that these symptoms were caused by the 
effects of the venom. Other factors, such as alcohol use, extreme anxiety, and 
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medications administered during the course of hospital treatment, may have contributed 
to or perhaps even elicited these symptoms. However, since significant venom variation 
is already known for two southern California taxa (Massey et al. 2012; Gren 2015), these 
unusual cases could be result of such variation. The findings we report here argue for 
further study of intraspecific venom variation within rattlesnakes, as such variation can 
have significant clinical effects.  
Conclusions 
This study, which compared the clinical symptoms and venom composition of 
seven rattlesnake taxa, provides the largest and most comprehensive study to date 
attributing the clinical symptoms of snakebite to venom composition. Our results suggest 
that clinicians may be underestimating the severity of mild or moderate envenomations 
from rattlesnakes with neurotoxic (Type II) venom, as they may fail to detect the direct 
neurotoxic effects of the venom and may inappropriately base their treatment decisions 
on hematological and local wound symptoms, resulting in under-treatment. Overall, this 
study shows distinct differences in envenomation symptomology between southern 
California rattlesnake taxa which can be correlated with venom composition differences 
between species. These findings can inform the design of more effective treatment 
algorithms and antivenoms for snakebite. 
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Summary 
This report describes the fecalith-induced intestinal obstruction of a free-ranging 
red diamond rattlesnake (Crotalus ruber) and the snake's subsequent history following 
surgical removal of the fecalith. The captured snake exhibited an abnormally distended 
abdomen and an extremely hard mass, detected via palpation, near its vent. Coeliotomy 
yielded a 2.5-cm, 5-g fecalith from the large intestine. Microscopic dissection of the 
fecalith revealed no evidence of gastrointestinal parasitic worms. Subsequently, we 
implanted a radio-transmitter that allowed us to track the snake’s movements for 7 
months (until the radio signal vanished), indicating normal behavior, complete recovery, 
and good health apart from the obstruction. This observation suggests that fecalith 
development and intestinal obstruction represent potential risks of long-term fecal 
retention, an unusual physiological trait well documented among rattlesnakes and other 
stout, heavy-bodied terrestrial viperid snakes. Dehydration and decreased gut motility 
associated with brumation (≈hibernation) may predispose temperate snakes to fecalith 
formation. Regional drought and a small mammal diet with indigestible hairs might have 
also promoted fecalith formation in this specimen. 
Key words 
Brumation; Crotalinae; Fecal retention; Gastrointestinal; Serpentes; Viperidae 
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Introduction 
Gastrointestinal obstruction and subsequent abdominal distension in snakes may 
be caused by several pathological conditions, including parasitism, blockage from a 
tumor, abscess, granuloma, or foreign body, or fecal impaction (Diaz-Figueroa and 
Mitchell, 2006). Snakes presenting with such obstructions may show significant lethargy, 
emaciation, and dehydration (Souza et al., 2004; Diaz-Figueroa and Mitchell, 2006). 
Gastrointestinal obstructions have been documented in both captive and wild snakes, with 
most wild examples involving black ratsnakes (Pantherophis spp., formerly Elaphe 
obsoleta) invading chicken coups and ingesting objects they mistake as eggs (e.g. Smith, 
1953; Adams and Sleeman, 2005). Conventional wisdom dictates surgical removal of the 
obstructing object from the gastrointestinal tract to preserve the snake’s life. 
In this paper, we describe the first reported case of such an obstruction, caused by 
an impacted fecalith, in a large-bodied terrestrial pitviper (Serpentes: Viperidae: 
Crotalinae): a red diamond rattlesnake (Crotalus ruber). This species, attaining a length 
of up 1200 mm snout-vent length, occupies Mediterranean and xeric habitats from 
southern California, USA, south to the tip of the Baja Peninsula of Mexico, including 
several Pacific and Gulf of California islands (Beaman and Dugan, 2006). As a relatively 
sedentary species that frequently employs ambush tactics, all age groups feed largely on 
rodents and small mammals, with occasional lizards and birds also consumed (Brown et 
al., 2008; Dugan et al., 2008; Dugan and Hayes, 2012). The intestinal obstruction in this 
case report is particularly unusual in that it involved a wild-caught snake showing no 
evidence of gastroinstestinal parasite infection. 
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Case Report 
As part of an ongoing radio-telemetry study of red diamond rattlesnakes in Loma 
Linda, California, USA, we collected an adult female rattlesnake (102 cm snout-vent 
length, 750 g) on 13 April 2010 at 1053 hr. A telemetered male snake was courting the 
female by chin-rubbing on the female’s dorsum (Hayes, 1986) prior to her capture. Both 
specimens were observed exposed on a grass-covered, northwest-facing slope near a 
clump of California buckwheat (Eriogonum fasciculatum).  
We brought the female into the laboratory for examination and transmitter 
implantation. Upon initial examination, palpation of the animal revealed an extremely 
hard mass about 10 cm anterior to the vent.  The area anterior to the hard mass appeared 
swollen and abnormally distended, suggesting a possible bowel obstruction. Concerned 
about the snake's health, we kept the specimen in the laboratory at 23°C in a 50.8 × 27.9 
× 33.0 cm (L × D × H) glass terrarium with newspaper substrate, ambient (low) humidity 
(due to a screen lid), an electrical heating pad adhered to a portion of the bottom, and no 
food. The snake’s failure to defecate after 1 week prompted us to surgically remove the 
potentially obstructing object on 21 April. 
The surgical procedure largely followed previously published surgical transmitter 
implantation methods (Reinert and Cundall, 1982; Hardy and Greene, 1999; Hardy and 
Greene, 2000). We anesthetized the snake by restraining it within a clear plastic tube 
(Midwest Tongs, Independence, MO, USA) and injecting 3 mL sevoflurane (SevoFlo, 
Abbott Laboratories, North Chicago, IL, USA) into a gauze plug at the distally sealed end 
of the tube. Once the snake reached the surgical plane of anesthesia, we placed it in a 
right lateral recumbent position and made a ca. 4-cm longitudinal incision between scales 
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2 and 3 on the left side of the snake and over the obstructing object. We gained access to 
the peritoneal space and intestine via an incision through the ventral abdominal muscles 
immediately ventral to the costal cartilage. The intestine appeared normal with no signs 
of inflammation or necrosis. A 1-cm incision in the large intestine allowed us to remove a 
solid fecalith measuring 2.5 × 2.0 × 2.0 cm and weighing 5 g . We closed the intestine 
with synthetic absorbable suture (Vicryl, Ethicon, Somerville, NJ, USA) in a simple 
continuous pattern. We then lavaged the peritoneal space with chlorhexadine solution 
(Phoenix Pharmaceutical Inc., St. Joseph, MO, USA) and packed it with nitrofurazone 
ointment (Fura-Zone, Squire Laboratories Inc., Revere, MA, USA) prior to closing the 
skin with Vicryl absorbable suture using an interrupted horizontal mattress pattern. We 
returned the snake to its terrarium with the electrical heating pad, and noted an uneventful 
recovery.  
We dissected the fecalith and thoroughly examined it microscopically for 
evidence of an exceptional load of parasites, which has been documented previously as a 
cause for impaction in reptiles (Kane et al., 1976; de la Navarre, 2002; Diaz-Figueroa and 
Mitchell, 2006). We found no evidence of nematodes, other parasitic worms, or eggs in 
the fecal material. Composition of the fecalith comprised primarily indigestible matter, 
such as hair from small mammal prey and other unidentified material which may have 
included vegetable matter from the gut of its prey. As the snake appeared to be healthy, 
we did not assess other health parameters. 
We held the snake in the laboratory without food until normal defecation 
indicated restored bowel function and healing sufficient for transmitter implantation and 
release to the wild. The snake produced a normal fecal bolus devoid of blood on 10 May, 
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which was 19 days after the surgery. At this point, we surgically implanted a transmitter 
(Reinert and Cundall, 1982; Hardy and Greene, 1999; Hardy and Greene, 2000). Methods 
for anesthesia, access to the peritoneal space, and skin closure were identical to the 
previous surgery except that the snake was placed in right lateral recumbency and a 3-cm 
incision was made approximately 70 cm (two-thirds the length of the snake) from the 
head on the right side of the snake. We chose the incision site in part to avoid negatively 
impacting the prior surgical wound. This second surgery was uneventful and the snake 
recovered without complications. We released the snake near the site of capture the 
following morning (11 May). 
Subsequent to release, we tracked the snake’s movements via radio-telemetry for 
seven months. We obtained 45 location fixes during this period, with no abnormal 
movement patterns detected (c.f. Brown et al., 2008; Dugan et al., 2008). On 28 June, we 
observed a large intact shed skin extending out of a burrow occupied by the snake, 
suggesting she was shedding normally. The last location fix was obtained on 1 December 
2010. Subsequent attempts to obtain a location fix failed because we were unable to 
detect a signal from the transmitter. The most likely explanation for this was transmitter 
failure, though a predation event could have moved the transmitter beyond detection 
range. 
Discussion 
Few reports exist of gastrointestinal blockage in snakes. Most literature records 
involve foreign body obstructions in the gastrointestinal tracts of the black ratsnake 
(Smith, 1953; Jacobson et al., 1980; Zwart et al., 1986; Souza et al., 2004; Adams and 
Sleeman, 2005), though partial obstruction due to cancerous tumor was reported in a 
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cornsnake (Pantherophis guttatus, formerly Elaphe guttata; Latimer and Rich, 1998), and 
an obstruction potentially caused by a fecalith was reported in a gopher snake (Pituophis 
melanolucus; Jessup, 1980). Outside the literature, a case of apparent fecalith-induced 
gastrointestional obstruction was reported in a Burmese python (Python molurus 
bivittatus) at the Long Beach Animal Hospital website (Long Beach Animal Hospital, 
undated).  
Considering the hardened nature of the obstruction and its large size, we believe 
the snake would not have survived without surgical intervention. We caught the 
obstruction early, as there was no evidence of body dehydration or emaciation, symptoms 
typical of other snake intestinal obstruction cases in the literature. Survival of the snake 
for at least seven months (until presumed transmitter failure) while exhibiting normal 
behaviors (c.f. Brown et al., 2008; Dugan et al., 2008) suggests that the snake was 
healthy.   
Stout, heavy-bodied terrestrial vipers have a normal propensity to accumulate 
fecal material for many months, in some cases exceeding more than a year (Lillywhite et 
al., 2002). Fecal retention is more protracted with larger body size and infrequent meals 
(Lillywhite et al., 2002), which are characteristics of C. ruber (Dugan and Hayes, 2012). 
Lillywhite et al. (2002) suggested that fecal retention helps anchor the posterior body to 
facilitate extension and acceleration of the forebody during a strike, and anchoring the 
body after capture of a large prey item (the adaptive ballast hypothesis). Arboreal vipers, 
in contrast, retain fecal material for only days or weeks following a meal, ostensibly to 
shorten the duration of overloading their bodies during locomotion and to decrease the 
energy expenditure required to counteract gravity (Lillywhite et al., 2002; Tsai et al., 
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2008). Regardless of the adaptive value of long-term fecal retention (if any), our 
observation suggests that it may pose an overlooked risk of fecalith development and 
intestinal obstruction in stout, heavy-bodied terrestrial vipers. 
 In this case, the snake was captured during spring mating season, which 
immediately followed winter brumation (≈hibernation). Low temperatures reduce 
gastrointestinal motility in reptiles (Naulleau, 1983; Diaz-Figueroa and Mitchell, 2006), 
and snakes during brumation may experience substantial water loss (Costanzo, 1989). 
These factors may place temperate snakes at greater risk for fecalith development and 
gastrointestinal obstruction than tropical snakes. Drought, which has plagued the 
southwestern United States (including our study site) in the recent decade, and is 
projected to feature prominently in the next century (MacDonald, 2010), may exacerbate 
the risk of fecalith development if it negatively affects the snake's hydration state. A diet 
composed largely of small mammals with indigestible hairs that accumulate in the feces 
(Dugan and Hayes, 2012) may also predispose fecalith development. We suggest that 
field researchers pay more attention to the frequency of palpable fecaliths in free-ranging 
snakes, especially with regard to taxonomic, climate, seasonal, and dietary variables. 
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Figure 1. Hardened fecalith and the posterior end of the wild, female red diamond 
rattlesnake (Crotalus ruber) it was removed from. Arrow shows the position of the fecalith 
prior to its removal. Photograph taken immediately after closure of the surgical incision 
and just before the snake was placed in a heated terrarium for recovery.  
 
